BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Sherr CJ. Cancer cell cycles. Science. 1996;274:1672-1677. [PMID: 8939849 DOI: 10.1126/science.274.5293.1672] [Cited by in Crossref: 3667] [Cited by in F6Publishing: 3563] [Article Influence: 146.7] [Reference Citation Analysis]
Number Citing Articles
1 Singh A, Singh N, Behera D, Sharma S. XRCC1 632 as a candidate for cancer predisposition via a complex interaction with genetic variants of base excision repair and double strand break repair genes. Future Oncology 2019;15:3845-59. [DOI: 10.2217/fon-2019-0297] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
2 Gjoerup O, Lukas J, Bartek J, Willumsen BM. Rac and Cdc42 are potent stimulators of E2F-dependent transcription capable of promoting retinoblastoma susceptibility gene product hyperphosphorylation. J Biol Chem 1998;273:18812-8. [PMID: 9668055 DOI: 10.1074/jbc.273.30.18812] [Cited by in Crossref: 57] [Cited by in F6Publishing: 58] [Article Influence: 2.4] [Reference Citation Analysis]
3 Phuphanich S, Supko JG, Carson KA, Grossman SA, Burt Nabors L, Mikkelsen T, Lesser G, Rosenfeld S, Desideri S, Olson JJ. Phase 1 clinical trial of bortezomib in adults with recurrent malignant glioma. J Neurooncol 2010;100:95-103. [PMID: 20213332 DOI: 10.1007/s11060-010-0143-7] [Cited by in Crossref: 56] [Cited by in F6Publishing: 51] [Article Influence: 4.7] [Reference Citation Analysis]
4 Chen XS, Wang KS, Guo W, Li LY, Yu P, Sun XY, Wang HY, Guan YD, Tao YG, Ding BN, Yin MZ, Ren XC, Zhang Y, Chen CS, Ye YC, Yang JM, Cheng Y. UCH-L1-mediated Down-regulation of Estrogen Receptor α Contributes to Insensitivity to Endocrine Therapy for Breast Cancer. Theranostics 2020;10:1833-48. [PMID: 32042339 DOI: 10.7150/thno.39814] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 1.5] [Reference Citation Analysis]
5 Li Z, Li J, Mo B, Hu C, Liu H, Qi H, Wang X, Xu J. Genistein induces G2/M cell cycle arrest via stable activation of ERK1/2 pathway in MDA-MB-231 breast cancer cells. Cell Biol Toxicol 2008;24:401-9. [DOI: 10.1007/s10565-008-9054-1] [Cited by in Crossref: 42] [Cited by in F6Publishing: 39] [Article Influence: 3.0] [Reference Citation Analysis]
6 Wong S, McLaughlin J, Cheng D, Zhang C, Shokat KM, Witte ON. Sole BCR-ABL inhibition is insufficient to eliminate all myeloproliferative disorder cell populations. Proc Natl Acad Sci U S A 2004;101:17456-61. [PMID: 15505216 DOI: 10.1073/pnas.0407061101] [Cited by in Crossref: 55] [Cited by in F6Publishing: 49] [Article Influence: 3.1] [Reference Citation Analysis]
7 Potesil D, Mikelova R, Adam V, Kizek R, Prusa R. Change of the Protein p53 Electrochemical Signal According to its Structural Form – Quick and Sensitive Distinguishing of Native, Denatured, and Aggregated Form of the “Guardian of the Genome”. Protein J 2006;25:23-32. [DOI: 10.1007/s10930-006-0014-4] [Cited by in Crossref: 27] [Cited by in F6Publishing: 21] [Article Influence: 1.7] [Reference Citation Analysis]
8 Yoshinaga Y, Kagawa T, Shimizu T, Inoue T, Takada S, Kuratsu J, Taga T. Wnt3a Promotes Hippocampal Neurogenesis by Shortening Cell Cycle Duration of Neural Progenitor Cells. Cell Mol Neurobiol 2010;30:1049-58. [DOI: 10.1007/s10571-010-9536-6] [Cited by in Crossref: 22] [Cited by in F6Publishing: 24] [Article Influence: 1.8] [Reference Citation Analysis]
9 Chisholm JA, Mayne GC, Hussey DJ, Watson DI. Molecular biomarkers and ablative therapies for Barrett's esophagus. Expert Rev Gastroenterol Hepatol 2012;6:567-81. [PMID: 23061708 DOI: 10.1586/egh.12.39] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
10 Ishikawa H, Goto M, Matsuura N, Murakami Y, Goto C, Sakai T, Kanazawa K. A Pilot, Randomized, Placebo-Controlled, Double-Blind Phase 0/Biomarker Study on Effect of Artepillin C–Rich Extract of Brazilian Propolis in Frequent Colorectal Adenoma Polyp Patients. Journal of the American College of Nutrition 2012;31:327-37. [DOI: 10.1080/07315724.2012.10720434] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 1.0] [Reference Citation Analysis]
11 Liu J, Dermatakis A, Lukacs C, Konzelmann F, Chen Y, Kammlott U, Depinto W, Yang H, Yin X, Chen Y, Schutt A, Simcox ME, Luk K. 3,5,6-Trisubstituted naphthostyrils as CDK2 inhibitors. Bioorganic & Medicinal Chemistry Letters 2003;13:2465-8. [DOI: 10.1016/s0960-894x(03)00488-8] [Cited by in Crossref: 26] [Cited by in F6Publishing: 2] [Article Influence: 1.4] [Reference Citation Analysis]
12 Poirier F, Pontet M, Labas V, le Caer JP, Sghiouar-Imam N, Raphael M, Caron M, Joubert-Caron R. Two-dimensional database of a Burkitt lymphoma cell line (DG 75) proteins: protein pattern changes following treatment with 5'-azycytidine. Electrophoresis. 2001;22:1867-1877. [PMID: 11425244 DOI: 10.1002/1522-2683(200105)22:9%3C1867::AID-ELPS1867%3E3.0.CO;2-7] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
13 Yue H, Na YL, Feng XL, Ma SR, Song FL, Yang B. Expression of p57kip2, Rb protein and PCNA and their relationships with clinicopathology in human pancreatic cancer. World J Gastroenterol 2003; 9(2): 377-380 [PMID: 12532471 DOI: 10.3748/wjg.v9.i2.377] [Cited by in CrossRef: 13] [Cited by in F6Publishing: 11] [Article Influence: 0.7] [Reference Citation Analysis]
14 Zhang JC, Gao B, Yu ZT, Liu XB, Lu J, Xie F, Luo HJ, Li HP. Promoter hypermethylation of p14 (ARF) , RB, and INK4 gene family in hepatocellular carcinoma with hepatitis B virus infection. Tumour Biol 2014;35:2795-802. [PMID: 24254306 DOI: 10.1007/s13277-013-1372-0] [Cited by in Crossref: 21] [Cited by in F6Publishing: 17] [Article Influence: 2.3] [Reference Citation Analysis]
15 Mousavi A, Sabouri A, Hassanzadeh Eskafi A, Alirahimi E, Kazemi-Lomedasht F, Ghaderi H, Behdani M. In Vivo Tumor Therapy with Novel Immunotoxin Containing Programmed Cell Death Protein-1 and Diphtheria Toxin. Monoclon Antib Immunodiagn Immunother 2021;40:113-7. [PMID: 34076502 DOI: 10.1089/mab.2020.0043] [Reference Citation Analysis]
16 Rho SB, Park YG, Park K, Lee SH, Lee JH. A novel cervical cancer suppressor 3 (CCS-3) interacts with the BTB domain of PLZF and inhibits the cell growth by inducing apoptosis. FEBS Lett 2006;580:4073-80. [PMID: 16828757 DOI: 10.1016/j.febslet.2006.06.047] [Cited by in Crossref: 21] [Cited by in F6Publishing: 19] [Article Influence: 1.3] [Reference Citation Analysis]
17 Van Sant C, Lopez P, Advani SJ, Roizman B. Role of cyclin D3 in the biology of herpes simplex virus 1 ICPO. J Virol. 2001;75:1888-1898. [PMID: 11160688 DOI: 10.1128/jvi.75.4.1888-1898.2001] [Cited by in Crossref: 39] [Cited by in F6Publishing: 32] [Article Influence: 1.9] [Reference Citation Analysis]
18 Skildum A, Faivre E, Lange CA. Progesterone receptors induce cell cycle progression via activation of mitogen-activated protein kinases. Mol Endocrinol 2005;19:327-39. [PMID: 15486045 DOI: 10.1210/me.2004-0306] [Cited by in Crossref: 94] [Cited by in F6Publishing: 88] [Article Influence: 5.2] [Reference Citation Analysis]
19 Scurr LL, Haferkamp S, Rizos H. The Role of Sumoylation in Senescence. Adv Exp Med Biol 2017;963:215-26. [PMID: 28197915 DOI: 10.1007/978-3-319-50044-7_13] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
20 Qian XL, Li YQ, Yu B, Gu F, Liu FF, Li WD, Zhang XM, Fu L. Syndecan binding protein (SDCBP) is overexpressed in estrogen receptor negative breast cancers, and is a potential promoter for tumor proliferation. PLoS One 2013;8:e60046. [PMID: 23533663 DOI: 10.1371/journal.pone.0060046] [Cited by in Crossref: 33] [Cited by in F6Publishing: 33] [Article Influence: 3.7] [Reference Citation Analysis]
21 Harbour J, Luo RX, Santi AD, Postigo AA, Dean DC. Cdk Phosphorylation Triggers Sequential Intramolecular Interactions that Progressively Block Rb Functions as Cells Move through G1. Cell 1999;98:859-69. [DOI: 10.1016/s0092-8674(00)81519-6] [Cited by in Crossref: 646] [Cited by in F6Publishing: 324] [Article Influence: 28.1] [Reference Citation Analysis]
22 Guo M, Hay BA. Cell proliferation and apoptosis. Curr Opin Cell Biol 1999;11:745-52. [PMID: 10600713 DOI: 10.1016/s0955-0674(99)00046-0] [Cited by in Crossref: 123] [Cited by in F6Publishing: 34] [Article Influence: 5.6] [Reference Citation Analysis]
23 Litofsky NS, Recht LD. The impact of p53 tumor suppressor gene on glioma biology. Neurosurg Focus 1997;3:e4. [PMID: 15104416 DOI: 10.3171/foc.1997.3.3.7] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.2] [Reference Citation Analysis]
24 Dei Tos AP, Doglioni C, Piccinin S, Sciot R, Furlanetto A, Boiocchi M, Dal Cin P, Maestro R, Fletcher CDM, Tallini G. Coordinated expression and amplification of theMDM2,CDK4, andHMGI-C genes in atypical lipomatous tumours. J Pathol 2000;190:531-6. [DOI: 10.1002/(sici)1096-9896(200004)190:5<531::aid-path579>3.0.co;2-w] [Cited by in Crossref: 199] [Cited by in F6Publishing: 64] [Article Influence: 9.0] [Reference Citation Analysis]
25 Li Z, Liu W, Mo B, Hu C, Liu H, Qi H, Wang X, Xu J. Caffeine Overcomes Genistein-Induced G2/M Cell Cycle Arrest in Breast Cancer Cells. Nutrition and Cancer 2008;60:382-8. [DOI: 10.1080/01635580701861785] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.4] [Reference Citation Analysis]
26 Mitra AK, Gangahar DM, Agrawal DK. Cellular, molecular and immunological mechanisms in the pathophysiology of vein graft intimal hyperplasia. Immunol Cell Biol 2006;84:115-24. [PMID: 16519729 DOI: 10.1111/j.1440-1711.2005.01407.x] [Cited by in Crossref: 107] [Cited by in F6Publishing: 98] [Article Influence: 6.7] [Reference Citation Analysis]
27 Lents NH, Keenan SM, Bellone C, Baldassare JJ. Stimulation of the Raf/MEK/ERK cascade is necessary and sufficient for activation and Thr-160 phosphorylation of a nuclear-targeted CDK2. J Biol Chem 2002;277:47469-75. [PMID: 12359725 DOI: 10.1074/jbc.M207425200] [Cited by in Crossref: 52] [Cited by in F6Publishing: 27] [Article Influence: 2.6] [Reference Citation Analysis]
28 Russo GL, Della Pietra V, Mercurio C, Palumbo R, Iacomino G, Russo M, Tosto M, Zappia V. Protective Effects of Butyric Acid in Colon Cancer. In: Zappia V, Della Ragione F, Barbarisi A, Russo GL, Iacovo RD, editors. Advances in Nutrition and Cancer 2. Boston: Springer US; 1999. pp. 131-47. [DOI: 10.1007/978-1-4757-3230-6_12] [Cited by in Crossref: 14] [Cited by in F6Publishing: 12] [Article Influence: 0.6] [Reference Citation Analysis]
29 Hulit J, Bash T, Fu M, Galbiati F, Albanese C, Sage DR, Schlegel A, Zhurinsky J, Shtutman M, Ben-Ze'ev A, Lisanti MP, Pestell RG. The cyclin D1 gene is transcriptionally repressed by caveolin-1. J Biol Chem 2000;275:21203-9. [PMID: 10747899 DOI: 10.1074/jbc.M000321200] [Cited by in Crossref: 104] [Cited by in F6Publishing: 48] [Article Influence: 4.7] [Reference Citation Analysis]
30 Catanzaro D, Ragazzi E, Vianello C, Caparrotta L, Montopoli M. Effect of Quercetin on Cell Cycle and Cyclin Expression in Ovarian Carcinoma and Osteosarcoma Cell Lines. Natural Product Communications 2015;10:1934578X1501000. [DOI: 10.1177/1934578x1501000813] [Cited by in Crossref: 11] [Article Influence: 1.6] [Reference Citation Analysis]
31 Moon SK, Kim HM, Kim CH. PTEN induces G1 cell cycle arrest and inhibits MMP-9 expression via the regulation of NF-kappaB and AP-1 in vascular smooth muscle cells. Arch Biochem Biophys. 2004;421:267-276. [PMID: 14984207 DOI: 10.1016/j.abb.2003.11.007] [Cited by in Crossref: 43] [Cited by in F6Publishing: 47] [Article Influence: 2.4] [Reference Citation Analysis]
32 Li GZ, Eller MS, Hanna K, Gilchrest BA. Signaling pathway requirements for induction of senescence by telomere homolog oligonucleotides. Exp Cell Res 2004;301:189-200. [PMID: 15530855 DOI: 10.1016/j.yexcr.2004.08.019] [Cited by in Crossref: 38] [Cited by in F6Publishing: 42] [Article Influence: 2.2] [Reference Citation Analysis]
33 Tringler B, Grimm C, Dudek G, Zeillinger R, Tempfer C, Speiser P, Joura E, Reinthaller A, Hefler LA. p16INK4a Expression in Invasive Vulvar Squamous Cell Carcinoma. Applied Immunohistochemistry & Molecular Morphology 2007;15:279-83. [DOI: 10.1097/01.pai.0000213118.81343.32] [Cited by in Crossref: 25] [Cited by in F6Publishing: 21] [Article Influence: 1.7] [Reference Citation Analysis]
34 Fernàndez V, Hartmann E, Ott G, Campo E, Rosenwald A. Pathogenesis of mantle-cell lymphoma: all oncogenic roads lead to dysregulation of cell cycle and DNA damage response pathways. J Clin Oncol. 2005;23:6364-6369. [PMID: 16155021 DOI: 10.1200/jco.2005.05.019] [Cited by in Crossref: 137] [Cited by in F6Publishing: 45] [Article Influence: 8.1] [Reference Citation Analysis]
35 Lam TL, Wong GK, Chong HC, Cheng PN, Choi SC, Chow TL, Kwok SY, Poon RT, Wheatley DN, Lo WH, Leung YC. Recombinant human arginase inhibits proliferation of human hepatocellular carcinoma by inducing cell cycle arrest. Cancer Lett. 2009;277:91-100. [PMID: 19138817 DOI: 10.1016/j.canlet.2008.11.031] [Cited by in Crossref: 55] [Cited by in F6Publishing: 57] [Article Influence: 4.2] [Reference Citation Analysis]
36 Koehler L, Graf F, Bergmann R, Steinbach J, Pietzsch J, Wuest F. Radiosynthesis and radiopharmacological evaluation of cyclin-dependent kinase 4 (Cdk4) inhibitors. Eur J Med Chem 2010;45:727-37. [PMID: 19954867 DOI: 10.1016/j.ejmech.2009.11.020] [Cited by in Crossref: 16] [Cited by in F6Publishing: 14] [Article Influence: 1.2] [Reference Citation Analysis]
37 Kalma Y, Marash L, Lamed Y, Ginsberg D. Expression analysis using DNA microarrays demonstrates that E2F-1 up-regulates expression of DNA replication genes including replication protein A2. Oncogene 2001;20:1379-87. [PMID: 11313881 DOI: 10.1038/sj.onc.1204230] [Cited by in Crossref: 44] [Cited by in F6Publishing: 50] [Article Influence: 2.1] [Reference Citation Analysis]
38 Natarajan E, Saeb M, Crum CP, Woo SB, McKee PH, Rheinwald JG. Co-expression of p16(INK4A) and laminin 5 gamma2 by microinvasive and superficial squamous cell carcinomas in vivo and by migrating wound and senescent keratinocytes in culture. Am J Pathol 2003;163:477-91. [PMID: 12875969 DOI: 10.1016/s0002-9440(10)63677-2] [Cited by in Crossref: 79] [Cited by in F6Publishing: 23] [Article Influence: 4.2] [Reference Citation Analysis]
39 Jones SM, Kazlauskas A. Growth factor-dependent signaling and cell cycle progression. FEBS Letters 2001;490:110-6. [DOI: 10.1016/s0014-5793(01)02113-5] [Cited by in Crossref: 73] [Cited by in F6Publishing: 15] [Article Influence: 3.5] [Reference Citation Analysis]
40 Cho HJ, Kim EJ, Lim SS, Kim MK, Sung M, Kim J, Park JHY. Trans-10,cis-12, Not cis-9,trans-11, Conjugated Linoleic Acid Inhibits G1-S Progression in HT-29 Human Colon Cancer Cells. The Journal of Nutrition 2006;136:893-8. [DOI: 10.1093/jn/136.4.893] [Cited by in Crossref: 45] [Cited by in F6Publishing: 41] [Article Influence: 2.8] [Reference Citation Analysis]
41 Shimada H, Liu TL, Ochiai T, Shimizu T, Haupt Y, Hamada H, Abe T, Oka M, Takiguchi M, Hiwasa T. Facilitation of adenoviral wild-type p53-induced apoptotic cell death by overexpression of p33(ING1) in T.Tn human esophageal carcinoma cells. Oncogene 2002;21:1208-16. [PMID: 11850840 DOI: 10.1038/sj.onc.1205176] [Cited by in Crossref: 28] [Cited by in F6Publishing: 30] [Article Influence: 1.4] [Reference Citation Analysis]
42 Scodelaro Bilbao P, Boland R. Extracellular ATP regulates FoxO family of transcription factors and cell cycle progression through PI3K/Akt in MCF-7 cells. Biochim Biophys Acta 2013;1830:4456-69. [PMID: 23742826 DOI: 10.1016/j.bbagen.2013.05.034] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 1.1] [Reference Citation Analysis]
43 Wang Q, Hirohashi Y, Furuuchi K, Zhao H, Liu Q, Zhang H, Murali R, Berezov A, Du X, Li B, Greene MI. The Centrosome in Normal and Transformed Cells. DNA and Cell Biology 2004;23:475-89. [DOI: 10.1089/1044549041562276] [Cited by in Crossref: 44] [Cited by in F6Publishing: 38] [Article Influence: 2.4] [Reference Citation Analysis]
44 Hashimoto O, Shinkawa M, Torimura T, Nakamura T, Selvendiran K, Sakamoto M, Koga H, Ueno T, Sata M. Cell cycle regulation by the Wee1 inhibitor PD0166285, pyrido [2,3-d] pyimidine, in the B16 mouse melanoma cell line. BMC Cancer 2006;6:292. [PMID: 17177986 DOI: 10.1186/1471-2407-6-292] [Cited by in Crossref: 50] [Cited by in F6Publishing: 47] [Article Influence: 3.1] [Reference Citation Analysis]
45 Gressani KM, Leone-Kabler S, O'Sullivan MG, Case LD, Malkinson AM, Miller MS. Strain-dependent lung tumor formation in mice transplacentally exposed to 3-methylcholanthrene and post-natally exposed to butylated hydroxytoluene. Carcinogenesis 1999;20:2159-65. [PMID: 10545420 DOI: 10.1093/carcin/20.11.2159] [Cited by in Crossref: 24] [Cited by in F6Publishing: 25] [Article Influence: 1.1] [Reference Citation Analysis]
46 Rizos H, Darmanian AP, Holland EA, Mann GJ, Kefford RF. Mutations in the INK4a/ARF Melanoma Susceptibility Locus Functionally Impair p14ARF. Journal of Biological Chemistry 2001;276:41424-34. [DOI: 10.1074/jbc.m105299200] [Cited by in Crossref: 78] [Cited by in F6Publishing: 22] [Article Influence: 3.7] [Reference Citation Analysis]
47 Hosokawa Y, Papanikolaou A, Cardiff RD, Yoshimoto K, Bernstein M, Wang TC, Schmidt EV, Arnold A. In vivo analysis of mammary and non-mammary tumorigenesis in MMTV-cyclin D1 transgenic mice deficient in p53. Transgenic Res 2001;10:471-8. [PMID: 11708657 DOI: 10.1023/a:1012064911751] [Cited by in Crossref: 11] [Cited by in F6Publishing: 6] [Article Influence: 0.6] [Reference Citation Analysis]
48 Sandoval R, Xue J, Pilkinton M, Salvi D, Kiyokawa H, Colamonici OR. Different requirements for the cytostatic and apoptotic effects of type I interferons. Induction of apoptosis requires ARF but not p53 in osteosarcoma cell lines. J Biol Chem 2004;279:32275-80. [PMID: 15169789 DOI: 10.1074/jbc.M313830200] [Cited by in Crossref: 35] [Cited by in F6Publishing: 19] [Article Influence: 1.9] [Reference Citation Analysis]
49 Viale G, Pellegrini C, Mazzarol G, Maisonneuve P, Silverman ML, Bosari S. p21WAF1/CIP1 expression in colorectal carcinoma correlates with advanced disease stage and p53 mutations. J Pathol 1999;187:302-7. [DOI: 10.1002/(sici)1096-9896(199902)187:3<302::aid-path243>3.0.co;2-u] [Cited by in Crossref: 35] [Cited by in F6Publishing: 10] [Article Influence: 1.5] [Reference Citation Analysis]
50 Duquesne F, Florent M, Roué G, Troussard X, Sola B. Ectopic expression of cyclin D1 impairs the proliferation and enhances the apoptosis of a murine lymphoid cell line. Cell Death Differ 2001;8:51-62. [DOI: 10.1038/sj.cdd.4400768] [Cited by in Crossref: 16] [Cited by in F6Publishing: 15] [Article Influence: 0.8] [Reference Citation Analysis]
51 Indovina P, Pentimalli F, Conti D, Giordano A. Translating RB1 predictive value in clinical cancer therapy: Are we there yet? Biochem Pharmacol 2019;166:323-34. [PMID: 31176618 DOI: 10.1016/j.bcp.2019.06.003] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
52 Liu J, Duan Z, Guo W, Zeng L, Wu Y, Chen Y, Tai F, Wang Y, Lin Y, Zhang Q, He Y, Deng J, Stewart RL, Wang C, Lin PC, Ghaffari S, Evers BM, Liu S, Zhou MM, Zhou BP, Shi J. Targeting the BRD4/FOXO3a/CDK6 axis sensitizes AKT inhibition in luminal breast cancer. Nat Commun. 2018;9:5200. [PMID: 30518851 DOI: 10.1038/s41467-018-07258-y] [Cited by in Crossref: 26] [Cited by in F6Publishing: 27] [Article Influence: 6.5] [Reference Citation Analysis]
53 Yi R, Saito K, Isegawa N, Shirasawa H. Alteration of cell cycle progression by Sindbis virus infection. Biochemical and Biophysical Research Communications 2015;462:426-32. [DOI: 10.1016/j.bbrc.2015.04.148] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.1] [Reference Citation Analysis]
54 Sladek TL. E2F transcription factor action, regulation and possible role in human cancer. Cell Proliferation 1997;30:97-105. [DOI: 10.1111/j.1365-2184.1997.tb00926.x] [Cited by in Crossref: 14] [Cited by in F6Publishing: 4] [Article Influence: 0.6] [Reference Citation Analysis]
55 Akamatsu E, Tanaka T, Kato J. Transcription Factor E2F and Cyclin E-Cdk2 Complex Cooperate to Induce Chromosomal DNA Replication in Xenopus Oocytes. Journal of Biological Chemistry 1998;273:16494-500. [DOI: 10.1074/jbc.273.26.16494] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 0.5] [Reference Citation Analysis]
56 Pertia A, Nikoleishvili D, Trsintsadze O, Gogokhia N, Managadze L, Chkhotua A. Immunoreactivity of p27(Kip1), cyclin D3, and Ki67 in conventional renal cell carcinoma. Int Urol Nephrol 2009;41:243-9. [PMID: 18679818 DOI: 10.1007/s11255-008-9442-8] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.4] [Reference Citation Analysis]
57 Matsumoto M, Furihata M, Ishikawa T, Ohtsuki Y, Ogoshi S. Comparison of deregulated expression of cyclin D1 and cyclin E with that of cyclin-dependent kinase 4 (CDK4) and CDK2 in human oesophageal squamous cell carcinoma. Br J Cancer. 1999;80:256-261. [PMID: 10390005 DOI: 10.1038/sj.bjc.6690348] [Cited by in Crossref: 18] [Cited by in F6Publishing: 20] [Article Influence: 0.8] [Reference Citation Analysis]
58 Clark W, Black EJ, MacLaren A, Kruse U, LaThangue N, Vogt PK, Gillespie DA. v-Jun overrides the mitogen dependence of S-phase entry by deregulating retinoblastoma protein phosphorylation and E2F-pocket protein interactions as a consequence of enhanced cyclin E-cdk2 catalytic activity. Mol Cell Biol 2000;20:2529-42. [PMID: 10713176 DOI: 10.1128/MCB.20.7.2529-2542.2000] [Cited by in Crossref: 16] [Cited by in F6Publishing: 11] [Article Influence: 0.7] [Reference Citation Analysis]
59 Aboushousha T, Hammam O, Helal N, El Dahshan S. Impact of Cyclin D1 and Heterogeneous Nuclear Ribonucleoprotein-K (HnRNP-K) on Urinary Bladder Carcinogenesis. Asian Pac J Cancer Prev 2018;19:513-9. [PMID: 29480994 DOI: 10.22034/APJCP.2018.19.2.513] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
60 Kotake Y, Cao R, Viatour P, Sage J, Zhang Y, Xiong Y. pRB family proteins are required for H3K27 trimethylation and Polycomb repression complexes binding to and silencing p16INK4alpha tumor suppressor gene. Genes Dev. 2007;21:49-54. [PMID: 17210787 DOI: 10.1101/gad.1499407] [Cited by in Crossref: 229] [Cited by in F6Publishing: 220] [Article Influence: 15.3] [Reference Citation Analysis]
61 Zhao J, Liang Q, Cheung KF, Kang W, Dong Y, Lung RW, Tong JH, To KF, Sung JJ, Yu J. Somatostatin receptor 1, a novel EBV-associated CpG hypermethylated gene, contributes to the pathogenesis of EBV-associated gastric cancer. Br J Cancer. 2013;108:2557-2564. [PMID: 23722468 DOI: 10.1038/bjc.2013.263] [Cited by in Crossref: 28] [Cited by in F6Publishing: 27] [Article Influence: 3.1] [Reference Citation Analysis]
62 Pilkinton M, Sandoval R, Barrett K, Tian X, Colamonici OR. Mip/LIN-9 can inhibit cell proliferation independent of the pocket proteins. Blood Cells Mol Dis 2007;39:272-7. [PMID: 17618148 DOI: 10.1016/j.bcmd.2007.05.006] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.3] [Reference Citation Analysis]
63 Imoto H, Okada M. Signal-dependent regulation of early-response genes and cell cycle: a quantitative view. Current Opinion in Systems Biology 2019;15:100-8. [DOI: 10.1016/j.coisb.2019.04.003] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.7] [Reference Citation Analysis]
64 Cao A, Briane D, Coudert R. Chapter 5: Cationic Liposomes as Transmembrane Carriers of Nucleic Acids. Elsevier; 2006. pp. 135-90. [DOI: 10.1016/s1554-4516(06)04005-1] [Cited by in Crossref: 5] [Article Influence: 0.3] [Reference Citation Analysis]
65 Le Roy L, Letondor A, Le Roux C, Amara A, Timsit S. Cellular and Molecular Mechanisms of R/S-Roscovitine and CDKs Related Inhibition under Both Focal and Global Cerebral Ischemia: A Focus on Neurovascular Unit and Immune Cells. Cells 2021;10:104. [PMID: 33429982 DOI: 10.3390/cells10010104] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
66 Fasshauer M, Iwig M, Glaesser D. Synthesis of proto-oncogene proteins and cyclins depends on intact microfilaments. European Journal of Cell Biology 1998;77:188-95. [DOI: 10.1016/s0171-9335(98)80106-4] [Cited by in Crossref: 9] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
67 Tan X, Wang JY. The caspase-RB connection in cell death. Trends Cell Biol 1998;8:116-20. [PMID: 9695821 DOI: 10.1016/s0962-8924(97)01208-7] [Cited by in Crossref: 92] [Cited by in F6Publishing: 27] [Article Influence: 3.8] [Reference Citation Analysis]
68 Davaadelger B, Shen H, Maki CG. Novel roles for p53 in the genesis and targeting of tetraploid cancer cells. PLoS One. 2014;9:e110844. [PMID: 25380055 DOI: 10.1371/journal.pone.0110844] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 1.3] [Reference Citation Analysis]
69 Gray SE, Kay E, Leader M, Mabruk M. Molecular genetic analysis of the BRCA2 tumor suppressor gene region in cutaneous squamous cell carcinomas. J Cutan Pathol 2008;35:1-9. [PMID: 18095987 DOI: 10.1111/j.1600-0560.2007.00760.x] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
70 Bai F, Pei XH, Pandolfi PP, Xiong Y. p18 Ink4c and Pten constrain a positive regulatory loop between cell growth and cell cycle control. Mol Cell Biol 2006;26:4564-76. [PMID: 16738322 DOI: 10.1128/MCB.00266-06] [Cited by in Crossref: 32] [Cited by in F6Publishing: 22] [Article Influence: 2.0] [Reference Citation Analysis]
71 Whitson BA, Kratzke RA. Molecular pathways in malignant pleural mesothelioma. Cancer Letters 2006;239:183-9. [DOI: 10.1016/j.canlet.2005.08.010] [Cited by in Crossref: 30] [Cited by in F6Publishing: 25] [Article Influence: 1.9] [Reference Citation Analysis]
72 Shivakumar L, Minna J, Sakamaki T, Pestell R, White MA. The RASSF1A tumor suppressor blocks cell cycle progression and inhibits cyclin D1 accumulation. Mol Cell Biol. 2002;22:4309-4318. [PMID: 12024041 DOI: 10.1128/MCB.22.12.4309-4318.2002] [Cited by in Crossref: 256] [Cited by in F6Publishing: 118] [Article Influence: 12.8] [Reference Citation Analysis]
73 Berndt N, Dohadwala M, Liu CW. Constitutively active protein phosphatase 1α causes Rb-dependent G1 arrest in human cancer cells. Current Biology 1997;7:375-86. [DOI: 10.1016/s0960-9822(06)00185-0] [Cited by in Crossref: 66] [Cited by in F6Publishing: 29] [Article Influence: 2.6] [Reference Citation Analysis]
74 Chapman CD, Gorczyca S, Robertson-Anderson RM. Crowding induces complex ergodic diffusion and dynamic elongation of large DNA molecules. Biophys J 2015;108:1220-8. [PMID: 25762333 DOI: 10.1016/j.bpj.2015.02.002] [Cited by in Crossref: 24] [Cited by in F6Publishing: 20] [Article Influence: 4.0] [Reference Citation Analysis]
75 Romero EL, Morilla MJ. Preclinical autophagy modulatory nanomedicines: big challenges, slow advances. Expert Opin Drug Deliv 2021;:1-19. [PMID: 34030559 DOI: 10.1080/17425247.2021.1933428] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
76 Herrick J, Bensimon A. Single molecule analysis of DNA replication. Biochimie 1999;81:859-71. [PMID: 10572299 DOI: 10.1016/s0300-9084(99)00210-2] [Cited by in Crossref: 60] [Cited by in F6Publishing: 24] [Article Influence: 2.7] [Reference Citation Analysis]
77 Smith GK, Ke Z, Guo H, Hengge AC. Insights into the phosphoryl transfer mechanism of cyclin-dependent protein kinases from ab initio QM/MM free-energy studies. J Phys Chem B 2011;115:13713-22. [PMID: 21999515 DOI: 10.1021/jp207532s] [Cited by in Crossref: 29] [Cited by in F6Publishing: 25] [Article Influence: 2.6] [Reference Citation Analysis]
78 Sasaki E, Yatabe Y, Hashimoto M, Yamashita Y, Hasegawa Y, Kojima H, Nagasawa T, Mori N. Development-dependent expression of cyclin D3 in precursor T-cell lymphoblastic leukemia/lymphoma. Pathol Int 2007;57:53-9. [PMID: 17300668 DOI: 10.1111/j.1440-1827.2006.02058.x] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.4] [Reference Citation Analysis]
79 Crowe DL, Nguyen DC, Tsang KJ, Kyo S. E2F-1 represses transcription of the human telomerase reverse transcriptase gene. Nucleic Acids Res 2001;29:2789-94. [PMID: 11433024 DOI: 10.1093/nar/29.13.2789] [Cited by in Crossref: 100] [Cited by in F6Publishing: 89] [Article Influence: 4.8] [Reference Citation Analysis]
80 Edessa D, Sisay M. Recent advances of cyclin-dependent kinases as potential therapeutic targets in HR+/HER2- metastatic breast cancer: a focus on ribociclib. Breast Cancer (Dove Med Press) 2017;9:567-79. [PMID: 29263697 DOI: 10.2147/BCTT.S150540] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 0.4] [Reference Citation Analysis]
81 Desai P, Jiménez JA, Kao C, Gardner TA. Future innovations in treating advanced prostate cancer. Urol Clin North Am 2006;33:247-72, viii. [PMID: 16631463 DOI: 10.1016/j.ucl.2005.12.005] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.1] [Reference Citation Analysis]
82 Dudhgaonkar S, Thyagarajan A, Sliva D. Suppression of the inflammatory response by triterpenes isolated from the mushroom Ganoderma lucidum. International Immunopharmacology 2009;9:1272-80. [DOI: 10.1016/j.intimp.2009.07.011] [Cited by in Crossref: 96] [Cited by in F6Publishing: 84] [Article Influence: 7.4] [Reference Citation Analysis]
83 Moon NS, Di Stefano L, Dyson N. A gradient of epidermal growth factor receptor signaling determines the sensitivity of rbf1 mutant cells to E2F-dependent apoptosis. Mol Cell Biol 2006;26:7601-15. [PMID: 16954388 DOI: 10.1128/MCB.00836-06] [Cited by in Crossref: 42] [Cited by in F6Publishing: 38] [Article Influence: 2.6] [Reference Citation Analysis]
84 Sauvageot CM, Kesari S, Stiles CD. Molecular pathogenesis of adult brain tumors and the role of stem cells. Neurol Clin 2007;25:891-924, vii. [PMID: 17964020 DOI: 10.1016/j.ncl.2007.07.014] [Cited by in Crossref: 23] [Cited by in F6Publishing: 24] [Article Influence: 1.6] [Reference Citation Analysis]
85 Workman P. Drugging the Cancer Kinome: Progress and Challenges in Developing Personalized Molecular Cancer Therapeutics. Cold Spring Harbor Symposia on Quantitative Biology 2005;70:499-515. [DOI: 10.1101/sqb.2005.70.020] [Cited by in Crossref: 20] [Cited by in F6Publishing: 19] [Article Influence: 1.2] [Reference Citation Analysis]
86 Wang J, Yang T, Chen H, Li H, Zheng S. Oncogene RPA1 promotes proliferation of hepatocellular carcinoma via CDK4/Cyclin-D pathway. Biochem Biophys Res Commun 2018;498:424-30. [PMID: 29477843 DOI: 10.1016/j.bbrc.2018.02.167] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 2.8] [Reference Citation Analysis]
87 Kim H, Watanabe S, Kitamatsu M, Watanabe K, Ohtsuki T. Cell cycle dependence of apoptosis photo-triggered using peptide-photosensitizer conjugate. Sci Rep 2020;10:19087. [PMID: 33154435 DOI: 10.1038/s41598-020-76100-7] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
88 Hwang HC, Martins CP, Bronkhorst Y, Randel E, Berns A, Fero M, Clurman BE. Identification of oncogenes collaborating with p27Kip1 loss by insertional mutagenesis and high-throughput insertion site analysis. Proc Natl Acad Sci U S A 2002;99:11293-8. [PMID: 12151601 DOI: 10.1073/pnas.162356099] [Cited by in Crossref: 82] [Cited by in F6Publishing: 87] [Article Influence: 4.1] [Reference Citation Analysis]
89 Serizawa H. Cyclin-dependent kinase inhibitor p16INK4A inhibits phosphorylation of RNA polymerase II by general transcription factor TFIIH. J Biol Chem 1998;273:5427-30. [PMID: 9488660 DOI: 10.1074/jbc.273.10.5427] [Cited by in Crossref: 16] [Cited by in F6Publishing: 15] [Article Influence: 0.7] [Reference Citation Analysis]
90 Wu L, Chen P, Shum CH, Chen C, Barsky LW, Weinberg KI, Jong A, Triche TJ. MAT1-modulated CAK activity regulates cell cycle G (1) exit. Mol Cell Biol. 2001;21:260-270. [PMID: 11113200 DOI: 10.1128/mcb.21.1.260-270.2001] [Cited by in Crossref: 23] [Cited by in F6Publishing: 11] [Article Influence: 1.1] [Reference Citation Analysis]
91 Mukherji A, Janbandhu VC, Kumar V. GSK-3beta-dependent destabilization of cyclin D1 mediates replicational stress-induced arrest of cell cycle. FEBS Lett 2008;582:1111-6. [PMID: 18328826 DOI: 10.1016/j.febslet.2008.02.068] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 0.7] [Reference Citation Analysis]
92 Chua SS, Ma Z, Ngan E, Tsai SY. Cdc25B as a steroid receptor coactivator. Vitam Horm 2004;68:231-56. [PMID: 15193457 DOI: 10.1016/S0083-6729(04)68008-3] [Cited by in Crossref: 13] [Cited by in F6Publishing: 6] [Article Influence: 0.7] [Reference Citation Analysis]
93 Guo ZS, Thorne SH, Bartlett DL. Oncolytic virotherapy: molecular targets in tumor-selective replication and carrier cell-mediated delivery of oncolytic viruses. Biochim Biophys Acta 2008;1785:217-31. [PMID: 18328829 DOI: 10.1016/j.bbcan.2008.02.001] [Cited by in Crossref: 28] [Cited by in F6Publishing: 76] [Article Influence: 2.0] [Reference Citation Analysis]
94 Li F, Zhang J, Arfuso F, Chinnathambi A, Zayed ME, Alharbi SA, Kumar AP, Ahn KS, Sethi G. NF-κB in cancer therapy. Arch Toxicol 2015;89:711-31. [PMID: 25690730 DOI: 10.1007/s00204-015-1470-4] [Cited by in Crossref: 115] [Cited by in F6Publishing: 112] [Article Influence: 16.4] [Reference Citation Analysis]
95 Swanton C, Jones N. Strategies in subversion: de-regulation of the mammalian cell cycle by viral gene products. Int J Exp Pathol 2001;82:3-13. [PMID: 11422537 DOI: 10.1046/j.1365-2613.2001.00165.x] [Cited by in Crossref: 33] [Cited by in F6Publishing: 32] [Article Influence: 1.6] [Reference Citation Analysis]
96 Reil TD, Kashyap VS, Sarkar R, Freishlag J, Gelabert HA. Dexamethasone inhibits the phosphorylation of retinoblastoma protein in the suppression of human vascular smooth muscle cell proliferation. J Surg Res 2000;92:108-13. [PMID: 10864490 DOI: 10.1006/jsre.2000.5942] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 0.5] [Reference Citation Analysis]
97 Borghesi J, Caceres S, Mario LC, Alonso-Diez A, Silveira Rabelo AC, Illera MJ, Silvan G, Miglino MA, Favaron PO, Carreira ACO, Illera JC. Effects of doxorubicin associated with amniotic membrane stem cells in the treatment of canine inflammatory breast carcinoma (IPC-366) cells. BMC Vet Res 2020;16:353. [PMID: 32972410 DOI: 10.1186/s12917-020-02576-0] [Reference Citation Analysis]
98 Adesina AM. Molecular heterogeneity in medulloblastoma with implications for differing tumor biology. J Child Neurol 1999;14:411-7. [PMID: 10573461 DOI: 10.1177/088307389901400701] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 0.3] [Reference Citation Analysis]
99 Molenaar JJ, Ebus ME, Koster J, Santo E, Geerts D, Versteeg R, Caron HN. Cyclin D1 is a direct transcriptional target of GATA3 in neuroblastoma tumor cells. Oncogene 2010;29:2739-45. [PMID: 20154722 DOI: 10.1038/onc.2010.21] [Cited by in Crossref: 30] [Cited by in F6Publishing: 30] [Article Influence: 2.5] [Reference Citation Analysis]
100 Nakabayashi H, Shimizu K, Hara M. Prognostic significance of cyclin a expression in meningiomas. Appl Immunohistochem Mol Morphol 2003;11:9-14. [PMID: 12610350 DOI: 10.1097/00129039-200303000-00002] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.1] [Reference Citation Analysis]
101 Agami R, Bernards R. Convergence of mitogenic and DNA damage signaling in the G1 phase of the cell cycle. Cancer Lett. 2002;177:111-118. [PMID: 11825657 DOI: 10.1016/s0304-3835(01)00785-6] [Cited by in Crossref: 19] [Cited by in F6Publishing: 8] [Article Influence: 1.0] [Reference Citation Analysis]
102 Yan Y, Mumby MC. Distinct roles for PP1 and PP2A in phosphorylation of the retinoblastoma protein. PP2a regulates the activities of G(1) cyclin-dependent kinases. J Biol Chem 1999;274:31917-24. [PMID: 10542219 DOI: 10.1074/jbc.274.45.31917] [Cited by in Crossref: 80] [Cited by in F6Publishing: 89] [Article Influence: 3.5] [Reference Citation Analysis]
103 Ledniczky G, Bognár G, Bereczky B, Barabás L, Ondrejka P. [Precursors of Pancreatic cancer: Intraepithelial Neoplasia (PanIN) and Intraductal Papillary Mucinous Neoplasms (IPMN)]. Magy Seb 2009;62:22-6. [PMID: 19218165 DOI: 10.1556/MaSeb.62.2009.1.6] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
104 Sutterlüty H, Chatelain E, Marti A, Wirbelauer C, Senften M, Müller U, Krek W. p45SKP2 promotes p27Kip1 degradation and induces S phase in quiescent cells. Nat Cell Biol 1999;1:207-14. [DOI: 10.1038/12027] [Cited by in Crossref: 488] [Cited by in F6Publishing: 483] [Article Influence: 21.2] [Reference Citation Analysis]
105 Suzuki H, Onto T, Iwasaki Y, Sakurai Y, Uenohara H, Suzuki S, Takei H, Tezuka F. Differential polymerase chain reaction and immunohistological studies on amplification and expression of cyclin D1 gene in human glioma tissues. Neuropathology 1998;18:270-5. [DOI: 10.1111/j.1440-1789.1998.tb00114.x] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.1] [Reference Citation Analysis]
106 Nishi K, Inoue H, Schnier JB, Rice RH. Cyclin D1 downregulation is important for permanent cell cycle exit and initiation of differentiation induced by anchorage-deprivation in human keratinocytes. J Cell Biochem 2009;106:63-72. [PMID: 19021145 DOI: 10.1002/jcb.21978] [Cited by in Crossref: 23] [Cited by in F6Publishing: 23] [Article Influence: 1.8] [Reference Citation Analysis]
107 Wiman KG. New p53-based anti-cancer therapeutic strategies. Med Oncol 1998;15:222-8. [DOI: 10.1007/bf02787204] [Cited by in Crossref: 12] [Article Influence: 0.5] [Reference Citation Analysis]
108 Carpagnano GE, Spanevello A, Carpagnano F, Palladino GP, Prato R, Martinelli D, Digioia G, Foschino-Barbaro MP. Prognostic value of exhaled microsatellite alterations at 3p in NSCLC patients. Lung Cancer 2009;64:334-40. [PMID: 18995925 DOI: 10.1016/j.lungcan.2008.09.004] [Cited by in Crossref: 20] [Cited by in F6Publishing: 20] [Article Influence: 1.4] [Reference Citation Analysis]
109 Lu Y, Gao K, Zhang M, Zhou A, Zhou X, Guan Z, Shi X, Ge S. Genetic Association Between CDKN1B rs2066827 Polymorphism and Susceptibility to Cancer. Medicine (Baltimore) 2015;94:e1217. [PMID: 26579796 DOI: 10.1097/MD.0000000000001217] [Cited by in Crossref: 8] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]
110 Gützkow KB, Naderi S, Blomhoff HK. Forskolin-mediated G1 arrest in acute lymphoblastic leukaemia cells: phosphorylated pRB sequesters E2Fs. Journal of Cell Science 2002;115:1073-82. [DOI: 10.1242/jcs.115.5.1073] [Cited by in Crossref: 10] [Cited by in F6Publishing: 7] [Article Influence: 0.5] [Reference Citation Analysis]
111 Li J, Hu W, Baldassare JJ, Bora PS, Chen S, Poulos JE, O'Neill R, Britton RS, Bacon BR. The ethanol metabolite, linolenic acid ethyl ester, stimulates mitogen-activated protein kinase and cyclin signaling in hepatic stellate cells. Life Sci. 2003;73:1083-1096. [PMID: 12818718 DOI: 10.1016/s0024-3205(03)00383-7] [Cited by in Crossref: 20] [Cited by in F6Publishing: 9] [Article Influence: 1.1] [Reference Citation Analysis]
112 Peters SL, Hlady RA, Opavska J, Klinkebiel D, Novakova S, Smith LM, Lewis RE, Karpf AR, Simpson MA, Wu L, Opavsky R. Essential role for Dnmt1 in the prevention and maintenance of MYC-induced T-cell lymphomas. Mol Cell Biol 2013;33:4321-33. [PMID: 24001767 DOI: 10.1128/MCB.00776-13] [Cited by in Crossref: 46] [Cited by in F6Publishing: 27] [Article Influence: 5.1] [Reference Citation Analysis]
113 Mohammadi-bardbori A, Bastan F, Akbarizadeh A. The highly bioactive molecule and signal substance 6-formylindolo[3,2-b]carbazole (FICZ) plays bi-functional roles in cell growth and apoptosis in vitro. Arch Toxicol 2017;91:3365-72. [DOI: 10.1007/s00204-017-1950-9] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 2.2] [Reference Citation Analysis]
114 Blais A, Labrie Y, Pouliot F, Lachance Y, Labrie C. Structure of the gene encoding the human cyclin-dependent kinase inhibitor p18 and mutational analysis in breast cancer. Biochem Biophys Res Commun 1998;247:146-53. [PMID: 9636670 DOI: 10.1006/bbrc.1998.8497] [Cited by in Crossref: 17] [Cited by in F6Publishing: 18] [Article Influence: 0.7] [Reference Citation Analysis]
115 Mohapatra S, Agrawal D, Pledger W. p27Kip1 Regulates T Cell Proliferation. Journal of Biological Chemistry 2001;276:21976-83. [DOI: 10.1074/jbc.m009788200] [Cited by in Crossref: 40] [Cited by in F6Publishing: 18] [Article Influence: 1.9] [Reference Citation Analysis]
116 Zhang FX, Chen ML, Shan QJ, Zou JG, Chen C, Yang B, Xu DJ, Jin Y, Cao KJ. Hypoxia reoxygenation induces premature senescence in neonatal SD rat cardiomyocytes. Acta Pharmacol Sin 2007;28:44-51. [PMID: 17184581 DOI: 10.1111/j.1745-7254.2007.00488.x] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 1.0] [Reference Citation Analysis]
117 Basile JR, Zacny V, Münger K. The Cytokines Tumor Necrosis Factor-α (TNF-α) and TNF-related Apoptosis-inducing Ligand Differentially Modulate Proliferation and Apoptotic Pathways in Human Keratinocytes Expressing the Human Papillomavirus-16 E7 Oncoprotein. Journal of Biological Chemistry 2001;276:22522-8. [DOI: 10.1074/jbc.m010505200] [Cited by in Crossref: 70] [Cited by in F6Publishing: 29] [Article Influence: 3.3] [Reference Citation Analysis]
118 Inoue K, Fry EA. Novel Molecular Markers for Breast Cancer. Biomark Cancer 2016;8:25-42. [PMID: 26997872 DOI: 10.4137/BIC.S38394] [Cited by in Crossref: 26] [Cited by in F6Publishing: 23] [Article Influence: 4.3] [Reference Citation Analysis]
119 Qiu L, Burgess A, Fairlie DP, Leonard H, Parsons PG, Gabrielli BG. Histone deacetylase inhibitors trigger a G2 checkpoint in normal cells that is defective in tumor cells. Mol Biol Cell 2000;11:2069-83. [PMID: 10848630 DOI: 10.1091/mbc.11.6.2069] [Cited by in Crossref: 183] [Cited by in F6Publishing: 160] [Article Influence: 8.3] [Reference Citation Analysis]
120 Yuan F, Ma Y, You P, Lin W, Lu H, Yu Y, Wang X, Jiang J, Yang P, Ma Q, Tao T. A novel role of proteasomal β1 subunit in tumorigenesis. Biosci Rep 2013;33:e00050. [PMID: 23725357 DOI: 10.1042/BSR20130013] [Cited by in Crossref: 10] [Cited by in F6Publishing: 5] [Article Influence: 1.1] [Reference Citation Analysis]
121 Moon J, Yu SJ, Kim HS, Sohn J. Induction of G(1) cell cycle arrest and p27(KIP1) increase by panaxydol isolated from Panax ginseng. Biochem Pharmacol 2000;59:1109-16. [PMID: 10704940 DOI: 10.1016/s0006-2952(00)00235-5] [Cited by in Crossref: 32] [Cited by in F6Publishing: 7] [Article Influence: 1.5] [Reference Citation Analysis]
122 Stephen JK, Vaught LE, Chen KM, Sethi S, Shah V, Benninger MS, Gardner GM, Schweitzer VG, Khan M, Worsham MJ. Epigenetic events underlie the pathogenesis of sinonasal papillomas. Mod Pathol 2007;20:1019-27. [PMID: 17673925 DOI: 10.1038/modpathol.3800944] [Cited by in Crossref: 23] [Cited by in F6Publishing: 19] [Article Influence: 1.5] [Reference Citation Analysis]
123 Sherr CJ, Sicinski P. The D-Type Cyclins: A Historical Perspective. In: Hinds PW, Brown NE, editors. D-type Cyclins and Cancer. Cham: Springer International Publishing; 2018. pp. 1-26. [DOI: 10.1007/978-3-319-64451-6_1] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
124 Kim MS, Lee CW, Kim JH, Lee JC, An WG. Extract of Rhus verniciflua Stokes Induces p53-Mediated Apoptosis in MCF-7 Breast Cancer Cells. Evid Based Complement Alternat Med 2019;2019:9407340. [PMID: 30881477 DOI: 10.1155/2019/9407340] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
125 Baek MJ, Piao Z, Kim N, Park C, Shin E, Park J, Jung H, Kim CG, Kim H. p16 is a major inactivation target in hepatocellular carcinoma. Cancer 2000;89:60-8. [DOI: 10.1002/1097-0142(20000701)89:1<60::aid-cncr9>3.0.co;2-3] [Cited by in Crossref: 78] [Cited by in F6Publishing: 23] [Article Influence: 3.5] [Reference Citation Analysis]
126 Bernards R. CDK-independent activities of D type cyclins. Biochim Biophys Acta 1999;1424:M17-22. [PMID: 10528151 DOI: 10.1016/s0304-419x(99)00024-4] [Cited by in Crossref: 5] [Cited by in F6Publishing: 14] [Article Influence: 0.2] [Reference Citation Analysis]
127 Kenny L, Aboagye E, Price P. Positron Emission Tomography Imaging of Cell Proliferation in Oncology. Clinical Oncology 2004;16:176-85. [DOI: 10.1016/j.clon.2003.10.009] [Cited by in Crossref: 23] [Cited by in F6Publishing: 18] [Article Influence: 1.3] [Reference Citation Analysis]
128 Nezu J, Oku A, Jones MH, Shimane M. Identification of two novel human putative serine/threonine kinases, VRK1 and VRK2, with structural similarity to vaccinia virus B1R kinase. Genomics 1997;45:327-31. [PMID: 9344656 DOI: 10.1006/geno.1997.4938] [Cited by in Crossref: 98] [Cited by in F6Publishing: 95] [Article Influence: 4.1] [Reference Citation Analysis]
129 Grinstein E, Wernet P. Cellular signaling in normal and cancerous stem cells. Cell Signal 2007;19:2428-33. [PMID: 17651940 DOI: 10.1016/j.cellsig.2007.06.021] [Cited by in Crossref: 40] [Cited by in F6Publishing: 35] [Article Influence: 2.7] [Reference Citation Analysis]
130 Fang Y, Cao Z, Hou Q, Ma C, Yao C, Li J, Wu XR, Huang C. Cyclin d1 downregulation contributes to anticancer effect of isorhapontigenin on human bladder cancer cells. Mol Cancer Ther 2013;12:1492-503. [PMID: 23723126 DOI: 10.1158/1535-7163.MCT-12-0922] [Cited by in Crossref: 37] [Cited by in F6Publishing: 28] [Article Influence: 4.1] [Reference Citation Analysis]
131 Kwak CS, Yeo EJ, Moon SC, Kim YW, Ahn HJ, Park SC. Perilla Leaf, Perilla frutescens , Induces Apoptosis and G1 Phase Arrest in Human Leukemia HL-60 Cells Through the Combinations of Death Receptor-Mediated, Mitochondrial, and Endoplasmic Reticulum Stress-Induced Pathways. Journal of Medicinal Food 2009;12:508-17. [DOI: 10.1089/jmf.2008.1103] [Cited by in Crossref: 18] [Cited by in F6Publishing: 14] [Article Influence: 1.4] [Reference Citation Analysis]
132 Hirose T, Tamaru T, Okumura N, Nagai K, Okada M. PCTAIRE 2, a Cdc2-related serine/threonine kinase, is predominantly expressed in terminally differentiated neurons. Eur J Biochem 1997;249:481-8. [PMID: 9370357 DOI: 10.1111/j.1432-1033.1997.t01-1-00481.x] [Cited by in Crossref: 33] [Cited by in F6Publishing: 32] [Article Influence: 1.3] [Reference Citation Analysis]
133 Sayle KL, Bentley J, Boyle F, Calvert A, Cheng Y, Curtin NJ, Endicott JA, Golding BT, Hardcastle IR, Jewsbury P, Mesguiche V, Newell DR, Noble ME, Parsons RJ, Pratt DJ, Wang LZ, Griffin RJ. Structure-Based design of 2-Arylamino-4-cyclohexylmethyl-5-nitroso-6-aminopyrimidine inhibitors of cyclin-Dependent kinases 1 and 2. Bioorganic & Medicinal Chemistry Letters 2003;13:3079-82. [DOI: 10.1016/s0960-894x(03)00651-6] [Cited by in Crossref: 55] [Cited by in F6Publishing: 5] [Article Influence: 2.9] [Reference Citation Analysis]
134 Kulkarni MV, Franklin DS. N-Myc is a downstream target of RET signaling and is required for transcriptional regulation of p18(Ink4c) by the transforming mutant RET(C634R). Mol Oncol 2011;5:24-35. [PMID: 21112821 DOI: 10.1016/j.molonc.2010.10.004] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.5] [Reference Citation Analysis]
135 Kastner A, Moyse E, Bauer S, Jourdan F, Brun G. Unusual regulation of cyclin D1 and cyclin-dependent kinases cdk2 and cdk4 during in vivo mitotic stimulation of olfactory neuron progenitors in adult mouse. J Neurochem 2000;74:2343-9. [PMID: 10820194 DOI: 10.1046/j.1471-4159.2000.0742343.x] [Cited by in Crossref: 19] [Cited by in F6Publishing: 23] [Article Influence: 0.9] [Reference Citation Analysis]
136 Quéva C, McArthur GA, Iritani BM, Eisenman RN. Targeted deletion of the S-phase-specific Myc antagonist Mad3 sensitizes neuronal and lymphoid cells to radiation-induced apoptosis. Mol Cell Biol 2001;21:703-12. [PMID: 11154258 DOI: 10.1128/MCB.21.3.703-712.2001] [Cited by in F6Publishing: 26] [Reference Citation Analysis]
137 Barnouin K, Dubuisson ML, Child ES, Fernandez de Mattos S, Glassford J, Medema RH, Mann DJ, Lam EW. H2O2 induces a transient multi-phase cell cycle arrest in mouse fibroblasts through modulating cyclin D and p21Cip1 expression. J Biol Chem. 2002;277:13761-13770. [PMID: 11827966 DOI: 10.1074/jbc.M111123200] [Cited by in Crossref: 126] [Cited by in F6Publishing: 41] [Article Influence: 6.3] [Reference Citation Analysis]
138 Liping X, Jia L, Qi C, Liang Y, Dongen L, Jianshuai J. Cell Cycle Genes Are Potential Diagnostic and Prognostic Biomarkers in Hepatocellular Carcinoma. Biomed Res Int 2020;2020:6206157. [PMID: 32596342 DOI: 10.1155/2020/6206157] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
139 Chao YJ, Chan JF, Hsu YH. Chemotherapy Drug Induced Discoordination of Mitochondrial Life Cycle Detected by Cardiolipin Fluctuation. PLoS One 2016;11:e0162457. [PMID: 27627658 DOI: 10.1371/journal.pone.0162457] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
140 Tarang S, Doi SM, Gurumurthy CB, Harms D, Quadros R, Rocha-Sanchez SM. Generation of a Retinoblastoma (Rb)1-inducible dominant-negative (DN) mouse model. Front Cell Neurosci 2015;9:52. [PMID: 25755634 DOI: 10.3389/fncel.2015.00052] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 0.9] [Reference Citation Analysis]
141 Saito M, Nishikawa J, Okada T, Morishige A, Sakai K, Nakamura M, Kiyotoki S, Hamabe K, Okamoto T, Oga A. Role of DNA methylation in the development of Epstein-Barr virus-associated gastric carcinoma. J Med Virol. 2013;85:121-127. [PMID: 23073987 DOI: 10.1002/jmv.23405] [Cited by in Crossref: 23] [Cited by in F6Publishing: 19] [Article Influence: 2.3] [Reference Citation Analysis]
142 Grønbæk K, de Nully Brown P, Møller M, Nedergaard T, Ralfkiaer E, Møller P, Zeuthen J, Guldberg P. Concurrent disruption of p16INK4a and the ARF-p53 pathway predicts poor prognosis in aggressive non-Hodgkin's lymphoma. Leukemia 2000;14:1727-35. [DOI: 10.1038/sj.leu.2401901] [Cited by in Crossref: 62] [Cited by in F6Publishing: 55] [Article Influence: 2.8] [Reference Citation Analysis]
143 Harwell RM, Mull BB, Porter DC, Keyomarsi K. Activation of Cyclin-dependent Kinase 2 by Full Length and Low Molecular Weight Forms of Cyclin E in Breast Cancer Cells. Journal of Biological Chemistry 2004;279:12695-705. [DOI: 10.1074/jbc.m313407200] [Cited by in Crossref: 23] [Cited by in F6Publishing: 6] [Article Influence: 1.3] [Reference Citation Analysis]
144 Lou D, Wang B, Wang Y, Cao Y. Selective killing of cancer stem cells by a novel dual-targeting strategy. Medical Hypotheses 2012;79:430-2. [DOI: 10.1016/j.mehy.2012.06.012] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 0.6] [Reference Citation Analysis]
145 Linggi B, Müller-tidow C, van de Locht L, Hu M, Nip J, Serve H, Berdel WE, van der Reijden B, Quelle DE, Rowley JD, Cleveland J, Jansen JH, Pandolfi PP, Hiebert SW. The t(8;21) fusion protein, AML1–ETO, specifically represses the transcription of the p14ARF tumor suppressor in acute myeloid leukemia. Nat Med 2002;8:743-50. [DOI: 10.1038/nm726] [Cited by in Crossref: 189] [Cited by in F6Publishing: 166] [Article Influence: 9.5] [Reference Citation Analysis]
146 Nyunoya T, Powers LS, Yarovinsky TO, Butler NS, Monick MM, Hunninghake GW. Hyperoxia induces macrophage cell cycle arrest by adhesion-dependent induction of p21Cip1 and activation of the retinoblastoma protein. J Biol Chem 2003;278:36099-106. [PMID: 12847100 DOI: 10.1074/jbc.M304370200] [Cited by in Crossref: 15] [Cited by in F6Publishing: 7] [Article Influence: 0.8] [Reference Citation Analysis]
147 Tang KS, Guralnick BJ, Wang WK, Fersht AR, Itzhaki LS. Stability and folding of the tumour suppressor protein p16. J Mol Biol 1999;285:1869-86. [PMID: 9917418 DOI: 10.1006/jmbi.1998.2420] [Cited by in Crossref: 104] [Cited by in F6Publishing: 97] [Article Influence: 4.5] [Reference Citation Analysis]
148 Fogal V, Hsieh JK, Royer C, Zhong S, Lu X. Cell cycle-dependent nuclear retention of p53 by E2F1 requires phosphorylation of p53 at Ser315. EMBO J 2005;24:2768-82. [PMID: 16037820 DOI: 10.1038/sj.emboj.7600735] [Cited by in Crossref: 36] [Cited by in F6Publishing: 36] [Article Influence: 2.1] [Reference Citation Analysis]
149 Zhao C, Hashiguchi A, Kondoh K, Du W, Hata J, Yamada T. Exogenous expression of heat shock protein 90kDa retards the cell cycle and impairs the heat shock response. Exp Cell Res 2002;275:200-14. [PMID: 11969290 DOI: 10.1006/excr.2002.5501] [Cited by in Crossref: 16] [Cited by in F6Publishing: 15] [Article Influence: 0.8] [Reference Citation Analysis]
150 Hay JG, Shapiro N, Sauthoff H, Heitner S, Phupakdi W, Rom WN. Targeting the replication of adenoviral gene therapy vectors to lung cancer cells: the importance of the adenoviral E1b-55kD gene. Hum Gene Ther 1999;10:579-90. [PMID: 10094201 DOI: 10.1089/10430349950018652] [Cited by in Crossref: 55] [Cited by in F6Publishing: 52] [Article Influence: 2.4] [Reference Citation Analysis]
151 Gautam Y, Dwivedi S, Srivastava A, Hamidullah H, Singh A, Chanda D, Singh J, Rai S, Konwar R, Negi AS. 2-(3′,4′-Dimethoxybenzylidene)tetralone induces anti-breast cancer activity through microtubule stabilization and activation of reactive oxygen species. RSC Adv 2016;6:33369-79. [DOI: 10.1039/c6ra02663j] [Cited by in Crossref: 8] [Article Influence: 1.3] [Reference Citation Analysis]
152 Kumar PS, Shiras A, Das G, Jagtap JC, Prasad V, Shastry P. Differential expression and role of p21cip/waf1 and p27kip1 in TNF-alpha-induced inhibition of proliferation in human glioma cells. Mol Cancer 2007;6:42. [PMID: 17565690 DOI: 10.1186/1476-4598-6-42] [Cited by in Crossref: 17] [Cited by in F6Publishing: 17] [Article Influence: 1.1] [Reference Citation Analysis]
153 Maeda Y, Chida J. Control of cell differentiation by mitochondria, typically evidenced in dictyostelium development. Biomolecules 2013;3:943-66. [PMID: 24970198 DOI: 10.3390/biom3040943] [Cited by in Crossref: 17] [Cited by in F6Publishing: 16] [Article Influence: 1.9] [Reference Citation Analysis]
154 Kukuruzinska MA, Lennon-hopkins K. ALG gene expression and cell cycle progression. Biochimica et Biophysica Acta (BBA) - General Subjects 1999;1426:359-72. [DOI: 10.1016/s0304-4165(98)00136-6] [Cited by in Crossref: 22] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
155 Yoon JS, Hwang DW, Kim ES, Kim JS, Kim S, Chung HJ, Lee SK, Yi JH, Uhm J, Won YW, Park BB, Choi JH, Lee YY. Anti-tumoral effect of arsenic compound, sodium metaarsenite (KML001), in non-Hodgkin’s lymphoma: an in vitro and in vivo study. Invest New Drugs 2016;34:1-14. [DOI: 10.1007/s10637-015-0301-z] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 1.3] [Reference Citation Analysis]
156 Huang XH, Jian WH, Wu ZF, Zhao J, Wang H, Li W, Xia JT. Small interfering RNA (siRNA)-mediated knockdown of macrophage migration inhibitory factor (MIF) suppressed cyclin D1 expression and hepatocellular carcinoma cell proliferation. Oncotarget 2014;5:5570-80. [PMID: 25015194 DOI: 10.18632/oncotarget.2141] [Cited by in Crossref: 29] [Cited by in F6Publishing: 27] [Article Influence: 4.1] [Reference Citation Analysis]
157 Ryk C, Kumar R, Sanyal S, de Verdier PJ, Hemminki K, Larsson P, Steineck G, Hou SM. Influence of polymorphism in DNA repair and defence genes on p53 mutations in bladder tumours. Cancer Lett 2006;241:142-9. [PMID: 16343742 DOI: 10.1016/j.canlet.2005.10.025] [Cited by in Crossref: 38] [Cited by in F6Publishing: 35] [Article Influence: 2.2] [Reference Citation Analysis]
158 McNair C, Xu K, Mandigo AC, Benelli M, Leiby B, Rodrigues D, Lindberg J, Gronberg H, Crespo M, De Laere B, Dirix L, Visakorpi T, Li F, Feng FY, de Bono J, Demichelis F, Rubin MA, Brown M, Knudsen KE. Differential impact of RB status on E2F1 reprogramming in human cancer. J Clin Invest 2018;128:341-58. [PMID: 29202480 DOI: 10.1172/JCI93566] [Cited by in Crossref: 46] [Cited by in F6Publishing: 31] [Article Influence: 9.2] [Reference Citation Analysis]
159 Adachi M, Roussel MF, Havenith K, Sherr CJ. Features of Macrophage Differentiation Induced by p19INK4d, a Specific Inhibitor of Cyclin D–Dependent Kinases. Blood 1997;90:126-37. [DOI: 10.1182/blood.v90.1.126.126_126_137] [Cited by in Crossref: 12] [Article Influence: 0.5] [Reference Citation Analysis]
160 Liu H, Zang C, Emde A, Planas-silva MD, Rosche M, Kühnl A, Schulz C, Elstner E, Possinger K, Eucker J. Anti-tumor effect of honokiol alone and in combination with other anti-cancer agents in breast cancer. European Journal of Pharmacology 2008;591:43-51. [DOI: 10.1016/j.ejphar.2008.06.026] [Cited by in Crossref: 83] [Cited by in F6Publishing: 76] [Article Influence: 5.9] [Reference Citation Analysis]
161 Chen M, Zhao Z, Yu S. Cytotoxicity and Apoptotic Effects of Polyphenols from Sugar Beet Molasses on Colon Carcinoma Cells in Vitro. Int J Mol Sci 2016;17:E993. [PMID: 27347927 DOI: 10.3390/ijms17070993] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
162 Hansson A, Manetopoulos C, Jönsson JI, Axelson H. The basic helix-loop-helix transcription factor TAL1/SCL inhibits the expression of the p16INK4A and pTalpha genes. Biochem Biophys Res Commun 2003;312:1073-81. [PMID: 14651981 DOI: 10.1016/j.bbrc.2003.11.030] [Cited by in Crossref: 17] [Cited by in F6Publishing: 15] [Article Influence: 0.9] [Reference Citation Analysis]
163 Moon D, Park C, Heo M, Park Y, Choi YH, Kim G. PD98059 triggers G1 arrest and apoptosis in human leukemic U937 cells through downregulation of Akt signal pathway. International Immunopharmacology 2007;7:36-45. [DOI: 10.1016/j.intimp.2006.08.009] [Cited by in Crossref: 19] [Cited by in F6Publishing: 20] [Article Influence: 1.3] [Reference Citation Analysis]
164 Yang CH, Hung WC, Wang SL, Kang WY, Chen WT, Huang YC, Su YC, Chai CY. Immunoexpression and prognostic role of hTERT and cyclin D1 in urothelial carcinoma. APMIS 2008;116:309-16. [PMID: 18397466 DOI: 10.1111/j.1600-0463.2008.00905.x] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.3] [Reference Citation Analysis]
165 Ho KK, Myatt SS, Lam EW. Many forks in the path: cycling with FoxO. Oncogene 2008;27:2300-11. [PMID: 18391972 DOI: 10.1038/onc.2008.23] [Cited by in Crossref: 117] [Cited by in F6Publishing: 118] [Article Influence: 8.4] [Reference Citation Analysis]
166 Warren RS, Kirn DH. Liver-directed viral therapy for cancer. Surgical Oncology Clinics of North America 2002;11:571-88. [DOI: 10.1016/s1055-3207(02)00043-1] [Cited by in Crossref: 15] [Cited by in F6Publishing: 1] [Article Influence: 0.8] [Reference Citation Analysis]
167 Burstein DE, Oami S, Dembitzer F, Chu C, Cernaianu G, Leytin A, Misilim E, Jammula SR, Strauchen J, Kohtz DS. Monoclonal Antibody Specific for Histone H1 Phosphorylated by Cyclin-Dependent Kinases: A Novel Immunohistochemical Probe of Proliferation and Neoplasia. Mod Pathol 2002;15:705-11. [DOI: 10.1038/modpathol.3880593] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 0.4] [Reference Citation Analysis]
168 Yee SB, Lee JH, Chung HY, Im KS, Bae SJ, Choi JS, Kim ND. Inhibitory effects of luteolin isolated from Ixeris sonchifolia Hance on the proliferation of HepG2 human hepatocellular carcinoma cells. Arch Pharm Res 2003;26:151-6. [PMID: 12643593 DOI: 10.1007/BF02976662] [Cited by in Crossref: 43] [Cited by in F6Publishing: 11] [Article Influence: 2.3] [Reference Citation Analysis]
169 Rossi FM, Guicherit OM, Spicher A, Kringstein AM, Fatyol K, Blakely BT, Blau. HM. Tetracycline-regulatable factors with distinct dimerization domains allow reversible growth inhibition by p16. Nat Genet 1998;20:389-93. [DOI: 10.1038/3871] [Cited by in Crossref: 92] [Cited by in F6Publishing: 83] [Article Influence: 3.8] [Reference Citation Analysis]
170 Gugger M, Kappeler A, Vonlanthen S, Altermatt H, Ris H, Lardinois D, Borner M, Heighway J, Betticher D. Alterations of cell cycle regulators are less frequent in advanced non-small cell lung cancer than in resectable tumours. Lung Cancer 2001;33:229-39. [DOI: 10.1016/s0169-5002(01)00196-9] [Cited by in Crossref: 23] [Cited by in F6Publishing: 7] [Article Influence: 1.1] [Reference Citation Analysis]
171 Velasco JA, Medina DL, Romero J, Mato ME, Santisteban P. Introduction of p53 induces cell-cycle arrest in p53-deficient human medullary-thyroid-carcinoma cells. Int J Cancer 1997;73:449-55. [PMID: 9359494 DOI: 10.1002/(sici)1097-0215(19971104)73:3<449::aid-ijc21>3.0.co;2-6] [Cited by in Crossref: 5] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
172 Ni J, Wang M, Wang M, Fu S, Zhou D, Zhang Z, Han S. CCND1 G870A polymorphism and cervical cancer risk: a case–control study and meta-analysis. J Cancer Res Clin Oncol 2011;137:489-94. [DOI: 10.1007/s00432-010-0904-x] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 1.0] [Reference Citation Analysis]
173 Molinari M. Cell cycle checkpoints and their inactivation in human cancer. Cell Prolif 2000;33:261-74. [PMID: 11063129 DOI: 10.1046/j.1365-2184.2000.00191.x] [Cited by in Crossref: 217] [Cited by in F6Publishing: 208] [Article Influence: 9.9] [Reference Citation Analysis]
174 Burdon D, Patel R, Challiss RA, Blank JL. Growth inhibition by the muscarinic M(3) acetylcholine receptor: evidence for p21(Cip1/Waf1) involvement in G(1) arrest. Biochem J 2002;367:549-59. [PMID: 12126481 DOI: 10.1042/BJ20020446] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 0.5] [Reference Citation Analysis]
175 Sylvester AM, Chen D, Krasinski K, Andrés V. Role of c-fos and E2F in the induction of cyclin A transcription and vascular smooth muscle cell proliferation. J Clin Invest 1998;101:940-8. [PMID: 9486962 DOI: 10.1172/JCI1630] [Cited by in Crossref: 56] [Cited by in F6Publishing: 17] [Article Influence: 2.3] [Reference Citation Analysis]
176 Indovina P, Pentimalli F, Casini N, Vocca I, Giordano A. RB1 dual role in proliferation and apoptosis: cell fate control and implications for cancer therapy. Oncotarget 2015;6:17873-90. [PMID: 26160835 DOI: 10.18632/oncotarget.4286] [Cited by in Crossref: 83] [Cited by in F6Publishing: 81] [Article Influence: 13.8] [Reference Citation Analysis]
177 Liu SS, Zheng HX, Jiang HD, He J, Yu Y, Qu YP, Yue L, Zhang Y, Li Y. Identification and characterization of a novel gene, c1orf109, encoding a CK2 substrate that is involved in cancer cell proliferation. J Biomed Sci 2012;19:49. [PMID: 22548824 DOI: 10.1186/1423-0127-19-49] [Cited by in Crossref: 8] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
178 Aihara H, Nakagawa T, Mizusaki H, Yoneda M, Kato M, Doiguchi M, Imamura Y, Higashi M, Ikura T, Hayashi T, Kodama Y, Oki M, Nakayama T, Cheung E, Aburatani H, Takayama K, Koseki H, Inoue S, Takeshima Y, Ito T. Histone H2A T120 Phosphorylation Promotes Oncogenic Transformation via Upregulation of Cyclin D1. Molecular Cell 2016;64:176-88. [DOI: 10.1016/j.molcel.2016.09.012] [Cited by in Crossref: 34] [Cited by in F6Publishing: 24] [Article Influence: 5.7] [Reference Citation Analysis]
179 Sharma SK, Ramsey TM, Chen YP, Chen W, Martin MS, Clune K, Sabio M, Bair KW. Identification of E2F-1/Cyclin A antagonists. Bioorganic & Medicinal Chemistry Letters 2001;11:2449-52. [DOI: 10.1016/s0960-894x(01)00486-3] [Cited by in Crossref: 8] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
180 Atanasoski S, Shumas S, Dickson C, Scherer SS, Suter U. Differential Cyclin D1 Requirements of Proliferating Schwann Cells during Development and after Injury. Molecular and Cellular Neuroscience 2001;18:581-92. [DOI: 10.1006/mcne.2001.1055] [Cited by in Crossref: 48] [Cited by in F6Publishing: 45] [Article Influence: 2.3] [Reference Citation Analysis]
181 Najafi SM, Li Z, Makino K, Shao R, Hung MC. The adenoviral E1A induces p21WAF1/CIP1 expression in cancer cells. Biochem Biophys Res Commun 2003;305:1099-104. [PMID: 12767945 DOI: 10.1016/s0006-291x(03)00905-7] [Cited by in Crossref: 14] [Cited by in F6Publishing: 5] [Article Influence: 0.7] [Reference Citation Analysis]
182 Kong Y, Chen G, Xu Z, Yang G, Li B, Wu X, Xiao W, Xie B, Hu L, Sun X, Chang G, Gao M, Gao L, Dai B, Tao Y, Zhu W, Shi J. Pterostilbene induces apoptosis and cell cycle arrest in diffuse large B-cell lymphoma cells. Sci Rep 2016;6:37417. [PMID: 27869173 DOI: 10.1038/srep37417] [Cited by in Crossref: 34] [Cited by in F6Publishing: 36] [Article Influence: 5.7] [Reference Citation Analysis]
183 Waldeck W, Strunz AM, Müller G, Hotz-wagenblatt A, Wijenne J, Langowski J, Didinger B, Debus J, Braun K. Induced and repressed genes after irradiation sensitizing by pentoxyphylline. Int J Cancer 2007;120:1198-207. [DOI: 10.1002/ijc.22441] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.2] [Reference Citation Analysis]
184 Schmidt EV. The role of c-myc in cellular growth control. Oncogene. 1999;18:2988-2996. [PMID: 10378694 DOI: 10.1038/sj.onc.1202751] [Cited by in Crossref: 239] [Cited by in F6Publishing: 241] [Article Influence: 10.4] [Reference Citation Analysis]
185 Wang B, Wu J, Wu Y, Chen C, Zou F, Wang A, Wu H, Hu Z, Jiang Z, Liu Q, Wang W, Zhang Y, Liu F, Zhao M, Hu J, Huang T, Ge J, Wang L, Ren T, Wang Y, Liu J, Liu Q. Discovery of 4-(((4-(5-chloro-2-(((1s,4s)-4-((2-methoxyethyl)amino)cyclohexyl)amino)pyridin-4-yl)thiazol-2-yl)amino)methyl)tetrahydro-2H-pyran-4-carbonitrile (JSH-150) as a novel highly selective and potent CDK9 kinase inhibitor. Eur J Med Chem 2018;158:896-916. [PMID: 30253346 DOI: 10.1016/j.ejmech.2018.09.025] [Cited by in Crossref: 16] [Cited by in F6Publishing: 14] [Article Influence: 4.0] [Reference Citation Analysis]
186 Lu S, Liu R, Su M, Wei Y, Yang S, He S, Wang X, Qiang F, Chen C, Zhao S, Zhang W, Xu P, Mao G. Spy1 participates in the proliferation and apoptosis of epithelial ovarian cancer. J Mol Hist 2016;47:47-57. [DOI: 10.1007/s10735-015-9646-z] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 0.9] [Reference Citation Analysis]
187 Poirier F, Pontet M, Labas V, Caër JL, Sghiouar-imam N, Raphaël M, Caron M, Joubert-caron R. Two-dimensional database of a Burkitt lymphoma cell line (DG 75) proteins: Protein pattern changes following treatment with 5′-azycytidine. Electrophoresis 2001;22:1867-78. [DOI: 10.1002/1522-2683(200105)22:9<1867::aid-elps1867>3.0.co;2-7] [Cited by in Crossref: 28] [Cited by in F6Publishing: 2] [Article Influence: 1.3] [Reference Citation Analysis]
188 Li Y, Pei J, Xia H, Ke H, Wang H, Tao W. Lats2, a putative tumor suppressor, inhibits G1/S transition. Oncogene 2003;22:4398-405. [DOI: 10.1038/sj.onc.1206603] [Cited by in Crossref: 144] [Cited by in F6Publishing: 142] [Article Influence: 7.6] [Reference Citation Analysis]
189 Pérez-plasencia C, Fernández-retana J, de la Garza-salazar JG. Transcriptome Studies Reveal Altered Signaling Pathways in Cervical Cancer. In: de la Garza-salazar JG, Morales-vásquez F, Meneses-garcia A, editors. Cervical Cancer. Cham: Springer International Publishing; 2017. pp. 57-70. [DOI: 10.1007/978-3-319-45231-9_4] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
190 Lei CY, Wang W, Zhu YT, Fang WY, Tan WL. The decrease of cyclin B2 expression inhibits invasion and metastasis of bladder cancer. Urol Oncol 2016;34:237.e1-10. [PMID: 26706119 DOI: 10.1016/j.urolonc.2015.11.011] [Cited by in Crossref: 17] [Cited by in F6Publishing: 25] [Article Influence: 2.4] [Reference Citation Analysis]
191 Lents NH, Keenan SM, Bellone C, Baldassare JJ. Activation and phosphorylation on Thr-160 of nuclear-targeted CDK2 Is ERK dependent. Ann N Y Acad Sci 2002;973:265-7. [PMID: 12485874 DOI: 10.1111/j.1749-6632.2002.tb04646.x] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
192 Suhardja A, Kovacs K, Rutka J. Genetic basis of pituitary adenoma invasiveness: a review. J Neurooncol 2001;52:195-204. [PMID: 11519849 DOI: 10.1023/a:1010655419332] [Cited by in Crossref: 25] [Cited by in F6Publishing: 9] [Article Influence: 1.3] [Reference Citation Analysis]
193 Farley JH, Birrer MJ. Biologic directed therapies in gynecologic oncology. Curr Oncol Rep 2003;5:459-67. [PMID: 14521804 DOI: 10.1007/s11912-003-0006-x] [Cited by in Crossref: 2] [Article Influence: 0.1] [Reference Citation Analysis]
194 Senderowicz AM. Development of cyclin-dependent kinase modulators as novel therapeutic approaches for hematological malignancies. Leukemia 2001;15:1-9. [PMID: 11243375 DOI: 10.1038/sj.leu.2401994] [Cited by in Crossref: 68] [Cited by in F6Publishing: 64] [Article Influence: 3.2] [Reference Citation Analysis]
195 Trehin C, Glab N, Perennes C, Planchais S, Bergounioux C. M phase-specific activation of theNicotiana sylvestris Cyclin B1promoter involves multiple regulatory elements. Plant J 1999;17:263-73. [DOI: 10.1046/j.1365-313x.1999.00374.x] [Cited by in Crossref: 18] [Article Influence: 0.8] [Reference Citation Analysis]
196 Kraker AJ, Booher RN. Chapter 25. New Targets in Cell Cycle Regulation. Elsevier; 1999. pp. 247-56. [DOI: 10.1016/s0065-7743(08)60587-4] [Cited by in Crossref: 1] [Article Influence: 0.0] [Reference Citation Analysis]
197 do-Amaral C, Pacheco B, Seixas F, Pereira C, Collares T. Antitumoral effects of fucoidan on bladder cancer. Algal Research 2020;47:101884. [DOI: 10.1016/j.algal.2020.101884] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 2.5] [Reference Citation Analysis]
198 Andrés D, Dı́ez-fernández C, Zaragoza A, Alvarez A, Cascales M. Induction of cell proliferation by cyclosporine A in primary cultures of rat hepatocytes11Abbreviations: CsA, cyclosporine A; CDK, cyclin-dependent kinase; ECL, enhanced chemiluminescence; IκB-α, inhibitory protein kappa B; LDH, lactate dehydrogenase; NF-κB, nuclear factor kappa B; PCNA, proliferating cell nuclear antigen; and pRb, retinoblastoma protein. Biochemical Pharmacology 2001;61:427-35. [DOI: 10.1016/s0006-2952(00)00571-2] [Cited by in Crossref: 9] [Cited by in F6Publishing: 1] [Article Influence: 0.4] [Reference Citation Analysis]
199 Hassani S, Khaleghian A, Ahmadian S, Alizadeh S, Alimoghaddam K, Ghavamzadeh A, Ghaffari SH. Redistribution of cell cycle by arsenic trioxide is associated with demethylation and expression changes of cell cycle related genes in acute promyelocytic leukemia cell line (NB4). Ann Hematol 2018;97:83-93. [DOI: 10.1007/s00277-017-3163-y] [Cited by in Crossref: 17] [Cited by in F6Publishing: 16] [Article Influence: 3.4] [Reference Citation Analysis]
200 Shastri S, Chatterjee B, Thakur SS. Achievements in Cancer Research and its Therapeutics in Hundred Years. Curr Top Med Chem 2019;19:1545-62. [PMID: 31362690 DOI: 10.2174/1568026619666190730093034] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
201 Wu ZZ, Chien CM, Yang SH, Lin YH, Hu XW, Lu YJ, Wu MJ, Lin SR. Induction of G2/M phase arrest and apoptosis by a novel enediyne derivative, THDA, in chronic myeloid leukemia (K562) cells. Mol Cell Biochem 2006;292:99-105. [PMID: 16733797 DOI: 10.1007/s11010-006-9222-7] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 0.6] [Reference Citation Analysis]
202 Griep AE, Zhang P. Lens Cell Proliferation: The Cell Cycle. In: Lovicu FJ, Robinson ML, editors. Development of the Ocular Lens. Cambridge University Press; 2010. pp. 191-213. [DOI: 10.1017/cbo9780511529825.009] [Cited by in Crossref: 4] [Article Influence: 0.2] [Reference Citation Analysis]
203 Guttridge DC, Albanese C, Reuther JY, Pestell RG, Baldwin AS Jr. NF-kappaB controls cell growth and differentiation through transcriptional regulation of cyclin D1. Mol Cell Biol 1999;19:5785-99. [PMID: 10409765 DOI: 10.1128/MCB.19.8.5785] [Cited by in Crossref: 970] [Cited by in F6Publishing: 410] [Article Influence: 42.2] [Reference Citation Analysis]
204 Johmura Y, Suzuki M, Osada S, Nishizuka M, Imagawa M. FAD24, a regulator of adipogenesis and DNA replication, inhibits H-RAS-mediated transformation by repressing NF-kappaB activity. Biochem Biophys Res Commun 2008;369:464-70. [PMID: 18284919 DOI: 10.1016/j.bbrc.2008.02.036] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 0.6] [Reference Citation Analysis]
205 Mckay JA, Githang'a J, Indalo A, Li T, Liu X, Ameyaw M, Ofori-adjei D, Mcleod HL. Distinct differences in a cyclin D1 single nucleotide polymorphism between ethnic groups. GeneScreen 2001;1:139-42. [DOI: 10.1046/j.1466-9218.2001.00014.x] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.2] [Reference Citation Analysis]
206 Kim S, Lee HS, Lee S, Kim SH, Hur SM, Kim JS, Kim J, Choe J, Shin I, Yang J, Lee JE, Nam SJ. 12-O-Tetradecanoyl phorbol-13-acetate (TPA)-induced growth arrest is increased by silibinin by the down-regulation of cyclin B1 and cdc2 and the up-regulation of p21 expression in MDA-MB231 human breast cancer cells. Phytomedicine 2010;17:1127-32. [DOI: 10.1016/j.phymed.2010.03.013] [Cited by in Crossref: 16] [Cited by in F6Publishing: 11] [Article Influence: 1.3] [Reference Citation Analysis]
207 Moschovi M, Alexiou GA, Patereli A, Stefanaki K, Doussis-Anagnostopoulou I, Stofas A, Sfakianos G, Prodromou N. Prognostic significance of cyclin A and B1 in pediatric embryonal tumors. J Neurooncol 2011;103:699-704. [PMID: 21069428 DOI: 10.1007/s11060-010-0451-y] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 0.8] [Reference Citation Analysis]
208 Sawey ET, Chanrion M, Cai C, Wu G, Zhang J, Zender L, Zhao A, Busuttil RW, Yee H, Stein L. Identification of a therapeutic strategy targeting amplified FGF19 in liver cancer by Oncogenomic screening. Cancer Cell. 2011;19:347-358. [PMID: 21397858 DOI: 10.1016/j.ccr.2011.01.040] [Cited by in Crossref: 269] [Cited by in F6Publishing: 255] [Article Influence: 24.5] [Reference Citation Analysis]
209 Blanchard JM. Cyclin A2 transcriptional regulation: modulation of cell cycle control at the G1/S transition by peripheral cues. Biochem Pharmacol 2000;60:1179-84. [PMID: 11007956 DOI: 10.1016/s0006-2952(00)00384-1] [Cited by in Crossref: 45] [Cited by in F6Publishing: 31] [Article Influence: 2.0] [Reference Citation Analysis]
210 Ju Z, Zhang J, Gao Y, Cheng T. Telomere dysfunction and cell cycle checkpoints in hematopoietic stem cell aging. Int J Hematol. 2011;94:33-43. [PMID: 21671044 DOI: 10.1007/s12185-011-0882-z] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 0.6] [Reference Citation Analysis]
211 Despouy G, Bastie JN, Deshaies S, Balitrand N, Mazharian A, Rochette-Egly C, Chomienne C, Delva L. Cyclin D3 is a cofactor of retinoic acid receptors, modulating their activity in the presence of cellular retinoic acid-binding protein II. J Biol Chem 2003;278:6355-62. [PMID: 12482873 DOI: 10.1074/jbc.M210697200] [Cited by in Crossref: 29] [Cited by in F6Publishing: 17] [Article Influence: 1.5] [Reference Citation Analysis]
212 Akiyama T, Sugiyama K, Shimizu M, Tamaoki T, Akinaga S. G1-checkpoint function including a cyclin-dependent kinase 2 regulatory pathway as potential determinant of 7-hydroxystaurosporine (UCN-01)-induced apoptosis and G1-phase accumulation. Jpn J Cancer Res 1999;90:1364-72. [PMID: 10665655 DOI: 10.1111/j.1349-7006.1999.tb00721.x] [Cited by in Crossref: 17] [Cited by in F6Publishing: 13] [Article Influence: 0.8] [Reference Citation Analysis]
213 Nettelbeck DM, Jérôme V, Müller R. Gene therapy: designer promoters for tumour targeting. Trends Genet 2000;16:174-81. [PMID: 10729833 DOI: 10.1016/s0168-9525(99)01950-2] [Cited by in Crossref: 157] [Cited by in F6Publishing: 32] [Article Influence: 7.1] [Reference Citation Analysis]
214 Muñiz LC, Yehia G, Mémin E, Ratnakar PV, Molina CA. Transcriptional Regulation of Cyclin D2 by the PKA Pathway and Inducible cAMP Early Repressor in Granulosa Cells1. Biology of Reproduction 2006;75:279-88. [DOI: 10.1095/biolreprod.105.049486] [Cited by in Crossref: 18] [Cited by in F6Publishing: 18] [Article Influence: 1.1] [Reference Citation Analysis]
215 Bauer S, Rasika S, Han J, Mauduit C, Raccurt M, Morel G, Jourdan F, Benahmed M, Moyse E, Patterson PH. Leukemia inhibitory factor is a key signal for injury-induced neurogenesis in the adult mouse olfactory epithelium. J Neurosci 2003;23:1792-803. [PMID: 12629183 [PMID: 12629183 DOI: 10.1523/jneurosci.23-05-01792.2003] [Cited by in Crossref: 106] [Article Influence: 5.6] [Reference Citation Analysis]
216 Slingerland J, Pagano M. Regulation of the Cell Cycle by the Ubiquitin Pathway. In: Pagano M, editor. Cell Cycle Control. Berlin: Springer Berlin Heidelberg; 1998. pp. 133-47. [DOI: 10.1007/978-3-540-69686-5_6] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.2] [Reference Citation Analysis]
217 Zhou L, Wu F, Jin W, Yan B, Chen X, He Y, Yang W, Du W, Zhang Q, Guo Y, Yuan Q, Dong X, Yu W, Zhang J, Xiao L, Tong P, Shan L, Efferth T. Theabrownin Inhibits Cell Cycle Progression and Tumor Growth of Lung Carcinoma through c-myc-Related Mechanism. Front Pharmacol 2017;8:75. [PMID: 28289384 DOI: 10.3389/fphar.2017.00075] [Cited by in Crossref: 17] [Cited by in F6Publishing: 20] [Article Influence: 3.4] [Reference Citation Analysis]
218 Montoya-durango DE, Ramos KS. Retinoblastoma family of proteins and chromatin epigenetics: a repetitive story in a few LINEs. BioMolecular Concepts 2011;2:233-45. [DOI: 10.1515/bmc.2011.027] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
219 Hajduch M, Skalnikova H, Halada P, Vydra D, Dzubak P, Dziechciarkova M, Strnad M, Radioch D, Gadher SJ, Kovarova H. Cyclin-Dependent Kinase Inhibitors and Cancer: Usefulness of Proteomic Approaches in Assessment of the Molecular Mechanisms and Efficacy of Novel Therapeutics. In: Van Eyk JE, Dunn MJ, editors. Clinical Proteomics. Weinheim: Wiley-VCH Verlag GmbH & Co. KGaA; 2007. pp. 177-202. [DOI: 10.1002/9783527622153.ch13] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
220 Hui AM, Shi YZ, Li X, Takayama T, Makuuchi M. Loss of p16(INK4) protein, alone and together with loss of retinoblastoma protein, correlate with hepatocellular carcinoma progression. Cancer Lett 2000;154:93-9. [PMID: 10799744 DOI: 10.1016/s0304-3835(00)00385-2] [Cited by in Crossref: 23] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
221 Ko HJ, Kim BY, Jung CH, Chun SW, Mok JO, Kim YJ, Park HK, Kim CH, Kim SJ, Byun DW, Suh KI, Yoo MH, Kang SG. DNA methylation of RUNX3 in papillary thyroid cancer. Korean J Intern Med 2012;27:407-10. [PMID: 23269881 DOI: 10.3904/kjim.2012.27.4.407] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]
222 Yasui W, Yokozaki H, Shimamoto F, Tahara H, Tahara E. Molecular-pathological diagnosis of gastrointestinal tissues and its contribution to cancer histopathology. Pathol Int. 1999;49:763-774. [PMID: 10504547 DOI: 10.1046/j.1440-1827.1999.00951.x] [Cited by in Crossref: 21] [Cited by in F6Publishing: 19] [Article Influence: 0.9] [Reference Citation Analysis]
223 Pan H, Yin C, Dyson NJ, Harlow E, Yamasaki L, Van Dyke T. Key roles for E2F1 in signaling p53-dependent apoptosis and in cell division within developing tumors. Mol Cell 1998;2:283-92. [PMID: 9774967 DOI: 10.1016/s1097-2765(00)80273-7] [Cited by in Crossref: 118] [Cited by in F6Publishing: 54] [Article Influence: 4.9] [Reference Citation Analysis]
224 Difilippantonio S, Chen Y, Pietas A, Schlüns K, Pacyna-gengelbach M, Deutschmann N, Padilla-nash H, Ried T, Petersen I. Gene expression profiles in human non-small and small-cell lung cancers. European Journal of Cancer 2003;39:1936-47. [DOI: 10.1016/s0959-8049(03)00419-2] [Cited by in Crossref: 46] [Cited by in F6Publishing: 17] [Article Influence: 2.4] [Reference Citation Analysis]
225 Damalas A, Kahan S, Shtutman M, Ben-Ze'ev A, Oren M. Deregulated beta-catenin induces a p53- and ARF-dependent growth arrest and cooperates with Ras in transformation. EMBO J 2001;20:4912-22. [PMID: 11532955 DOI: 10.1093/emboj/20.17.4912] [Cited by in Crossref: 149] [Cited by in F6Publishing: 141] [Article Influence: 7.1] [Reference Citation Analysis]
226 Gala S, Williamson P. E2F1 promotes cytokine mediated cell survival via a mechanism that is separable from its cell cycle regulatory effects. Immunol Invest 2004;33:173-91. [PMID: 15195696 DOI: 10.1081/imm-120034233] [Reference Citation Analysis]
227 Figueiredo ML, Kim Y, Zhou XC, Myers JN, Wong DD. Molecular mechanisms of head and neck cancer. Drug Discovery Today: Disease Mechanisms 2004;1:273-81. [DOI: 10.1016/j.ddmec.2004.10.003] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
228 Loercher AE, Harbour JW. Molecular genetics of uveal melanoma. Curr Eye Res 2003;27:69-74. [PMID: 14632157 DOI: 10.1076/ceyr.27.2.69.15952] [Cited by in Crossref: 14] [Cited by in F6Publishing: 11] [Article Influence: 0.8] [Reference Citation Analysis]
229 Fink JR, Lebien TW. Novel expression of cyclin-dependent kinase inhibitors in human B-cell precursors. Experimental Hematology 2001;29:490-8. [DOI: 10.1016/s0301-472x(01)00619-1] [Cited by in Crossref: 11] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
230 Boukamp P, Popp S, Bleuel K, Tomakidi E, Bürkle A, Fusenig NE. Tumorigenic conversion of immortal human skin keratinocytes (HaCaT) by elevated temperature. Oncogene 1999;18:5638-45. [DOI: 10.1038/sj.onc.1202934] [Cited by in Crossref: 60] [Cited by in F6Publishing: 50] [Article Influence: 2.6] [Reference Citation Analysis]
231 Ashton KA, Proietto A, Otton G, Symonds I, McEvoy M, Attia J, Gilbert M, Hamann U, Scott RJ. The influence of the Cyclin D1 870 G>A polymorphism as an endometrial cancer risk factor. BMC Cancer 2008;8:272. [PMID: 18822177 DOI: 10.1186/1471-2407-8-272] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 0.5] [Reference Citation Analysis]
232 Yasunaga M, Tabira Y, Kondo K, Okuma T, Kitamura N. The prognostic significance of cell cycle markers in esophageal cancer after neoadjuvant chemotherapy. Dis Esophagus 1999;12:120-7. [PMID: 10466044 DOI: 10.1046/j.1442-2050.1999.00031.x] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.1] [Reference Citation Analysis]
233 Krämer M, Markart P, Drakopanagiotakis F, Mamazhakypov A, Schaefer L, Didiasova M, Wygrecka M. Pirfenidone inhibits motility of NSCLC cells by interfering with the urokinase system. Cellular Signalling 2020;65:109432. [DOI: 10.1016/j.cellsig.2019.109432] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
234 Knudsen ES, Wang JY. Dual mechanisms for the inhibition of E2F binding to RB by cyclin-dependent kinase-mediated RB phosphorylation. Mol Cell Biol 1997;17:5771-83. [PMID: 9315635 DOI: 10.1128/MCB.17.10.5771] [Cited by in Crossref: 191] [Cited by in F6Publishing: 98] [Article Influence: 7.6] [Reference Citation Analysis]
235 Yang J, Sun Y, Liu X, Xu F, Liu W, Hayashi T, Imamura Y, Mizuno K, Hattori S, Tanaka K, Fujisaki H, Tashiro S, Onodera S, Ikejima T. Silibinin’s regulation of proliferation and collagen gene expressions of rat pancreatic β-cells cultured on types I and V collagen involves β-catenin nuclear translocation. Connective Tissue Research 2019;60:463-76. [DOI: 10.1080/03008207.2019.1593393] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
236 Yoneda K, Yamamoto T, Ueta E, Osaki T. Induction of cyclin-dependent kinase inhibitor p21 in vesnarinone-induced differentiation of squamous cell carcinoma cells. Cancer Lett. 1998;133:35-45. [PMID: 9929158 DOI: 10.1016/s0304-3835(98)00187-6] [Cited by in Crossref: 9] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
237 Ibañez IL, Policastro LL, Tropper I, Bracalente C, Palmieri MA, Rojas PA, Molinari BL, Durán H. H2O2 scavenging inhibits G1/S transition by increasing nuclear levels of p27KIP1. Cancer Letters 2011;305:58-68. [DOI: 10.1016/j.canlet.2011.02.026] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 1.1] [Reference Citation Analysis]
238 Cottone G, Baldi A, Palescandolo E, Manente L, Penta R, Paggi MG, De Luca A. Pkn is a novel partner of cyclin T2a in muscle differentiation. J Cell Physiol 2006;207:232-7. [PMID: 16331689 DOI: 10.1002/jcp.20566] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 0.6] [Reference Citation Analysis]
239 Wang W, Zhang R, Wang J, Tang J, Wang M, Kuang Y. Antitumour Activity of Muricatacin Isomers and its Derivatives in Human Colorectal Carcinoma Cell HCT116. Anticancer Agents Med Chem 2020;20:254-63. [PMID: 31729294 DOI: 10.2174/1871520619666191115111032] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
240 Mcinnes C. REPLACE Strategy for Generating Non-ATP-Competitive Inhibitors of Cell Cycle Protein Kinases. In: Dömling A, editor. Protein-Protein Interactions in Drug Discovery. Weinheim: Wiley-VCH Verlag GmbH & Co. KGaA; 2013. pp. 291-304. [DOI: 10.1002/9783527648207.ch12] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
241 Arcuri C, Bianchi R, Brozzi F, Donato R. S100B increases proliferation in PC12 neuronal cells and reduces their responsiveness to nerve growth factor via Akt activation. J Biol Chem. 2005;280:4402-4414. [PMID: 15572370 DOI: 10.1074/jbc.m406440200] [Cited by in Crossref: 52] [Cited by in F6Publishing: 24] [Article Influence: 2.9] [Reference Citation Analysis]
242 Brennan P. Signalling events regulating lymphoid growth and survival. Seminars in Cancer Biology 2001;11:415-21. [DOI: 10.1006/scbi.2001.0408] [Cited by in Crossref: 13] [Cited by in F6Publishing: 15] [Article Influence: 0.6] [Reference Citation Analysis]
243 Derenzini M, Montanaro L, Trerè D. Ribosome biogenesis and cancer. Acta Histochem 2017;119:190-7. [PMID: 28168996 DOI: 10.1016/j.acthis.2017.01.009] [Cited by in Crossref: 58] [Cited by in F6Publishing: 57] [Article Influence: 11.6] [Reference Citation Analysis]
244 Vessey CJ, Norbury CJ, Hickson ID. Genetic Disorders Associated with Cancer Predisposition and Genomic Instability. Elsevier; 1999. pp. 189-221. [DOI: 10.1016/s0079-6603(08)60723-0] [Cited by in F6Publishing: 13] [Reference Citation Analysis]
245 Byth KF, Cooper N, Culshaw JD, Heaton DW, Oakes SE, Minshull CA, Norman RA, Pauptit RA, Tucker JA, Breed J, Pannifer A, Rowsell S, Stanway JJ, Valentine AL, Thomas AP. Imidazo[1,2-b]pyridazines: a potent and selective class of cyclin-dependent kinase inhibitors. Bioorg Med Chem Lett 2004;14:2249-52. [PMID: 15081018 DOI: 10.1016/j.bmcl.2004.02.008] [Cited by in Crossref: 58] [Cited by in F6Publishing: 45] [Article Influence: 3.2] [Reference Citation Analysis]
246 Nakanishi K, Kawai T, Aida S, Kasamatsu H, Aurues T, Ikeda T. Expression of p27Kip1 Protein in Transitional Cell Carcinoma of the Upper Urinary Tract. Mod Pathol 2001;14:371-6. [DOI: 10.1038/modpathol.3880320] [Cited by in Crossref: 12] [Cited by in F6Publishing: 9] [Article Influence: 0.6] [Reference Citation Analysis]
247 Chen T, Stephens PA, Middleton FK, Curtin NJ. Targeting the S and G2 checkpoint to treat cancer. Drug Discov Today. 2012;17:194-202. [PMID: 22192883 DOI: 10.1016/j.drudis.2011.12.009] [Cited by in Crossref: 109] [Cited by in F6Publishing: 99] [Article Influence: 9.9] [Reference Citation Analysis]
248 Wali A, Strayer DS. Comparative Effects of Virulent and Avirulent Poxviruses on Cell Cycle Progression. Experimental and Molecular Pathology 1999;66:31-8. [DOI: 10.1006/exmp.1999.2249] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.2] [Reference Citation Analysis]
249 Pevarello P, Villa M. Cyclin-dependent kinase inhibitors: a survey of the recent patent literature. Expert Opinion on Therapeutic Patents 2005;15:675-703. [DOI: 10.1517/13543776.15.6.675] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 0.7] [Reference Citation Analysis]
250 Schmidt M, Fan Z. Protection against chemotherapy-induced cytotoxicity by cyclin-dependent kinase inhibitors (CKI) in CKI-responsive cells compared with CKI-unresponsive cells. Oncogene 2001;20:6164-71. [PMID: 11593424 DOI: 10.1038/sj.onc.1204814] [Cited by in Crossref: 27] [Cited by in F6Publishing: 25] [Article Influence: 1.3] [Reference Citation Analysis]
251 Parker JE, Mufti GJ. The Role of Apoptosis in the Pathogenesis of the Myelodysplastic Syndromes. Int J Hematol 2001;73:416-28. [DOI: 10.1007/bf02994003] [Cited by in Crossref: 33] [Cited by in F6Publishing: 7] [Article Influence: 1.6] [Reference Citation Analysis]
252 Pibiri M, Ledda-columbano GM, Cossu C, Simbula G, Menegazzi M, Shinozuka H, Columbano A. Cyclin D1 is an early target in hepatocyte proliferation induced by thyroid hormone (T3). The FASEB Journal 2001;15:1006-13. [DOI: 10.1096/fj.00-0416com] [Cited by in Crossref: 80] [Cited by in F6Publishing: 86] [Article Influence: 3.8] [Reference Citation Analysis]
253 Goudreau G, Bäumer N, Gruss P. Transcription Factors in Early Lens Development. In: Lovicu FJ, Robinson ML, editors. Development of the Ocular Lens. Cambridge University Press; 2010. pp. 48-68. [DOI: 10.1017/cbo9780511529825.004] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
254 Fisher RP. The CDK Network: Linking Cycles of Cell Division and Gene Expression. Genes Cancer 2012;3:731-8. [PMID: 23634260 DOI: 10.1177/1947601912473308] [Cited by in Crossref: 59] [Cited by in F6Publishing: 54] [Article Influence: 6.6] [Reference Citation Analysis]
255 Yuan DZ, Lei Y, Zhao D, Pan JL, Zhao YB, Nie L, Liu M, Long Y, Zhang JH, Yue LM. Progesterone-Induced miR-145/miR-143 Inhibits the Proliferation of Endometrial Epithelial Cells. Reprod Sci 2019;26:233-43. [PMID: 29661100 DOI: 10.1177/1933719118768687] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 1.5] [Reference Citation Analysis]
256 Sasaki T, Katayose Y, Yamamoto K, Mizuma M, Shiraso S, Yabuuchi S, Oda A, Rikiyama T, Oikawa M, Onogawa T, Suzuki M, Lee C, Unno M. Adenovirus Expressing Mutant p27 kip1 Enhanced Apoptosis and Inhibited the Growth of Xenografted Human Breast Cancer. Surg Today 2007;37:1073-82. [DOI: 10.1007/s00595-007-3546-0] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
257 Erlanson M, Portin C, Linderholm B, Lindh J, Roos G, Landberg G. Expression of Cyclin E and the Cyclin-Dependent Kinase Inhibitor p27 in Malignant Lymphomas—Prognostic Implications. Blood 1998;92:770-7. [DOI: 10.1182/blood.v92.3.770.415k37_770_777] [Cited by in Crossref: 4] [Article Influence: 0.2] [Reference Citation Analysis]
258 Liu L, Broaddus RR, Yao JC, Xie S, White JA, Wu TT, Hamilton SR, Rashid A. Epigenetic alterations in neuroendocrine tumors: methylation of RAS-association domain family 1, isoform A and p16 genes are associated with metastasis. Mod Pathol. 2005;18:1632-1640. [PMID: 16258509 DOI: 10.1038/modpathol.3800490] [Cited by in Crossref: 62] [Cited by in F6Publishing: 56] [Article Influence: 3.9] [Reference Citation Analysis]
259 Liu J, Cui T, Ding Y. Biomimetic gold nanoparticles. Composites Communications 2018;10:209-16. [DOI: 10.1016/j.coco.2018.10.011] [Cited by in Crossref: 8] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
260 Tao W, Zhang S, Turenchalk GS, Stewart RA, St John MA, Chen W, Xu T. Human homologue of the Drosophila melanogaster lats tumour suppressor modulates CDC2 activity. Nat Genet. 1999;21:177-181. [PMID: 9988268 DOI: 10.1038/5960] [Cited by in Crossref: 185] [Cited by in F6Publishing: 181] [Article Influence: 8.0] [Reference Citation Analysis]
261 Cen WJ, Feng Y, Li SS, Huang LW, Zhang T, Zhang W, Kong WD, Jiang JW. Iron overload induces G1 phase arrest and autophagy in murine preosteoblast cells. J Cell Physiol 2018;233:6779-89. [PMID: 29244196 DOI: 10.1002/jcp.26405] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 3.8] [Reference Citation Analysis]
262 Suzuki T, Urano T, Miki Y, Moriya T, Akahira J, Ishida T, Horie K, Inoue S, Sasano H. Nuclear cyclin B1 in human breast carcinoma as a potent prognostic factor. Cancer Science 2007;98:644-51. [DOI: 10.1111/j.1349-7006.2007.00444.x] [Cited by in Crossref: 71] [Cited by in F6Publishing: 69] [Article Influence: 4.7] [Reference Citation Analysis]
263 Jiménez-orozco FA, López-gonzález JS, Nieto-rodriguez A, Velasco-velázquez MA, Molina-guarneros JA, Mendoza-patiño N, Garcı́a-mondragón MJ, Elizalde-galvan P, León-cedeño F, Mandoki JJ. Decrease of cyclin D1 in the human lung adenocarcinoma cell line A-427 by 7-hydroxycoumarin. Lung Cancer 2001;34:185-94. [DOI: 10.1016/s0169-5002(01)00263-x] [Cited by in Crossref: 39] [Cited by in F6Publishing: 8] [Article Influence: 1.9] [Reference Citation Analysis]
264 O'Reilly MA, Staversky RJ, Watkins RH, Maniscalco WM. Accumulation of p21(Cip1/WAF1) during hyperoxic lung injury in mice. Am J Respir Cell Mol Biol 1998;19:777-85. [PMID: 9806742 DOI: 10.1165/ajrcmb.19.5.3200] [Cited by in Crossref: 54] [Cited by in F6Publishing: 52] [Article Influence: 2.3] [Reference Citation Analysis]
265 Asavaroengchai W, Wang H, Wang S, Wang L, Bronson R, Sykes M, Yang YG. An essential role for IFN-gamma in regulation of alloreactive CD8 T cells following allogeneic hematopoietic cell transplantation. Biol Blood Marrow Transplant 2007;13:46-55. [PMID: 17222752 DOI: 10.1016/j.bbmt.2006.09.014] [Cited by in Crossref: 33] [Cited by in F6Publishing: 36] [Article Influence: 2.2] [Reference Citation Analysis]
266 Lee YM, Lim DY, Choi HJ, Jung JI, Chung WY, Park JH. Induction of cell cycle arrest in prostate cancer cells by the dietary compound isoliquiritigenin. J Med Food 2009;12:8-14. [PMID: 19298190 DOI: 10.1089/jmf.2008.0039] [Cited by in Crossref: 31] [Cited by in F6Publishing: 34] [Article Influence: 2.4] [Reference Citation Analysis]
267 Natarajan U, Venkatesan T, Radhakrishnan V, Samuel S, Rasappan P, Rathinavelu A. Cell Cycle Arrest and Cytotoxic Effects of SAHA and RG7388 Mediated through p21WAF1/CIP1 and p27KIP1 in Cancer Cells. Medicina (Kaunas) 2019;55:E30. [PMID: 30700046 DOI: 10.3390/medicina55020030] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
268 Zhang YW, Morita I, Ikeda M, Ma KW, Murota S. Connexin43 suppresses proliferation of osteosarcoma U2OS cells through post-transcriptional regulation of p27. Oncogene 2001;20:4138-49. [PMID: 11464280 DOI: 10.1038/sj.onc.1204563] [Cited by in Crossref: 89] [Cited by in F6Publishing: 85] [Article Influence: 4.2] [Reference Citation Analysis]
269 Chang Y, Chi C, Chern Y, Wang J. Effects of 1, 6-Bis[4-(4-amino-3-hydroxyphenoxy)phenyl]diamantane (DPD), a reactive oxygen species and apoptosis inducing agent, on human leukemia cells in vitro and in vivo. Toxicology and Applied Pharmacology 2005;202:1-12. [DOI: 10.1016/j.taap.2004.06.013] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 0.5] [Reference Citation Analysis]
270 Rosenwald IB, Hutzler MJ, Wang S, Savas L, Fraire AE. Expression of eukaryotic translation initiation factors 4E and 2alpha is increased frequently in bronchioloalveolar but not in squamous cell carcinomas of the lung. Cancer 2001;92:2164-71. [PMID: 11596034 DOI: 10.1002/1097-0142(20011015)92:8<2164::aid-cncr1559>3.0.co;2-a] [Cited by in Crossref: 75] [Cited by in F6Publishing: 37] [Article Influence: 3.6] [Reference Citation Analysis]
271 Hama S, Matsuura S, Tauchi H, Yamasaki F, Kajiwara Y, Arita K, Yoshioka H, Heike Y, Mandai K, Kurisu K. p16 Gene transfer increases cell killing with abnormal nucleation after ionising radiation in glioma cells. Br J Cancer 2003;89:1802-11. [PMID: 14583787 DOI: 10.1038/sj.bjc.6601299] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 0.6] [Reference Citation Analysis]
272 Decker T, Hipp S, Ringshausen I, Bogner C, Oelsner M, Schneller F, Peschel C. Rapamycin-induced G1 arrest in cycling B-CLL cells is associated with reduced expression of cyclin D3, cyclin E, cyclin A, and survivin. Blood. 2003;101:278-285. [PMID: 12393642 DOI: 10.1182/blood-2002-01-0189] [Cited by in Crossref: 127] [Cited by in F6Publishing: 121] [Article Influence: 6.4] [Reference Citation Analysis]
273 Billon N, Carlisi D, Datto MB, Grunsven LAV, Watt A, Wang X, Rudkin BB. Cooperation of Sp1 and p300 in the induction of the CDK inhibitor p21WAF1/CIP1 during NGF-mediated neuronal differentiation. Oncogene 1999;18:2872-82. [DOI: 10.1038/sj.onc.1202712] [Cited by in Crossref: 110] [Cited by in F6Publishing: 105] [Article Influence: 4.8] [Reference Citation Analysis]
274 Riou-Khamlichi C, Menges M, Healy JM, Murray JA. Sugar control of the plant cell cycle: differential regulation of Arabidopsis D-type cyclin gene expression. Mol Cell Biol 2000;20:4513-21. [PMID: 10848578 DOI: 10.1128/MCB.20.13.4513-4521.2000] [Cited by in Crossref: 290] [Cited by in F6Publishing: 111] [Article Influence: 13.2] [Reference Citation Analysis]
275 Nakasu S, Nakajima M, Handa J. Anomalous p27kip1 expression in a subset of malignant gliomas. Brain Tumor Pathol 1999;16:17-21. [DOI: 10.1007/bf02478897] [Cited by in Crossref: 11] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
276 Wierstra I, Alves J. The c‐myc Promoter: Still MysterY and Challenge. Elsevier; 2008. pp. 113-333. [DOI: 10.1016/s0065-230x(07)99004-1] [Cited by in Crossref: 133] [Cited by in F6Publishing: 79] [Article Influence: 9.5] [Reference Citation Analysis]
277 Ranki T, Särkioja M, Hakkarainen T, von Smitten K, Kanerva A, Hemminki A. Systemic efficacy of oncolytic adenoviruses in imagable orthotopic models of hormone refractory metastatic breast cancer. Int J Cancer 2007;121:165-74. [PMID: 17315187 DOI: 10.1002/ijc.22627] [Cited by in Crossref: 24] [Cited by in F6Publishing: 25] [Article Influence: 1.6] [Reference Citation Analysis]
278 Porter DC, Zhang N, Danes C, McGahren MJ, Harwell RM, Faruki S, Keyomarsi K. Tumor-specific proteolytic processing of cyclin E generates hyperactive lower-molecular-weight forms. Mol Cell Biol. 2001;21:6254-6269. [PMID: 11509668 DOI: 10.1128/MCB.21.18.6254-6269.2001] [Cited by in Crossref: 125] [Cited by in F6Publishing: 64] [Article Influence: 6.0] [Reference Citation Analysis]
279 Dias JD, Hemminki O, Diaconu I, Hirvinen M, Bonetti A, Guse K, Escutenaire S, Kanerva A, Pesonen S, Löskog A. Targeted cancer immunotherapy with oncolytic adenovirus coding for a fully human monoclonal antibody specific for CTLA-4. Gene Ther. 2012;19:988-998. [PMID: 22071969 DOI: 10.1038/gt.2011.176] [Cited by in Crossref: 92] [Cited by in F6Publishing: 95] [Article Influence: 8.4] [Reference Citation Analysis]
280 Pillay OC, Te Fong LF, Crow JC, Benjamin E, Mould T, Atiomo W, Menon PA, Leonard AJ, Hardiman P. The association between polycystic ovaries and endometrial cancer. Hum Reprod 2006;21:924-9. [PMID: 16361289 DOI: 10.1093/humrep/dei420] [Cited by in Crossref: 75] [Cited by in F6Publishing: 61] [Article Influence: 4.4] [Reference Citation Analysis]
281 Lu T, Li J, Xu W. The role of SOX11 in mantle cell lymphoma. Leukemia Research 2013;37:1412-9. [DOI: 10.1016/j.leukres.2013.07.039] [Cited by in Crossref: 16] [Cited by in F6Publishing: 15] [Article Influence: 1.8] [Reference Citation Analysis]
282 Shen A, Liu L, Chen H, Qi F, Huang Y, Lin J, Sferra TJ, Sankararaman S, Wei L, Chu J, Chen Y, Peng J. Cell division cycle associated 5 promotes colorectal cancer progression by activating the ERK signaling pathway. Oncogenesis 2019;8:19. [PMID: 30808873 DOI: 10.1038/s41389-019-0123-5] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 4.3] [Reference Citation Analysis]
283 Jeon EM, Choi HC, Lee KY, Chang KC, Kang YJ. Hemin inhibits hypertensive rat vascular smooth muscle cell proliferation through regulation of cyclin D and p21. Arch Pharm Res 2009;32:375-82. [PMID: 19387581 DOI: 10.1007/s12272-009-1310-2] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 1.0] [Reference Citation Analysis]
284 Pruneri G, Pignataro L, Carboni N, Buffa R, Di Finizio D, Cesana BM, Neri A. Clinical Relevance of Expression of the CIP/KIP Cell-Cycle Inhibitors p21 and p27 in Laryngeal Cancer. JCO 1999;17:3150-9. [DOI: 10.1200/jco.1999.17.10.3150] [Cited by in Crossref: 49] [Cited by in F6Publishing: 8] [Article Influence: 2.1] [Reference Citation Analysis]
285 Singh U, Null K, Sinha R. In vitro growth inhibition of mouse mammary epithelial tumor cells by methylseleninic acid: involvement of protein kinases. Mol Nutr Food Res 2008;52:1281-8. [PMID: 18686292 DOI: 10.1002/mnfr.200700356] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 0.8] [Reference Citation Analysis]
286 Kawaguchi Y, Van Sant C, Roizman B. Herpes simplex virus 1 alpha regulatory protein ICP0 interacts with and stabilizes the cell cycle regulator cyclin D3. J Virol 1997;71:7328-36. [PMID: 9311810 DOI: 10.1128/JVI.71.10.7328-7336.1997] [Cited by in Crossref: 201] [Cited by in F6Publishing: 168] [Article Influence: 8.0] [Reference Citation Analysis]
287 De Marzo AM, Nelson WG, Meeker AK, Coffey DS. Stem cell features of benign and malignant prostate epithelial cells. J Urol 1998;160:2381-92. [PMID: 9817389 DOI: 10.1097/00005392-199812020-00004] [Cited by in Crossref: 12] [Cited by in F6Publishing: 53] [Article Influence: 0.5] [Reference Citation Analysis]
288 Lodén M, Nielsen NH, Roos G, Emdin SO, Landberg G. Cyclin E dependent kinase activity in human breast cancer in relation to cyclin E, p27 and p21 expression and retinoblastoma protein phosphorylation. Oncogene. 1999;18:2557-2566. [PMID: 10353599 DOI: 10.1038/sj.onc.1202488] [Cited by in Crossref: 30] [Cited by in F6Publishing: 37] [Article Influence: 1.3] [Reference Citation Analysis]
289 Piperno-neumann S, Oudar O, Reynier P, Briane D, Cao A, Jaurand M, Naejus R, Kraemer M, Breau J, Taillandier E. Transfer into a mesothelioma cell line of tumor suppressor gene p16 by cholesterol-based cationic lipids. Biochimica et Biophysica Acta (BBA) - Biomembranes 2003;1611:131-9. [DOI: 10.1016/s0005-2736(03)00034-8] [Cited by in Crossref: 4] [Article Influence: 0.2] [Reference Citation Analysis]
290 Bao Y, Yuan Y, Xia L, Jiang H, Wu W, Zhang X. Neutral lipid isolated from endosperm of Job's tears inhibits the growth of pancreatic cancer cells via apoptosis, G2/M arrest, and regulation of gene expression. J Gastroenterol Hepatol 2005;20:1046-53. [PMID: 15955213 DOI: 10.1111/j.1440-1746.2005.03864.x] [Cited by in Crossref: 10] [Cited by in F6Publishing: 7] [Article Influence: 0.6] [Reference Citation Analysis]
291 Knillová J, Kolář Z, Hlobilková A. THE SIGNIFICANCE OF KEY REGULATORS OF APOPTOSIS IN THE DEVELOPMENT AND PROGNOSIS OF PROSTATE CARCINOMA. II. PRODUCTS OF SUPPRESSOR GENES RB AND PTEN, CDKI, FAS. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub 2003;147:11-7. [DOI: 10.5507/bp.2003.002] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.1] [Reference Citation Analysis]
292 Hongo F, Takaha N, Oishi M, Ueda T, Nakamura T, Naitoh Y, Naya Y, Kamoi K, Okihara K, Matsushima T, Nakayama S, Ishihara H, Sakai T, Miki T. CDK1 and CDK2 activity is a strong predictor of renal cell carcinoma recurrence. Urologic Oncology: Seminars and Original Investigations 2014;32:1240-6. [DOI: 10.1016/j.urolonc.2014.05.006] [Cited by in Crossref: 33] [Cited by in F6Publishing: 31] [Article Influence: 4.1] [Reference Citation Analysis]
293 Hateboer G, Wobst A, Petersen BO, Le Cam L, Vigo E, Sardet C, Helin K. Cell cycle-regulated expression of mammalian CDC6 is dependent on E2F. Mol Cell Biol 1998;18:6679-97. [PMID: 9774682 DOI: 10.1128/MCB.18.11.6679] [Cited by in Crossref: 125] [Cited by in F6Publishing: 71] [Article Influence: 5.2] [Reference Citation Analysis]
294 Lelliott EJ, McArthur GA, Oliaro J, Sheppard KE. Immunomodulatory Effects of BRAF, MEK, and CDK4/6 Inhibitors: Implications for Combining Targeted Therapy and Immune Checkpoint Blockade for the Treatment of Melanoma. Front Immunol 2021;12:661737. [PMID: 34025662 DOI: 10.3389/fimmu.2021.661737] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
295 Kawauchi S, Goto Y, Liu XP, Furuya T, Oga A, Oda Y, Tsuneyoshi M, Ihara K, Sasaki K. Low expression of p27Kip1, a cyclin-dependent kinase inhibitor, is a marker of poor prognosis in synovial sarcoma. Cancer 2001;91:1005-12. [DOI: 10.1002/1097-0142(20010301)91:5<1005::aid-cncr1091>3.0.co;2-o] [Cited by in Crossref: 25] [Article Influence: 1.2] [Reference Citation Analysis]
296 Roh MS, Hong SH, Jeong JS, Kwon HC, Kim MC, Cho SH, Yoon JH, Hwang TH. Gene expression profiling of breast cancers with emphasis of beta-catenin regulation. J Korean Med Sci 2004;19:275-82. [PMID: 15082903 DOI: 10.3346/jkms.2004.19.2.275] [Cited by in Crossref: 21] [Cited by in F6Publishing: 16] [Article Influence: 1.2] [Reference Citation Analysis]
297 Wen H, Ao S. Identification and characterization of a novel human cDNA encoding a 21 kDa pRb-associated protein. Gene 2001;263:85-92. [DOI: 10.1016/s0378-1119(00)00585-0] [Cited by in Crossref: 7] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
298 Zhou XQ, Sun Q, Jiang L, Li ST, Gu W, Tian JL, Liu X, Yan SP. Synthesis, characterization, DNA/BSA interactions and anticancer activity of achiral and chiral copper complexes. Dalton Trans 2015;44:9516-27. [PMID: 25919814 DOI: 10.1039/c5dt00931f] [Cited by in Crossref: 39] [Cited by in F6Publishing: 2] [Article Influence: 6.5] [Reference Citation Analysis]
299 Moreau JL, Marques F, Barakat A, Schatt P, Lozano JC, Peaucellier G, Picard A, Genevière AM. Cdk2 activity is dispensable for the onset of DNA replication during the first mitotic cycles of the sea urchin early embryo. Dev Biol 1998;200:182-97. [PMID: 9705226 DOI: 10.1006/dbio.1998.8961] [Cited by in Crossref: 31] [Cited by in F6Publishing: 30] [Article Influence: 1.3] [Reference Citation Analysis]
300 Jirawatnotai S, Moons DS, Stocco CO, Franks R, Hales DB, Gibori G, Kiyokawa H. The Cyclin-dependent Kinase Inhibitors p27Kip1 and p21Cip1 Cooperate to Restrict Proliferative Life Span in Differentiating Ovarian Cells. Journal of Biological Chemistry 2003;278:17021-7. [DOI: 10.1074/jbc.m301206200] [Cited by in Crossref: 49] [Cited by in F6Publishing: 14] [Article Influence: 2.6] [Reference Citation Analysis]
301 Strobeck MW, Fribourg AF, Puga A, Knudsen ES. Restoration of retinoblastoma mediated signaling to Cdk2 results in cell cycle arrest. Oncogene 2000;19:1857-67. [DOI: 10.1038/sj.onc.1203510] [Cited by in Crossref: 56] [Cited by in F6Publishing: 59] [Article Influence: 2.5] [Reference Citation Analysis]
302 Dobashi Y. Cell cycle regulation and its aberrations in human lung carcinoma. Pathol Int 2005;55:95-105. [PMID: 15743317 DOI: 10.1111/j.1440-1827.2005.01799.x] [Cited by in Crossref: 17] [Cited by in F6Publishing: 15] [Article Influence: 1.0] [Reference Citation Analysis]
303 Saqub H, Proetsch-Gugerbauer H, Bezrookove V, Nosrati M, Vaquero EM, de Semir D, Ice RJ, McAllister S, Soroceanu L, Kashani-Sabet M, Osorio R, Dar AA. Dinaciclib, a cyclin-dependent kinase inhibitor, suppresses cholangiocarcinoma growth by targeting CDK2/5/9. Sci Rep 2020;10:18489. [PMID: 33116269 DOI: 10.1038/s41598-020-75578-5] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 3.5] [Reference Citation Analysis]
304 Beadling C, Cereseto A, Fan W, Naramura M, Smith KA. Cytokine response gene 8 (CR8) regulates the cell cycle G1-S phase transition and promotes cellular survival. Oncogene 2001;20:1771-83. [PMID: 11313924 DOI: 10.1038/sj.onc.1204212] [Cited by in Crossref: 4] [Cited by in F6Publishing: 7] [Article Influence: 0.2] [Reference Citation Analysis]
305 Ledda-columbano GM, Pibiri M, Cossu C, Molotzu F, Locker J, Columbano A. Aging does not reduce the hepatocyte proliferative response of mice to the primary mitogen TCPOBOP. Hepatology 2004;40:981-8. [DOI: 10.1002/hep.1840400429] [Cited by in Crossref: 36] [Cited by in F6Publishing: 15] [Article Influence: 2.0] [Reference Citation Analysis]
306 Lebe B, Saǧol Ö, Ulukuş Ç, Çoker A, Karademir S, Astarcιoglu H, Küpelioǧlu A, Astarcιoǧlu I, Obuz F. The importance of cyclin D1 and Ki67 expression on the biological behavior of pancreatic adenocarcinomas. Pathology - Research and Practice 2004;200:389-96. [DOI: 10.1016/j.prp.2004.02.010] [Cited by in Crossref: 21] [Cited by in F6Publishing: 20] [Article Influence: 1.2] [Reference Citation Analysis]
307 Hara KT, Oda S, Naito K, Nagata M, Schultz RM, Aoki F. Cyclin A2-CDK2 regulates embryonic gene activation in 1-cell mouse embryos. Dev Biol 2005;286:102-13. [PMID: 16137671 DOI: 10.1016/j.ydbio.2005.07.012] [Cited by in Crossref: 18] [Cited by in F6Publishing: 18] [Article Influence: 1.1] [Reference Citation Analysis]
308 Tahara T, Shibata T, Yamashita H, Hirata I, Arisawa T. Effect of cyclin D1 (CCND1) polymorphism on gastric premalignant condition. Clin Chem Lab Med 2008;46:1696-701. [PMID: 19055446 DOI: 10.1515/CCLM.2008.340] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
309 Tsao H, Sober AJ. Ultraviolet radiation and malignant melanoma. Clinics in Dermatology 1998;16:67-73. [DOI: 10.1016/s0738-081x(97)00191-0] [Cited by in Crossref: 26] [Cited by in F6Publishing: 1] [Article Influence: 1.1] [Reference Citation Analysis]
310 Yuan K, Wang X, Dong H, Min W, Hao H, Yang P. Selective inhibition of CDK4/6: A safe and effective strategy for developing anticancer drugs. Acta Pharm Sin B 2021;11:30-54. [PMID: 33532179 DOI: 10.1016/j.apsb.2020.05.001] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 3.5] [Reference Citation Analysis]
311 Chang H, Jiang N, Jiang H, Saha MN, Qi C, Xu W, Reece D. CKS1B nuclear expression is inversely correlated with p27Kip1 expression and is predictive of an adverse survival in patients with multiple myeloma. Haematologica 2010;95:1542-7. [PMID: 20421271 DOI: 10.3324/haematol.2010.022210] [Cited by in Crossref: 23] [Cited by in F6Publishing: 18] [Article Influence: 1.9] [Reference Citation Analysis]
312 Akçay Nİ, Bashirov R, Tüzmen Ş. Validation of signalling pathways: Case study of the p16-mediated pathway. J Bioinform Comput Biol 2015;13:1550007. [DOI: 10.1142/s0219720015500079] [Cited by in Crossref: 6] [Cited by in F6Publishing: 1] [Article Influence: 0.9] [Reference Citation Analysis]
313 Kawano M, Tanaka K, Itonaga I, Iwasaki T, Tsumura H. c-Myc Represses Tumor-Suppressive microRNAs, let-7a, miR-16 and miR-29b, and Induces Cyclin D2-Mediated Cell Proliferation in Ewing's Sarcoma Cell Line. PLoS One 2015;10:e0138560. [PMID: 26393798 DOI: 10.1371/journal.pone.0138560] [Cited by in Crossref: 23] [Cited by in F6Publishing: 24] [Article Influence: 3.3] [Reference Citation Analysis]
314 Pahl PM, Horwitz MA, Horwitz KB, Horwitz LD. Desferri-exochelin induces death by apoptosis in human breast cancer cells but does not kill normal breast cells. Breast Cancer Res Treat 2001;69:69-79. [DOI: 10.1023/a:1012211828319] [Cited by in Crossref: 32] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
315 Bishnupuri KS, Sainathan SK, Bishnupuri K, Leahy DR, Luo Q, Anant S, Houchen CW, Dieckgraefe BK. Reg4-induced mitogenesis involves Akt-GSK3β-β-Catenin-TCF-4 signaling in human colorectal cancer. Mol Carcinog 2014;53 Suppl 1:E169-80. [PMID: 24151146 DOI: 10.1002/mc.22088] [Cited by in Crossref: 21] [Cited by in F6Publishing: 21] [Article Influence: 2.3] [Reference Citation Analysis]
316 Kim TY, Kaelin WG Jr. Differential control of transcription by DNA-bound cyclins. Mol Biol Cell 2001;12:2207-17. [PMID: 11452014 DOI: 10.1091/mbc.12.7.2207] [Cited by in Crossref: 13] [Cited by in F6Publishing: 15] [Article Influence: 0.6] [Reference Citation Analysis]
317 Mizesko MC, Grewe C, Grabner A, Miller MS. Alterations at the Ink4a locus in transplacentally induced murine lung tumors. Cancer Lett 2001;172:59-66. [PMID: 11595130 DOI: 10.1016/s0304-3835(01)00647-4] [Cited by in Crossref: 7] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
318 Liao DJ, Natarajan G, Deming SL, Jamerson MH, Johnson M, Chepko G, Dickson RB. Cell cycle basis for the onset and progression of c-Myc-induced, TGFalpha-enhanced mouse mammary gland carcinogenesis. Oncogene 2000;19:1307-17. [PMID: 10713672 DOI: 10.1038/sj.onc.1203430] [Cited by in Crossref: 28] [Cited by in F6Publishing: 35] [Article Influence: 1.3] [Reference Citation Analysis]
319 Lin Y, Yang S, Chien C, Hu X, Huang Y, Lu C, Chen Y, Lin S. Induction of G2/M phase arrest and apoptosis by a novel indoloquinoline derivative, IQDMA, in K562 cells. Drug Dev Res 2006;67:743-51. [DOI: 10.1002/ddr.20113] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 0.6] [Reference Citation Analysis]
320 Lin K, Chen H, Su C, Zhu H, Lai C, Shi Y. Long Non-Coding RNA TTN-AS1 Serves as a Competing Endogenous RNA of miR-195 to Facilitate Clear Cell Renal Cell Carcinoma Progression. Cancer Manag Res 2020;12:3091-7. [PMID: 32440207 DOI: 10.2147/CMAR.S249456] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
321 Holley SL, Parkes G, Matthias C, Bockmühl U, Jahnke V, Leder K, Strange RC, Fryer AA, Hoban PR. Cyclin D1 polymorphism and expression in patients with squamous cell carcinoma of the head and neck. Am J Pathol 2001;159:1917-24. [PMID: 11696452 DOI: 10.1016/S0002-9440(10)63038-6] [Cited by in Crossref: 60] [Cited by in F6Publishing: 18] [Article Influence: 2.9] [Reference Citation Analysis]
322 Lam PYP. Gene Therapy for Hepatocellular Carcinoma. Cancer Rev A P 2003;01:281-8. [DOI: 10.1142/s021983630300027x] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
323 Monkawa T, Hiromura K, Wolf G, Shankland SJ. The hypertrophic effect of transforming growth factor-beta is reduced in the absence of cyclin-dependent kinase-inhibitors p21 and p27. J Am Soc Nephrol 2002;13:1172-8. [PMID: 11961004 DOI: 10.1097/01.asn.0000013162.29833.45] [Cited by in Crossref: 64] [Cited by in F6Publishing: 15] [Article Influence: 3.2] [Reference Citation Analysis]
324 Ordulu Z, Nucci MR, Dal Cin P, Hollowell ML, Otis CN, Hornick JL, Park PJ, Kim TM, Quade BJ, Morton CC. Intravenous leiomyomatosis: an unusual intermediate between benign and malignant uterine smooth muscle tumors. Mod Pathol 2016;29:500-10. [PMID: 26892441 DOI: 10.1038/modpathol.2016.36] [Cited by in Crossref: 33] [Cited by in F6Publishing: 26] [Article Influence: 5.5] [Reference Citation Analysis]
325 Bosco EE, Knudsen ES. Differential role of RB in response to UV and IR damage. Nucleic Acids Res 2005;33:1581-92. [PMID: 15767283 DOI: 10.1093/nar/gki283] [Cited by in Crossref: 17] [Cited by in F6Publishing: 13] [Article Influence: 1.0] [Reference Citation Analysis]
326 Mao S, Jin J, Li Z, Yang W. Knockdown of long non‑coding RNA ANRIL inhibits the proliferation and promotes the apoptosis of Burkitt lymphoma cells through the TGF‑β1 signaling pathway. Mol Med Rep 2021;23:146. [PMID: 33325535 DOI: 10.3892/mmr.2020.11785] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
327 Zhang T, Guo P, Zhang Y, Xiong H, Yu X, Xu S, Wang X, He D, Jin X. The antidiabetic drug metformin inhibits the proliferation of bladder cancer cells in vitro and in vivo. Int J Mol Sci 2013;14:24603-18. [PMID: 24351837 DOI: 10.3390/ijms141224603] [Cited by in Crossref: 45] [Cited by in F6Publishing: 42] [Article Influence: 5.0] [Reference Citation Analysis]
328 Novák B, Tyson JJ. A model for restriction point control of the mammalian cell cycle. J Theor Biol 2004;230:563-79. [PMID: 15363676 DOI: 10.1016/j.jtbi.2004.04.039] [Cited by in Crossref: 205] [Cited by in F6Publishing: 169] [Article Influence: 11.4] [Reference Citation Analysis]
329 Payton M, Coats S. Cyclin E2, the cycle continues. The International Journal of Biochemistry & Cell Biology 2002;34:315-20. [DOI: 10.1016/s1357-2725(01)00137-6] [Cited by in Crossref: 40] [Cited by in F6Publishing: 22] [Article Influence: 2.0] [Reference Citation Analysis]
330 Cao M, Zheng L, Liu J, Dobleman T, Hu S, Go VLW, Gao G, Xiao GG. MicroRNAs as effective surrogate biomarkers for early diagnosis of oral cancer. Clin Oral Investig 2018;22:571-81. [PMID: 29299731 DOI: 10.1007/s00784-017-2317-6] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 1.8] [Reference Citation Analysis]
331 Zhang X, Wharton W, Donovan M, Coppola D, Croxton R, Cress WD, Pledger WJ. Density-dependent growth inhibition of fibroblasts ectopically expressing p27(kip1). Mol Biol Cell 2000;11:2117-30. [PMID: 10848633 DOI: 10.1091/mbc.11.6.2117] [Cited by in Crossref: 24] [Cited by in F6Publishing: 23] [Article Influence: 1.1] [Reference Citation Analysis]
332 Siurala M, Bramante S, Vassilev L, Hirvinen M, Parviainen S, Tähtinen S, Guse K, Cerullo V, Kanerva A, Kipar A, Vähä-koskela M, Hemminki A. Oncolytic adenovirus and doxorubicin-based chemotherapy results in synergistic antitumor activity against soft-tissue sarcoma: Oncolytic adenovirus and doxorubicin-based chemotherapy. Int J Cancer 2015;136:945-54. [DOI: 10.1002/ijc.29048] [Cited by in Crossref: 36] [Cited by in F6Publishing: 35] [Article Influence: 4.5] [Reference Citation Analysis]
333 Fan S, Zhao C, Zhang L, Dai S, Ren J, Zhang X, Ban N, He X, Yang L, Bao Z, Chen W, Sun J, Gao Y, Tao T. Knockdown of PFTK1 Inhibits the Migration of Glioma Cells. J Mol Neurosci 2015;57:257-64. [PMID: 26234562 DOI: 10.1007/s12031-015-0600-z] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 1.6] [Reference Citation Analysis]
334 Yang HS, Hinds PW. pRb-mediated control of epithelial cell proliferation and Indian hedgehog expression in mouse intestinal development. BMC Dev Biol 2007;7:6. [PMID: 17257418 DOI: 10.1186/1471-213X-7-6] [Cited by in Crossref: 16] [Cited by in F6Publishing: 13] [Article Influence: 1.1] [Reference Citation Analysis]
335 Sedlacek HH. Mechanisms of action of flavopiridol. Crit Rev Oncol Hematol 2001;38:139-70. [PMID: 11311660 DOI: 10.1016/s1040-8428(00)00124-4] [Cited by in Crossref: 152] [Cited by in F6Publishing: 58] [Article Influence: 7.2] [Reference Citation Analysis]
336 Hirata Y, Maeda S, Mitsuno Y, Akanuma M, Yamaji Y, Ogura K, Yoshida H, Shiratori Y, Omata M. Helicobacter pylori activates the cyclin D1 gene through mitogen-activated protein kinase pathway in gastric cancer cells. Infect Immun. 2001;69:3965-3971. [PMID: 11349065 DOI: 10.1128/iai.69.6.3965-3971.2001] [Cited by in Crossref: 54] [Cited by in F6Publishing: 21] [Article Influence: 2.6] [Reference Citation Analysis]
337 Ausserlechner MJ, Obexer P, Wiegers GJ, Hartmann BL, Geley S, Kofler R. The cell cycle inhibitor p16(INK4A) sensitizes lymphoblastic leukemia cells to apoptosis by physiologic glucocorticoid levels. J Biol Chem 2001;276:10984-9. [PMID: 11278393 DOI: 10.1074/jbc.M008188200] [Cited by in Crossref: 27] [Cited by in F6Publishing: 12] [Article Influence: 1.3] [Reference Citation Analysis]
338 Leibundgut K, Schmitz NM, Hirt A. Catalytic Activities of G 1 Cyclin-Dependent Kinases and Phosphorylation of Retinoblastoma Protein in Mobilized Peripheral Blood CD34 + Hematopoietic Progenitor Cells. Stem Cells 2005;23:1002-11. [DOI: 10.1634/stemcells.2004-0088] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 0.4] [Reference Citation Analysis]
339 Sharma MR, Tuszynski GP, Sharma MC. Angiostatin-induced inhibition of endothelial cell proliferation/apoptosis is associated with the down-regulation of cell cycle regulatory protein cdk5. J Cell Biochem. 2004;91:398-409. [PMID: 14743398 DOI: 10.1002/jcb.10762] [Cited by in Crossref: 41] [Cited by in F6Publishing: 40] [Article Influence: 2.3] [Reference Citation Analysis]
340 Tanner FC, Yang ZY, Duckers E, Gordon D, Nabel GJ, Nabel EG. Expression of cyclin-dependent kinase inhibitors in vascular disease. Circ Res 1998;82:396-403. [PMID: 9486668 DOI: 10.1161/01.res.82.3.396] [Cited by in Crossref: 166] [Cited by in F6Publishing: 35] [Article Influence: 6.9] [Reference Citation Analysis]
341 Pizarro JG, Yeste-velasco M, Esparza JL, Verdaguer E, Palls M, Camins A, Folch J. The antiproliferative activity of melatonin in B65 rat dopaminergic neuroblastoma cells is related to the downregulation of cell cycle-related genes. Journal of Pineal Research 2008;45:8-16. [DOI: 10.1111/j.1600-079x.2007.00548.x] [Cited by in Crossref: 43] [Cited by in F6Publishing: 12] [Article Influence: 3.1] [Reference Citation Analysis]
342 Otsubo A, Bhawal UK, Nomura Y, Mitani Y, Ozawa K, Kuniyasu H, Sugiyama M. UCN-01 (7-hydroxystaurosporine) induces apoptosis and G1 arrest of both primary and metastatic oral cancer cell lines in vitro. Oral Surgery, Oral Medicine, Oral Pathology, Oral Radiology, and Endodontology 2007;103:391-7. [DOI: 10.1016/j.tripleo.2005.11.022] [Cited by in Crossref: 12] [Cited by in F6Publishing: 7] [Article Influence: 0.8] [Reference Citation Analysis]
343 Ye Y, Lippman SM, Lee JJ, Chen M, Frazier ML, Spitz MR, Wu X. Genetic variations in cell-cycle pathway and the risk of oral premalignant lesions. Cancer 2008;113:2488-95. [PMID: 18823025 DOI: 10.1002/cncr.23854] [Cited by in Crossref: 15] [Cited by in F6Publishing: 12] [Article Influence: 1.1] [Reference Citation Analysis]
344 Liu SC, Bassi DE, Zhang SY, Holoran D, Conti CJ, Klein-Szanto AJ. Overexpression of cyclin D2 is associated with increased in vivo invasiveness of human squamous carcinoma cells. Mol Carcinog. 2002;34:131-139. [PMID: 12112307 DOI: 10.1002/mc.10057] [Cited by in Crossref: 37] [Cited by in F6Publishing: 34] [Article Influence: 1.9] [Reference Citation Analysis]
345 Wasserman R, Zeng X, Hardy RR. The Evolution of B Precursor Leukemia in the Eμ-ret Mouse. Blood 1998;92:273-82. [DOI: 10.1182/blood.v92.1.273.413a32_273_282] [Cited by in Crossref: 32] [Article Influence: 1.3] [Reference Citation Analysis]
346 Yang H, Zhang X, Cai XY, Wen DY, Ye ZH, Liang L, Zhang L, Wang HL, Chen G, Feng ZB. From big data to diagnosis and prognosis: gene expression signatures in liver hepatocellular carcinoma. PeerJ 2017;5:e3089. [PMID: 28316892 DOI: 10.7717/peerj.3089] [Cited by in Crossref: 15] [Cited by in F6Publishing: 17] [Article Influence: 3.0] [Reference Citation Analysis]
347 Su GH, Bansal R, Murphy KM, Montgomery E, Yeo CJ, Hruban RH, Kern SE. ACVR1B (ALK4, activin receptor type 1B) gene mutations in pancreatic carcinoma. Proc Natl Acad Sci U S A 2001;98:3254-7. [PMID: 11248065 DOI: 10.1073/pnas.051484398] [Cited by in Crossref: 93] [Cited by in F6Publishing: 79] [Article Influence: 4.4] [Reference Citation Analysis]
348 Huang G, Elferink CJ. Multiple mechanisms are involved in Ah receptor-mediated cell cycle arrest. Mol Pharmacol 2005;67:88-96. [PMID: 15492120 DOI: 10.1124/mol.104.002410] [Cited by in Crossref: 78] [Cited by in F6Publishing: 72] [Article Influence: 4.3] [Reference Citation Analysis]
349 Quek M, Quinn D, Daneshmand S, Stein J. Molecular prognostication in bladder cancer—a current perspective. European Journal of Cancer 2003;39:1501-10. [DOI: 10.1016/s0959-8049(03)00300-9] [Cited by in Crossref: 31] [Cited by in F6Publishing: 3] [Article Influence: 1.6] [Reference Citation Analysis]
350 Kudo Y, Takata T, Ogawa I, Zhao M, Sato S, Takekoshi T, Miyauchi M, Nikai H. Reduced expression of p27Kip1 correlates with an early stage of cancer invasion in oral squamous cell carcinoma. Cancer Letters 2000;151:217-22. [DOI: 10.1016/s0304-3835(99)00419-x] [Cited by in Crossref: 40] [Cited by in F6Publishing: 7] [Article Influence: 1.8] [Reference Citation Analysis]
351 Østby I, Øyehaug L, Steen HB. A stochastic model of cancer initiation including a bystander effect. J Theor Biol 2006;241:751-64. [PMID: 16499930 DOI: 10.1016/j.jtbi.2006.01.013] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 0.3] [Reference Citation Analysis]
352 Ahdesmäki M, Lähdesmäki H, Pearson R, Huttunen H, Yli-Harja O. Robust detection of periodic time series measured from biological systems. BMC Bioinformatics 2005;6:117. [PMID: 15892890 DOI: 10.1186/1471-2105-6-117] [Cited by in Crossref: 87] [Cited by in F6Publishing: 34] [Article Influence: 5.1] [Reference Citation Analysis]
353 Meng X, Liang H, Luo L. Antitumor polysaccharides from mushrooms: a review on the structural characteristics, antitumor mechanisms and immunomodulating activities. Carbohydrate Research 2016;424:30-41. [DOI: 10.1016/j.carres.2016.02.008] [Cited by in Crossref: 250] [Cited by in F6Publishing: 207] [Article Influence: 41.7] [Reference Citation Analysis]
354 Kohno T, Yamada Y, Tawara M, Takasaki Y, Kamihira S, Tomonaga M, Matsuyama T. Inactivation of p14ARF as a key event for the progression of adult T cell leukemia/lymphoma. Leuk Res 2007;31:1625-32. [PMID: 18246599 DOI: 10.1016/j.leukres.2006.12.007] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 0.8] [Reference Citation Analysis]
355 Vidaki M, Tivodar S, Doulgeraki K, Tybulewicz V, Kessaris N, Pachnis V, Karagogeos D. Rac1-dependent cell cycle exit of MGE precursors and GABAergic interneuron migration to the cortex. Cereb Cortex 2012;22:680-92. [PMID: 21690261 DOI: 10.1093/cercor/bhr145] [Cited by in Crossref: 25] [Cited by in F6Publishing: 24] [Article Influence: 2.3] [Reference Citation Analysis]
356 Boxem M, van den Heuvel S. lin-35 Rb and cki-1 Cip/Kip cooperate in developmental regulation of G1 progression in C. elegans. Development 2001;128:4349-59. [DOI: 10.1242/dev.128.21.4349] [Cited by in Crossref: 47] [Cited by in F6Publishing: 23] [Article Influence: 2.2] [Reference Citation Analysis]
357 Molenaar JJ, Koster J, Ebus ME, van Sluis P, Westerhout EM, de Preter K, Gisselsson D, Øra I, Speleman F, Caron HN, Versteeg R. Copy number defects of G1-cell cycle genes in neuroblastoma are frequent and correlate with high expression of E2F target genes and a poor prognosis. Genes Chromosomes Cancer 2012;51:10-9. [PMID: 22034077 DOI: 10.1002/gcc.20926] [Cited by in Crossref: 47] [Cited by in F6Publishing: 40] [Article Influence: 4.3] [Reference Citation Analysis]
358 Hsieh CH, Chu CY, Lin SE, Yang YSH, Chang HS, Yen Y. TESC Promotes TGF-α/EGFR-FOXM1-Mediated Tumor Progression in Cholangiocarcinoma. Cancers (Basel) 2020;12:E1105. [PMID: 32365487 DOI: 10.3390/cancers12051105] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
359 Kassam S, Montoto S. Oncologic, Endocrine & Metabolic Emerging drugs in B-cell non-Hodgkin's lymphoma. Expert Opinion on Emerging Drugs 2008;13:323-43. [DOI: 10.1517/14728214.13.2.323] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
360 Yamasaki L. Balancing proliferation and apoptosis in vivo: the Goldilocks theory of E2F/DP action. Biochim Biophys Acta 1999;1423:M9-15. [PMID: 10214348 DOI: 10.1016/s0304-419x(99)00003-7] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 0.2] [Reference Citation Analysis]
361 Chinen AB, Guan CM, Ferrer JR, Barnaby SN, Merkel TJ, Mirkin CA. Nanoparticle Probes for the Detection of Cancer Biomarkers, Cells, and Tissues by Fluorescence. Chem Rev 2015;115:10530-74. [PMID: 26313138 DOI: 10.1021/acs.chemrev.5b00321] [Cited by in Crossref: 629] [Cited by in F6Publishing: 507] [Article Influence: 89.9] [Reference Citation Analysis]
362 Tsuji T, Ikeda H, Tsuchikawa T, Kikuchi K, Baba T, Ishizu A, Yoshiki T. Malignant transformation of thymoma in recipient rats by heterotopic thymus transplantation from HTLV-I transgenic rats. Lab Invest 2005;85:851-61. [DOI: 10.1038/labinvest.3700292] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 0.4] [Reference Citation Analysis]
363 Muguruma M, Nishimura J, Jin M, Kashida Y, Moto M, Takahashi M, Yokouchi Y, Mitsumori K. Molecular pathological analysis for determining the possible mechanism of piperonyl butoxide-induced hepatocarcinogenesis in mice. Toxicology 2006;228:178-87. [PMID: 17014948 DOI: 10.1016/j.tox.2006.08.029] [Cited by in Crossref: 23] [Cited by in F6Publishing: 15] [Article Influence: 1.4] [Reference Citation Analysis]
364 Taneja P, Maglic D, Kai F, Zhu S, Kendig RD, Fry EA, Inoue K. Classical and Novel Prognostic Markers for Breast Cancer and their Clinical Significance. Clin Med Insights Oncol 2010;4:15-34. [PMID: 20567632 DOI: 10.4137/cmo.s4773] [Cited by in Crossref: 64] [Cited by in F6Publishing: 47] [Article Influence: 5.3] [Reference Citation Analysis]
365 Aravinthan A, Pietrosi G, Hoare M, Jupp J, Marshall A, Verrill C, Davies S, Bateman A, Sheron N, Allison M, Alexander GJ. Hepatocyte expression of the senescence marker p21 is linked to fibrosis and an adverse liver-related outcome in alcohol-related liver disease. PLoS One 2013;8:e72904. [PMID: 24086266 DOI: 10.1371/journal.pone.0072904] [Cited by in Crossref: 47] [Cited by in F6Publishing: 47] [Article Influence: 5.2] [Reference Citation Analysis]
366 Ravera S, Ghiotto F, Tenca C, Gugiatti E, Santamaria S, Ledda B, Ibatici A, Cutrona G, Mazzarello AN, Bagnara D, Cardillo M, Zarcone D, Darzynkiewicz Z, Ciccone E, Fais F, Bruno S. Berberine affects mitochondrial activity and cell growth of leukemic cells from chronic lymphocytic leukemia patients. Sci Rep 2020;10:16519. [PMID: 33020573 DOI: 10.1038/s41598-020-73594-z] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
367 Igata M, Motoshima H, Tsuruzoe K, Kojima K, Matsumura T, Kondo T, Taguchi T, Nakamaru K, Yano M, Kukidome D. Adenosine monophosphate-activated protein kinase suppresses vascular smooth muscle cell proliferation through the inhibition of cell cycle progression. Circ Res. 2005;97:837-844. [PMID: 16151020 DOI: 10.1161/01.res.0000185823.73556.06] [Cited by in Crossref: 179] [Cited by in F6Publishing: 103] [Article Influence: 10.5] [Reference Citation Analysis]
368 Valle-argos B, Gómez-nicola D, Nieto-sampedro M. Neurostatin blocks glioma cell cycle progression by inhibiting EGFR activation. Molecular and Cellular Neuroscience 2011;46:89-100. [DOI: 10.1016/j.mcn.2010.08.009] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.5] [Reference Citation Analysis]
369 Kang HS, Jung HM, Jun DY, Huh TL, Kim YH. Expression of the human homologue of the small nucleolar RNA-binding protein NHP2 gene during monocytic differentiation of U937 cells. Biochimica et Biophysica Acta (BBA) - Gene Structure and Expression 2002;1575:31-9. [DOI: 10.1016/s0167-4781(02)00240-3] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
370 Ouyang W, Li J, Ma Q, Huang C. Essential roles of PI-3K/Akt/IKKbeta/NFkappaB pathway in cyclin D1 induction by arsenite in JB6 Cl41 cells. Carcinogenesis 2006;27:864-73. [PMID: 16387740 DOI: 10.1093/carcin/bgi321] [Cited by in Crossref: 67] [Cited by in F6Publishing: 65] [Article Influence: 3.9] [Reference Citation Analysis]
371 Hilbe W, Dirnhofer S, Greil R, Wöll E. Biomarkers in non-small cell lung cancer prevention. Eur J Cancer Prev 2004;13:425-36. [PMID: 15452456 DOI: 10.1097/00008469-200410000-00011] [Cited by in Crossref: 24] [Cited by in F6Publishing: 19] [Article Influence: 1.4] [Reference Citation Analysis]
372 Tschan MP, Peters UR, Cajot JF, Betticher DC, Fey MF, Tobler A. The cyclin-dependent kinase inhibitors p18INK4c and p19INK4d are highly expressed in CD34+ progenitor and acute myeloid leukaemic cells but not in normal differentiated myeloid cells. Br J Haematol 1999;106:644-51. [PMID: 10468852 DOI: 10.1046/j.1365-2141.1999.01617.x] [Cited by in Crossref: 16] [Cited by in F6Publishing: 15] [Article Influence: 0.7] [Reference Citation Analysis]
373 Sionov RV, Haupt Y. Apoptosis by p53: mechanisms, regulation, and clinical implications. Springer Semin Immunopathol 1998;19:345-62. [PMID: 9540161 DOI: 10.1007/BF00787230] [Cited by in Crossref: 17] [Cited by in F6Publishing: 5] [Article Influence: 0.7] [Reference Citation Analysis]
374 Dhar KK, Branigan K, Howells REJ, Musgrove C, Jones PW, Strange RC, Fryer AA, Redman CWE, Hoban PR. Prognostic significance of cyclin D1 gene (CCND1) polymorphism in epithelial ovarian cancer. Int J Gynecol Cancer 1999;9:342-7. [DOI: 10.1046/j.1525-1438.1999.99048.x] [Cited by in Crossref: 23] [Cited by in F6Publishing: 19] [Article Influence: 1.0] [Reference Citation Analysis]
375 Cruz M, Reinert T, Cristofanilli M. Emerging Innovative Therapeutic Approaches Leveraging Cyclin‐Dependent Kinase Inhibitors to Treat Advanced Breast Cancer. Clin Pharmacol Ther 2018;103:1009-19. [DOI: 10.1002/cpt.965] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
376 Zhang Z, Rosen DG, Yao JL, Huang J, Liu J. Expression of p14ARF, p15INK4b, p16INK4a, and DCR2 increases during prostate cancer progression. Mod Pathol 2006;19:1339-43. [PMID: 16799475 DOI: 10.1038/modpathol.3800655] [Cited by in Crossref: 45] [Cited by in F6Publishing: 39] [Article Influence: 2.8] [Reference Citation Analysis]
377 Cho JW, Baek WK, Suh SI, Yang SH, Chang J, Sung YC, Suh MH. Hepatitis C virus core protein promotes cell proliferation through the upregulation of cyclin E expression levels. Liver. 2001;21:137-142. [PMID: 11318983 DOI: 10.1034/j.1600-0676.2001.021002137.x] [Cited by in Crossref: 39] [Cited by in F6Publishing: 38] [Article Influence: 1.9] [Reference Citation Analysis]
378 Xu W, Li Y, Feng R, He P, Zhang Y. γ-Tocotrienol induced the proliferation and differentiation of MC3T3-E1 cells through the stimulation of the Wnt/β-catenin signaling pathway. Food Funct 2021. [PMID: 34908071 DOI: 10.1039/d1fo02583j] [Reference Citation Analysis]
379 Takemura M, Ohoka F, Perpelescu M, Ogawa M, Matsushita H, Takaba T, Akiyama T, Umekawa H, Furuichi Y, Cook PR. Phosphorylation-dependent migration of retinoblastoma protein into the nucleolus triggered by binding to nucleophosmin/B23. Exp Cell Res. 2002;276:233-241. [PMID: 12027453 DOI: 10.1006/excr.2002.5523] [Cited by in Crossref: 32] [Cited by in F6Publishing: 31] [Article Influence: 1.6] [Reference Citation Analysis]
380 Luh FY, Archer SJ, Domaille PJ, Smith BO, Owen D, Brotherton DH, Raine ARC, Xu X, Brizuela L, Brenner SL, Laue ED. Structure of the cyclin-dependent kinase inhibitor p19Ink4d. Nature 1997;389:999-1003. [DOI: 10.1038/40202] [Cited by in Crossref: 77] [Cited by in F6Publishing: 74] [Article Influence: 3.1] [Reference Citation Analysis]
381 Reynaud EG, Pelpel K, Guillier M, Leibovitch MP, Leibovitch SA. p57(Kip2) stabilizes the MyoD protein by inhibiting cyclin E-Cdk2 kinase activity in growing myoblasts. Mol Cell Biol 1999;19:7621-9. [PMID: 10523650 DOI: 10.1128/MCB.19.11.7621] [Cited by in Crossref: 73] [Cited by in F6Publishing: 33] [Article Influence: 3.2] [Reference Citation Analysis]
382 Schöndorf T, Eisele L, Göhring U, Valter MM, Warm M, Mallmann P, Becker M, Fechteler R, Weisshaar M, Hoopmann M. The V109G Polymorphism of the p27 Gene <i>CDKN1B</i> Indicates a Worse Outcome in Node-Negative Breast Cancer Patients. Tumor Biol 2004;25:306-12. [DOI: 10.1159/000081396] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 0.8] [Reference Citation Analysis]
383 Dai M, Mantel CR, Xia Z, Broxmeyer HE, Lu L. An expansion phase precedes terminal erythroid differentiation of hematopoietic progenitor cells from cord blood in vitro and is associated with up-regulation of cyclin E and cyclin-dependent kinase 2. Blood 2000;96:3985-7. [DOI: 10.1182/blood.v96.12.3985.h8003985_3985_3987] [Cited by in Crossref: 1] [Article Influence: 0.0] [Reference Citation Analysis]
384 Miehlke S, Yu J, Ebert M, Szokodi D, Vieth M, Kuhlisch E, Buchcik R, Schimmin W, Wehrmann U, Malfertheiner P. Expression of G1 phase cyclins in human gastric cancer and gastric mucosa of first-degree relatives. Dig Dis Sci. 2002;47:1248-1256. [PMID: 12064799 DOI: 10.1023/a:1015358127751] [Cited by in Crossref: 14] [Cited by in F6Publishing: 5] [Article Influence: 0.7] [Reference Citation Analysis]
385 Carr BI, Wang Z, Kar S. K vitamins, PTP antagonism, and cell growth arrest. J Cell Physiol 2002;193:263-74. [DOI: 10.1002/jcp.10171] [Cited by in Crossref: 30] [Cited by in F6Publishing: 21] [Article Influence: 1.5] [Reference Citation Analysis]
386 Jemal A, Siegel R, Ward E, Murray T, Xu J, Thun MJ. Cancer statistics, 2007. CA Cancer J Clin. 2007;57:43-66. [PMID: 17237035 DOI: 10.1016/j.bbcan.2007.12.001] [Cited by in Crossref: 1] [Cited by in F6Publishing: 13] [Article Influence: 0.1] [Reference Citation Analysis]
387 Lin JJ, Hsu HY, Yang JS, Lu KW, Wu RS, Wu KC, Lai TY, Chen PY, Ma CY, Wood WG. Molecular evidence of anti-leukemia activity of gypenosides on human myeloid leukemia HL-60 cells in vitro and in vivo using a HL-60 cells murine xenograft model. Phytomedicine. 2011;18:1075-1085. [PMID: 21596541 DOI: 10.1016/j.phymed.2011.03.009] [Cited by in Crossref: 31] [Cited by in F6Publishing: 26] [Article Influence: 2.8] [Reference Citation Analysis]
388 Fabbrizio E, Le Cam L, Polanowska J, Kaczorek M, Lamb N, Brent R, Sardet C. Inhibition of mammalian cell proliferation by genetically selected peptide aptamers that functionally antagonize E2F activity. Oncogene 1999;18:4357-63. [DOI: 10.1038/sj.onc.1202825] [Cited by in Crossref: 57] [Cited by in F6Publishing: 56] [Article Influence: 2.5] [Reference Citation Analysis]
389 Kitisin K, Ganesan N, Tang Y, Jogunoori W, Volpe EA, Kim SS, Katuri V, Kallakury B, Pishvaian M, Albanese C. Disruption of transforming growth factor-beta signaling through beta-spectrin ELF leads to hepatocellular cancer through cyclin D1 activation. Oncogene. 2007;26:7103-7110. [PMID: 17546056 DOI: 10.1038/sj.onc.1210513] [Cited by in Crossref: 84] [Cited by in F6Publishing: 90] [Article Influence: 5.6] [Reference Citation Analysis]
390 Balint E, Lapointe D, Drissi H, van der Meijden C, Young DW, van Wijnen AJ, Stein JL, Stein GS, Lian JB. Phenotype discovery by gene expression profiling: mapping of biological processes linked to BMP-2-mediated osteoblast differentiation. J Cell Biochem. 2003;89:401-426. [PMID: 12704803 DOI: 10.1002/jcb.10515] [Cited by in Crossref: 127] [Cited by in F6Publishing: 119] [Article Influence: 6.7] [Reference Citation Analysis]
391 Hosokawa Y, Joh T, Maeda Y, Arnold A, Seto M. Cyclin D1/PRAD1/BCL-1 alternative transcript [B] protein product in B-lymphoid malignancies with t(11;14)(q13;q32) translocation. Int J Cancer 1999;81:616-9. [DOI: 10.1002/(sici)1097-0215(19990517)81:4<616::aid-ijc18>3.0.co;2-s] [Cited by in Crossref: 19] [Cited by in F6Publishing: 9] [Article Influence: 0.8] [Reference Citation Analysis]
392 Elayat G, Selim AG, Gorman P, Tomlinson I, Wells CA. Cyclin D-1 protein over-expression is not associated with gene amplification in benign and atypical apocrine lesions of the breast. Pathol Res Pract 2011;207:75-8. [PMID: 21159451 DOI: 10.1016/j.prp.2010.06.003] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.1] [Reference Citation Analysis]
393 Tuna G, Küçükhüseyin O, Arıkan S, Kaytan Sağlam E, Güler E, Cacına C, Oztop O, Turan S, Korkmaz G, Yaylım I. Do CDKN2 p16 540 C>G, CDKN2 p16 580 C>T, and MDM2 SNP309 T>G gene variants act on colorectal cancer development or progression? DNA Cell Biol 2013;32:400-8. [PMID: 23777425 DOI: 10.1089/dna.2012.1933] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 1.0] [Reference Citation Analysis]
394 Wang Y, Zhang S, Xu T, Zhang T, Mo Y, Liu J, Yan L, Xing F. Ultra-sensitive and ultra-fast detection of whole unlabeled living cancer cell responses to paclitaxel with a graphene-based biosensor. Sensors and Actuators B: Chemical 2018;263:417-25. [DOI: 10.1016/j.snb.2018.02.095] [Cited by in Crossref: 13] [Cited by in F6Publishing: 6] [Article Influence: 3.3] [Reference Citation Analysis]
395 Rollins LA, Leone-Kabler S, O'Sullivan MG, Miller MS. Role of tumor suppressor genes in transplacental lung carcinogenesis. Mol Carcinog 1998;21:177-84. [PMID: 9537649 DOI: 10.1002/(sici)1098-2744(199803)21:3<177::aid-mc5>3.0.co;2-j] [Cited by in Crossref: 13] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
396 Liu Q, Loo WT, Sze SC, Tong Y. Curcumin inhibits cell proliferation of MDA-MB-231 and BT-483 breast cancer cells mediated by down-regulation of NFkappaB, cyclinD and MMP-1 transcription. Phytomedicine 2009;16:916-22. [PMID: 19524420 DOI: 10.1016/j.phymed.2009.04.008] [Cited by in Crossref: 72] [Cited by in F6Publishing: 69] [Article Influence: 5.5] [Reference Citation Analysis]
397 Huang W, Wang P, Shen T, Hu C, Han Y, Song M, Bian Y, Li Y, Zhu Y. Aluminum Trichloride Inhibited Osteoblastic Proliferation and Downregulated the Wnt/β-Catenin Pathway. Biol Trace Elem Res 2017;177:323-30. [DOI: 10.1007/s12011-016-0880-3] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 1.3] [Reference Citation Analysis]
398 Fabiani R, De Bartolomeo A, Rosignoli P, Servili M, Selvaggini R, Montedoro GF, Di Saverio C, Morozzi G. Virgin Olive Oil Phenols Inhibit Proliferation of Human Promyelocytic Leukemia Cells (HL60) by Inducing Apoptosis and Differentiation. The Journal of Nutrition 2006;136:614-9. [DOI: 10.1093/jn/136.3.614] [Cited by in Crossref: 102] [Cited by in F6Publishing: 92] [Article Influence: 6.4] [Reference Citation Analysis]
399 Wang F, Shi C, Yang Y, Fang Y, Sheng L, Li N. Medicinal mushroom Phellinus igniarius induced cell apoptosis in gastric cancer SGC-7901 through a mitochondria-dependent pathway. Biomedicine & Pharmacotherapy 2018;102:18-25. [DOI: 10.1016/j.biopha.2018.03.038] [Cited by in Crossref: 16] [Cited by in F6Publishing: 15] [Article Influence: 4.0] [Reference Citation Analysis]
400 Adhami VM, Afaq F, Ahmad N. Involvement of the Retinoblastoma (pRb)–E2F/DP Pathway during Antiproliferative Effects of Resveratrol in Human Epidermoid Carcinoma (A431) Cells. Biochemical and Biophysical Research Communications 2001;288:579-85. [DOI: 10.1006/bbrc.2001.5819] [Cited by in Crossref: 61] [Cited by in F6Publishing: 50] [Article Influence: 2.9] [Reference Citation Analysis]
401 Lee S, Cho Y, Park K, Kim E, Jung K, Park S, Kim W, Moon S. Magnolol elicits activation of the extracellular signal-regulated kinase pathway by inducing p27KIP1-mediated G2/M-phase cell cycle arrest in human urinary bladder cancer 5637 cells. Biochemical Pharmacology 2008;75:2289-300. [DOI: 10.1016/j.bcp.2008.03.022] [Cited by in Crossref: 30] [Cited by in F6Publishing: 28] [Article Influence: 2.1] [Reference Citation Analysis]
402 Gäbele E, Reif S, Tsukada S, Bataller R, Yata Y, Morris T, Schrum LW, Brenner DA, Rippe RA. The role of p70S6K in hepatic stellate cell collagen gene expression and cell proliferation. J Biol Chem. 2005;280:13374-13382. [PMID: 15677443 DOI: 10.1074/jbc.m409444200] [Cited by in Crossref: 68] [Cited by in F6Publishing: 31] [Article Influence: 4.0] [Reference Citation Analysis]
403 Jiang W, Jimenez G, Wells NJ, Hope TJ, Wahl GM, Hunter T, Fukunaga R. PRC1. Molecular Cell 1998;2:877-85. [DOI: 10.1016/s1097-2765(00)80302-0] [Cited by in Crossref: 256] [Cited by in F6Publishing: 138] [Article Influence: 10.7] [Reference Citation Analysis]
404 Yu J, Kim J, Kim T, Kim B, Jang Y, Lee J. (E)-1-(3,4-dihydroxyphenethyl)-3-styrylurea inhibits proliferation of MCF-7 cells through G1 cell cycle arrest and mitochondria-mediated apoptosis. Mol Cells 2010;30:303-10. [DOI: 10.1007/s10059-010-0119-7] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 0.6] [Reference Citation Analysis]
405 Titova E, Shagieva G, Ivanova O, Domnina L, Domninskaya M, Strelkova O, Khromova N, Kopnin P, Chernyak B, Skulachev V, Dugina V. Mitochondria-targeted antioxidant SkQ1 suppresses fibrosarcoma and rhabdomyosarcoma tumour cell growth. Cell Cycle 2018;17:1797-811. [PMID: 29995559 DOI: 10.1080/15384101.2018.1496748] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 2.8] [Reference Citation Analysis]
406 Wang C, Li Z, Fu M, Bouras T, Pestell RG. Signal Transduction Mediated by Cyclin D1: from Mitogens to Cell Proliferation: A Molecular Target with Therapeutic Potential. In: Kumar R, editor. Molecular Targeting and Signal Transduction. Boston: Kluwer Academic Publishers; 2004. pp. 217-37. [DOI: 10.1007/1-4020-7847-1_11] [Cited by in Crossref: 61] [Cited by in F6Publishing: 59] [Reference Citation Analysis]
407 Potemski P, Pluciennik E, Bednarek AK, Kusinska R, Jesionek-kupnicka D, Pasz-walczak G, Watala C, Kordek R. Cyclin E Expression in Operable Breast Cancer Quantified Using Real-Time RT–PCR: A Comparative Study with Immunostaining. Japanese Journal of Clinical Oncology 2006;36:142-9. [DOI: 10.1093/jjco/hyi246] [Cited by in Crossref: 5] [Cited by in F6Publishing: 7] [Article Influence: 0.3] [Reference Citation Analysis]
408 Shima H, Pende M, Chen Y, Fumagalli S, Thomas G, Kozma SC. Disruption of the p70(s6k)/p85(s6k) gene reveals a small mouse phenotype and a new functional S6 kinase. EMBO J 1998;17:6649-59. [PMID: 9822608 DOI: 10.1093/emboj/17.22.6649] [Cited by in Crossref: 462] [Cited by in F6Publishing: 471] [Article Influence: 20.1] [Reference Citation Analysis]
409 Kim JY, Kim JY, Kim JH, Jung H, Lee WT, Lee JE. Restorative Mechanism of Neural Progenitor Cells Overexpressing Arginine Decarboxylase Genes Following Ischemic Injury. Exp Neurobiol 2019;28:85-103. [PMID: 30853827 DOI: 10.5607/en.2019.28.1.85] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
410 Shao L, Lerner SL, Bondaruk J, Czerniak BA, Zeng X, Grossman HB, Spitz MR, Wu X. Specific chromosome aberrations in peripheral blood lymphocytes are associated with risk of bladder cancer. Genes Chromosomes Cancer 2004;41:379-89. [PMID: 15390184 DOI: 10.1002/gcc.20095] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
411 Fukada T, Ohtani T, Yoshida Y, Shirogane T, Nishida K, Nakajima K, Hibi M, Hirano T. STAT3 orchestrates contradictory signals in cytokine-induced G1 to S cell-cycle transition. EMBO J. 1998;17:6670-6677. [PMID: 9822610 DOI: 10.1093/emboj/17.22.6670] [Cited by in Crossref: 168] [Cited by in F6Publishing: 167] [Article Influence: 7.3] [Reference Citation Analysis]
412 Park MR, Lee JH, Park MS, Hwang JE, Shim HJ, Cho SH, Chung IJ, Bae WK. Suppressive effect of 19-nor-1α-25-dihydroxyvitamin D2 on gastric cancer cells and peritoneal metastasis model. J Korean Med Sci. 2012;27:1037-1043. [PMID: 22969249 DOI: 10.3346/jkms.2012.27.9.1037] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 1.2] [Reference Citation Analysis]
413 Pavlopoulou A, Kossida S. Cytosine methyltransferases as tumor markers. Curr Genomics 2010;11:568-77. [PMID: 21629434 DOI: 10.2174/138920210793360916] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.2] [Reference Citation Analysis]
414 Misra RN, Xiao H, Kim KS, Lu S, Han W, Barbosa SA, Hunt JT, Rawlins DB, Shan W, Ahmed SZ, Qian L, Chen B, Zhao R, Bednarz MS, Kellar KA, Mulheron JG, Batorsky R, Roongta U, Kamath A, Marathe P, Ranadive SA, Sack JS, Tokarski JS, Pavletich NP, Lee FYF, Webster KR, Kimball SD. N -(Cycloalkylamino)acyl-2-aminothiazole Inhibitors of Cyclin-Dependent Kinase 2. N -[5-[[[5-(1,1-Dimethylethyl)-2-oxazolyl]methyl]thio]-2-thiazolyl]-4- piperidinecarboxamide (BMS-387032), a Highly Efficacious and Selective Antitumor Agent. J Med Chem 2004;47:1719-28. [DOI: 10.1021/jm0305568] [Cited by in Crossref: 186] [Cited by in F6Publishing: 155] [Article Influence: 10.3] [Reference Citation Analysis]
415 Coskun V, Venkatraman G, Yang H, Rao MS, Luskin MB. Retroviral manipulation of the expression of bone morphogenetic protein receptor Ia by SVZa progenitor cells leads to changes in their p19 INK4d expression but not in their neuronal commitment. Int j dev neurosci 2001;19:219-27. [DOI: 10.1016/s0736-5748(00)00092-7] [Cited by in Crossref: 20] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
416 Agas D, Sabbieti MG, Capacchietti M, Materazzi S, Menghi G, Materazzi G, Hurley MM, Marchetti L. Benzyl butyl phthalate influences actin distribution and cell proliferation in rat Py1a osteoblasts. J Cell Biochem 2007;101:543-51. [PMID: 17171637 DOI: 10.1002/jcb.21212] [Cited by in Crossref: 16] [Cited by in F6Publishing: 14] [Article Influence: 1.1] [Reference Citation Analysis]
417 Adachi S, Yasuda I, Nakashima M, Yamauchi T, Kawaguchi J, Shimizu M, Itani M, Nakamura M, Nishii Y, Yoshioka T, Hirose Y, Okano Y, Moriwaki H, Kozawa O. Ultraviolet irradiation can induce evasion of colon cancer cells from stimulation of epidermal growth factor. J Biol Chem 2011;286:26178-87. [PMID: 21646361 DOI: 10.1074/jbc.M111.240630] [Cited by in Crossref: 13] [Cited by in F6Publishing: 6] [Article Influence: 1.2] [Reference Citation Analysis]
418 Huang YC, Hasegawa H, Wang SW, Ku CC, Lin YC, Chiou SS, Hou MF, Wu DC, Tsai EM, Saito S, Yamaguchi N, Yokoyama KK. Jun dimerization protein 2 controls senescence and differentiation via regulating histone modification. J Biomed Biotechnol 2011;2011:569034. [PMID: 21197464 DOI: 10.1155/2011/569034] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 0.8] [Reference Citation Analysis]
419 Sasiadek MM, Stembalska-Kozlowska A, Smigiel R, Ramsey D, Kayademir T, Blin N. Impairment of MLH1 and CDKN2A in oncogenesis of laryngeal cancer. Br J Cancer 2004;90:1594-9. [PMID: 15083191 DOI: 10.1038/sj.bjc.6601679] [Cited by in Crossref: 27] [Cited by in F6Publishing: 22] [Article Influence: 1.5] [Reference Citation Analysis]
420 Walker DK, Fry CS, Drummond MJ, Dickinson JM, Timmerman KL, Gundermann DM, Jennings K, Volpi E, Rasmussen BB. PAX7+ satellite cells in young and older adults following resistance exercise. Muscle Nerve 2012;46:51-9. [PMID: 22644638 DOI: 10.1002/mus.23266] [Cited by in Crossref: 29] [Cited by in F6Publishing: 28] [Article Influence: 2.9] [Reference Citation Analysis]
421 Rose AE, Wang G, Hanniford D, Monni S, Tu T, Shapiro RL, Berman RS, Pavlick AC, Pagano M, Darvishian F, Mazumdar M, Hernando E, Osman I. Clinical relevance of SKP2 alterations in metastatic melanoma. Pigment Cell Melanoma Res 2011;24:197-206. [PMID: 20883453 DOI: 10.1111/j.1755-148X.2010.00784.x] [Cited by in Crossref: 26] [Cited by in F6Publishing: 22] [Article Influence: 2.2] [Reference Citation Analysis]
422 Takemura M, Yamamoto T, Kitagawa M, Taya Y, Akiyama T, Asahara H, Linn S, Suzuki S, Tamai K, Yoshida S. Stimulation of DNA Polymerase α Activity by Cdk2-Phosphorylated Rb Protein. Biochemical and Biophysical Research Communications 2001;282:984-90. [DOI: 10.1006/bbrc.2001.4675] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 0.3] [Reference Citation Analysis]
423 Lee JY, Dong SM, Shin MS, Kim SY, Lee SH, Kang SJ, Lee JD, Kim CS, Kim SH, Yoo NJ. Genetic Alterations ofp16INK4aandp53Genes in Sporadic Dysplastic Nevus. Biochemical and Biophysical Research Communications 1997;237:667-72. [DOI: 10.1006/bbrc.1997.7212] [Cited by in Crossref: 50] [Cited by in F6Publishing: 43] [Article Influence: 2.0] [Reference Citation Analysis]
424 Robinson ML, Lovicu FJ. The Lens: Historical and Comparative Perspectives. In: Lovicu FJ, Robinson ML, editors. Development of the Ocular Lens. Cambridge University Press; 2010. pp. 3-26. [DOI: 10.1017/cbo9780511529825.002] [Cited by in Crossref: 3] [Article Influence: 0.2] [Reference Citation Analysis]
425 Bae T, Weon K, Lee J, Eum K, Kim S, Choi JW. Restoration of paclitaxel resistance by CDK1 intervention in drug-resistant ovarian cancer. CARCIN. [DOI: 10.1093/carcin/bgv140] [Cited by in Crossref: 11] [Cited by in F6Publishing: 16] [Article Influence: 1.6] [Reference Citation Analysis]
426 Kanerva A, Bauerschmitz G, Yamamoto M, Lam J, Alvarez R, Siegal G, Curiel D, Hemminki A. A cyclooxygenase-2 promoter-based conditionally replicating adenovirus with enhanced infectivity for treatment of ovarian adenocarcinoma. Gene Ther 2004;11:552-9. [DOI: 10.1038/sj.gt.3302181] [Cited by in Crossref: 39] [Cited by in F6Publishing: 32] [Article Influence: 2.2] [Reference Citation Analysis]
427 Liu L, Wang D, Wang J, Ji H, Zhang Y. NOAD, a novel nitric oxide donor, induces G2/M phase arrest and apoptosis in human hepatocellular carcinoma Bel-7402 cells. Toxicol In Vitro 2015;29:1289-97. [PMID: 26001517 DOI: 10.1016/j.tiv.2015.05.003] [Cited by in Crossref: 19] [Cited by in F6Publishing: 16] [Article Influence: 2.7] [Reference Citation Analysis]
428 Brennan P, Babbage JW, Burgering BM, Groner B, Reif K, Cantrell DA. Phosphatidylinositol 3-Kinase Couples the Interleukin-2 Receptor to the Cell Cycle Regulator E2F. Immunity 1997;7:679-89. [DOI: 10.1016/s1074-7613(00)80388-x] [Cited by in Crossref: 288] [Cited by in F6Publishing: 92] [Article Influence: 11.5] [Reference Citation Analysis]
429 Nahum A, Zeller L, Danilenko M, Prall OWJ, Watts CKW, Sutherland RL, Levy J, Sharoni Y. Lycopene inhibition of IGF-induced cancer cell growth depends on the level of cyclin D1. Eur J Nutr 2006;45:275-82. [DOI: 10.1007/s00394-006-0595-x] [Cited by in Crossref: 66] [Cited by in F6Publishing: 55] [Article Influence: 4.1] [Reference Citation Analysis]
430 Bakiri L, Matsuo K, Wisniewska M, Wagner EF, Yaniv M. Promoter specificity and biological activity of tethered AP-1 dimers. Mol Cell Biol 2002;22:4952-64. [PMID: 12052899 DOI: 10.1128/MCB.22.13.4952-4964.2002] [Cited by in Crossref: 136] [Cited by in F6Publishing: 71] [Article Influence: 6.8] [Reference Citation Analysis]
431 Mei Y, Yang JP, Lang YH, Peng LX, Yang MM, Liu Q, Meng DF, Zheng LS, Qiang YY, Xu L, Li CZ, Wei WW, Niu T, Peng XS, Yang Q, Lin F, Hu H, Xu HF, Huang BJ, Wang LJ, Qian CN. Global expression profiling and pathway analysis of mouse mammary tumor reveals strain and stage specific dysregulated pathways in breast cancer progression. Cell Cycle 2018;17:963-73. [PMID: 29712537 DOI: 10.1080/15384101.2018.1442629] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
432 Herzog CR, Noh S, Lantry LE, Guan K, You M. Cdkn2a encodes functional variation of p16INK4a but not p14ARF, which confers selection in mouse lung tumorigenesis. Mol Carcinog 1999;25:92-8. [DOI: 10.1002/(sici)1098-2744(199906)25:2<92::aid-mc3>3.0.co;2-2] [Cited by in Crossref: 14] [Cited by in F6Publishing: 4] [Article Influence: 0.6] [Reference Citation Analysis]
433 Kim HK, Park I, Heo DS, Noh D, Choe K, Bang Y, Kim NK. Cyclin E overexpression as an independent risk factor of visceral relapse in breast cancer. European Journal of Surgical Oncology (EJSO) 2001;27:464-71. [DOI: 10.1053/ejso.2001.1137] [Cited by in Crossref: 30] [Cited by in F6Publishing: 24] [Article Influence: 1.4] [Reference Citation Analysis]
434 White PC, Shore AM, Clement M, Mclaren J, Soeiro I, Lam EW, Brennan P. Regulation of cyclin D2 and the cyclin D2 promoter by protein kinase A and CREB in lymphocytes. Oncogene 2006;25:2170-80. [DOI: 10.1038/sj.onc.1209255] [Cited by in Crossref: 37] [Cited by in F6Publishing: 37] [Article Influence: 2.2] [Reference Citation Analysis]
435 Haga Y, Hiroshima K, Iyoda A, Shibuya K, Shimamura F, Iizasa T, Fujisawa T, Ohwada H. Ki-67 expression and prognosis for smokers with resected stage i Non–Small cell lung cancer. The Annals of Thoracic Surgery 2003;75:1727-32. [DOI: 10.1016/s0003-4975(03)00119-x] [Cited by in Crossref: 34] [Cited by in F6Publishing: 12] [Article Influence: 1.8] [Reference Citation Analysis]
436 Liang Y, Lin-shiau S, Chen C, Lin J. Inhibition of cyclin-dependent kinases 2 and 4 activities as well as induction of cdk inhibitors p21 and p27 during growth arrest of human breast carcinoma cells by (?)-epigallocatechin-3-gallate. J Cell Biochem 1999;75:1-12. [DOI: 10.1002/(sici)1097-4644(19991001)75:1<1::aid-jcb1>3.0.co;2-n] [Reference Citation Analysis]
437 Zhu B, Zhu Y, Tian J, Shen N, Li J, Lou J, Ke J, Yang Y, Gong Y, Gong J, Chang J, Miao X, Zhong R. A functional variant rs1537373 in 9p21.3 region is associated with pancreatic cancer risk. Mol Carcinog 2019;58:760-6. [PMID: 30604909 DOI: 10.1002/mc.22968] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
438 Fuentealba L, Schworer C, Schroering A, Rahmatullah M, Carey DJ. Heregulin and forskolin-induced cyclin D3 expression in Schwann cells: Role of a CCAAT promoter element and CCAAT enhancer binding protein. Glia 2004;45:238-48. [DOI: 10.1002/glia.10325] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 0.5] [Reference Citation Analysis]
439 Hoozemans JJ, van Haastert ES, Veerhuis R, Arendt T, Scheper W, Eikelenboom P, Rozemuller AJ. Maximal COX-2 and ppRb expression in neurons occurs during early Braak stages prior to the maximal activation of astrocytes and microglia in Alzheimer's disease. J Neuroinflammation 2005;2:27. [PMID: 16300681 DOI: 10.1186/1742-2094-2-27] [Cited by in Crossref: 32] [Cited by in F6Publishing: 36] [Article Influence: 1.9] [Reference Citation Analysis]
440 Xue Y, Harris E, Wang W, Baybutt RC. Vitamin A depletion induced by cigarette smoke is associated with an increase in lung cancer-related markers in rats. J Biomed Sci 2015;22:84. [PMID: 26462767 DOI: 10.1186/s12929-015-0189-0] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 0.7] [Reference Citation Analysis]
441 Polley SR, Fay DS. A network of genes antagonistic to the LIN-35 retinoblastoma protein of Caenorhabditis elegans. Genetics 2012;191:1367-80. [PMID: 22542970 DOI: 10.1534/genetics.112.140152] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.5] [Reference Citation Analysis]
442 Wu D, Zhang X, Liu Z, Yan H, Mai J, Zhao Z, Zhong Q, Liu X. Decreased expression of protein tyrosine kinase 6 contributes to tumor progression and metastasis in laryngeal squamous cell carcinoma. Biochem Biophys Res Commun 2018;503:1378-84. [PMID: 30029880 DOI: 10.1016/j.bbrc.2018.07.051] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.8] [Reference Citation Analysis]
443 Radisavljevic Z. Inactivated tumor suppressor Rb by nitric oxide promotes mitosis in human breast cancer cells. J Cell Biochem 2004;92:1-5. [PMID: 15095398 DOI: 10.1002/jcb.20063] [Cited by in Crossref: 23] [Cited by in F6Publishing: 21] [Article Influence: 1.3] [Reference Citation Analysis]
444 Yamada S, Sumrejkanchanakij P, Amagasa T, Ikeda MA. Loss of cyclin E requirement in cell growth of an oral squamous cell carcinoma cell line implies deregulation of its downstream pathway. Int J Cancer 2004;111:17-22. [PMID: 15185338 DOI: 10.1002/ijc.20234] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.2] [Reference Citation Analysis]
445 Ge N, Elferink CJ. A Direct Interaction between the Aryl Hydrocarbon Receptor and Retinoblastoma Protein. Journal of Biological Chemistry 1998;273:22708-13. [DOI: 10.1074/jbc.273.35.22708] [Cited by in Crossref: 176] [Cited by in F6Publishing: 168] [Article Influence: 7.3] [Reference Citation Analysis]
446 Zheng T, Lu M, Wang T, Zhang C, Du X. NRBE3 promotes metastasis of breast cancer by down-regulating E-cadherin expression. Biochim Biophys Acta Mol Cell Res 2018;1865:1869-77. [PMID: 30262434 DOI: 10.1016/j.bbamcr.2018.09.003] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 1.3] [Reference Citation Analysis]
447 Sarfraz S, Hamid S, Ali S, Jafri W, Siddiqui AA. Modulations of cell cycle checkpoints during HCV associated disease. BMC Infect Dis 2009;9:125. [PMID: 19664251 DOI: 10.1186/1471-2334-9-125] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 0.7] [Reference Citation Analysis]
448 López-Cara LC, Conejo-García A, Marchal JA, Macchione G, Cruz-López O, Boulaiz H, García MA, Rodríguez-Serrano F, Ramírez A, Cativiela C, Jiménez AI, García-Ruiz JM, Choquesillo-Lazarte D, Aránega A, Campos JM. New (RS)-benzoxazepin-purines with antitumour activity: The chiral switch from (RS)-2,6-dichloro-9-[1-(p-nitrobenzenesulfonyl)-1,2,3,5-tetrahydro-4,1-benzoxazepin-3-yl]-9H-purine. Eur J Med Chem 2011;46:249-58. [PMID: 21126804 DOI: 10.1016/j.ejmech.2010.11.011] [Cited by in Crossref: 31] [Cited by in F6Publishing: 28] [Article Influence: 2.6] [Reference Citation Analysis]
449 Zhu L, Gong B, Bisgaier CL, Aviram M, Newton RS. Induction of PPARgamma1 expression in human THP-1 monocytic leukemia cells by 9-cis-retinoic acid is associated with cellular growth suppression. Biochem Biophys Res Commun. 1998;251:842-848. [PMID: 9790997 DOI: 10.1006/bbrc.1998.9567] [Cited by in Crossref: 17] [Cited by in F6Publishing: 15] [Article Influence: 0.7] [Reference Citation Analysis]
450 Horiuchi T, Chiba J, Uoto K, Soga T. Discovery of novel thieno[2,3-d]pyrimidin-4-yl hydrazone-based inhibitors of Cyclin D1-CDK4: synthesis, biological evaluation, and structure-activity relationships. Bioorg Med Chem Lett 2009;19:305-8. [PMID: 19091560 DOI: 10.1016/j.bmcl.2008.11.090] [Cited by in Crossref: 70] [Cited by in F6Publishing: 46] [Article Influence: 5.0] [Reference Citation Analysis]
451 Hizli AA, Black AR, Pysz MA, Black JD. Protein kinase C alpha signaling inhibits cyclin D1 translation in intestinal epithelial cells. J Biol Chem 2006;281:14596-603. [PMID: 16556598 DOI: 10.1074/jbc.M601959200] [Cited by in Crossref: 29] [Cited by in F6Publishing: 20] [Article Influence: 1.8] [Reference Citation Analysis]
452 Fabbro D, Ruetz S, Buchdunger E, Cowan-Jacob SW, Fendrich G, Liebetanz J, Mestan J, O'Reilly T, Traxler P, Chaudhuri B, Fretz H, Zimmermann J, Meyer T, Caravatti G, Furet P, Manley PW. Protein kinases as targets for anticancer agents: from inhibitors to useful drugs. Pharmacol Ther 2002;93:79-98. [PMID: 12191602 DOI: 10.1016/s0163-7258(02)00179-1] [Cited by in Crossref: 207] [Cited by in F6Publishing: 33] [Article Influence: 10.9] [Reference Citation Analysis]
453 Ogias D, de Andrade Sá ER, Kasai A, Moisan MP, Alvares EP, Gama P. Fasting differentially regulates plasma corticosterone-binding globulin, glucocorticoid receptor, and cell cycle in the gastric mucosa of pups and adult rats. Am J Physiol Gastrointest Liver Physiol 2010;298:G117-25. [PMID: 19833863 DOI: 10.1152/ajpgi.00245.2009] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 0.7] [Reference Citation Analysis]
454 Promwikorn W, Hawley SR, Pennington SR. Changes in p21Cip1 and p27Kip1 expression are not required for cell cycle entry and progression to S phase in Swiss 3T3 cells. Cellular Signalling 2000;12:619-27. [DOI: 10.1016/s0898-6568(00)00104-2] [Cited by in Crossref: 4] [Article Influence: 0.2] [Reference Citation Analysis]
455 Chen TC, Ng KF, Lien JM, Jeng LB, Chen MF, Hsieh LL. Mutational analysis of the p27(kip1) gene in hepatocellular carcinoma. Cancer Lett. 2000;153:169-173. [PMID: 10779646 DOI: 10.1016/s0304-3835(00)00366-9] [Cited by in Crossref: 13] [Cited by in F6Publishing: 7] [Article Influence: 0.6] [Reference Citation Analysis]
456 Chiba T, Zheng Y, Kita K, Yokosuka O, Saisho H, Onodera M, Miyoshi H, Nakano M, Zen Y, Nakanuma Y, Nakauchi H, Iwama A, Taniguchi H. Enhanced Self-Renewal Capability in Hepatic Stem/Progenitor Cells Drives Cancer Initiation. Gastroenterology 2007;133:937-50. [DOI: 10.1053/j.gastro.2007.06.016] [Cited by in Crossref: 156] [Cited by in F6Publishing: 153] [Article Influence: 10.4] [Reference Citation Analysis]
457 Stiewe T, Stanelle J, Theseling CC, Pollmeier B, Beitzinger M, Pützer BM. Inactivation of Retinoblastoma (RB) Tumor Suppressor by Oncogenic Isoforms of the p53 Family Member p73. Journal of Biological Chemistry 2003;278:14230-6. [DOI: 10.1074/jbc.m300357200] [Cited by in Crossref: 27] [Cited by in F6Publishing: 10] [Article Influence: 1.4] [Reference Citation Analysis]
458 Alfieri R, Barberis M, Chiaradonna F, Gaglio D, Milanesi L, Vanoni M, Klipp E, Alberghina L. Towards a systems biology approach to mammalian cell cycle: modeling the entrance into S phase of quiescent fibroblasts after serum stimulation. BMC Bioinformatics 2009;10 Suppl 12:S16. [PMID: 19828076 DOI: 10.1186/1471-2105-10-S12-S16] [Cited by in Crossref: 31] [Cited by in F6Publishing: 17] [Article Influence: 2.4] [Reference Citation Analysis]
459 Sigoillot FD, Berkowski JA, Sigoillot SM, Kotsis DH, Guy HI. Cell cycle-dependent regulation of pyrimidine biosynthesis. J Biol Chem 2003;278:3403-9. [PMID: 12438317 DOI: 10.1074/jbc.M211078200] [Cited by in Crossref: 47] [Cited by in F6Publishing: 24] [Article Influence: 2.4] [Reference Citation Analysis]
460 Santiskulvong C, Sinnett-smith J, Rozengurt E. Insulin reduces the requirement for EGFR transactivation in bombesin-induced DNA synthesis. Biochemical and Biophysical Research Communications 2004;318:826-32. [DOI: 10.1016/j.bbrc.2004.04.100] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
461 Wilson CS, Butch AW, Lai R, Medeiros LJ, Sawyer JR, Barlogie B, McCourty A, Kelly K, Brynes RK. Cyclin D1 and E2F-1 immunoreactivity in bone marrow biopsy specimens of multiple myeloma: relationship to proliferative activity, cytogenetic abnormalities and DNA ploidy. Br J Haematol 2001;112:776-82. [PMID: 11260083 DOI: 10.1046/j.1365-2141.2001.02499.x] [Cited by in Crossref: 21] [Cited by in F6Publishing: 19] [Article Influence: 1.0] [Reference Citation Analysis]
462 Seol JG, Park WH, Kim ES, Jung CW, Hyun JM, Kim BK, Lee YY. Effect of arsenic trioxide on cell cycle arrest in head and neck cancer cell line PCI-1. Biochem Biophys Res Commun. 1999;265:400-404. [PMID: 10558879 DOI: 10.1006/bbrc.1999.1697] [Cited by in Crossref: 54] [Cited by in F6Publishing: 52] [Article Influence: 2.3] [Reference Citation Analysis]
463 Garrett MD, Fattaey A. CDK inhibition and cancer therapy. Current Opinion in Genetics & Development 1999;9:104-11. [DOI: 10.1016/s0959-437x(99)80015-x] [Cited by in Crossref: 100] [Cited by in F6Publishing: 17] [Article Influence: 4.3] [Reference Citation Analysis]
464 Pertia A, Nikoleishvili D, Trsintsadze O, Gogokhia N, Managadze L, Chkhotua A. Loss of p27(Kip1) CDKI is a predictor of poor recurrence-free and cancer-specific survival in patients with renal cancer. Int Urol Nephrol 2007;39:381-7. [DOI: 10.1007/s11255-006-9077-6] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 0.7] [Reference Citation Analysis]
465 Rayson D, Erlichman C, Suman VJ, Roche PC, Wold LE, Ingle JN, Donohue JH. Molecular markers in male breast carcinoma. Cancer 1998;83:1947-55. [DOI: 10.1002/(sici)1097-0142(19981101)83:9<1947::aid-cncr10>3.0.co;2-j] [Cited by in Crossref: 101] [Cited by in F6Publishing: 15] [Article Influence: 4.2] [Reference Citation Analysis]
466 Xu L, Cao Y. Native musk and synthetic musk ketone strongly induced the growth repression and the apoptosis of cancer cells. BMC Complement Altern Med 2016;16:511. [PMID: 27931220 DOI: 10.1186/s12906-016-1493-2] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.2] [Reference Citation Analysis]
467 Zhu W, Liu C, Lu T, Zhang Y, Zhang S, Chen Q, Deng N. Knockout of EGFL6 by CRISPR/Cas9 Mediated Inhibition of Tumor Angiogenesis in Ovarian Cancer. Front Oncol 2020;10:1451. [PMID: 32983976 DOI: 10.3389/fonc.2020.01451] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
468 Zheng M, Wan L, He X, Qi X, Liu F, Zhang DH. Effect of the CCND1 A870G polymorphism on prostate cancer risk: a meta-analysis of 3,820 cases and 3,825 controls. World J Surg Oncol 2015;13:55. [PMID: 25888980 DOI: 10.1186/s12957-015-0479-8] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
469 Moon SK, Jung SY, Choi YH, Lee YC, Kim CH. Platelet-derived growth factor induces p21/WAF1 promoter in vascular smooth muscle cells via activation of an Sp1 site. FEBS Lett 2003;552:130-4. [PMID: 14527674 DOI: 10.1016/s0014-5793(03)00935-9] [Cited by in Crossref: 9] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
470 Peters J, Loud J, Dimond E, Jenkins J. Cancer Genetics Fundamentals: . Cancer Nursing 2001;24:446-61. [DOI: 10.1097/00002820-200112000-00005] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.2] [Reference Citation Analysis]
471 Pestell RG, Albanese C, Reutens AT, Segall JE, Lee RJ, Arnold A. The cyclins and cyclin-dependent kinase inhibitors in hormonal regulation of proliferation and differentiation. Endocr Rev 1999;20:501-34. [PMID: 10453356 DOI: 10.1210/edrv.20.4.0373] [Cited by in Crossref: 9] [Cited by in F6Publishing: 88] [Article Influence: 0.4] [Reference Citation Analysis]
472 Zachleder V, Bišová K, Vítová M. The Cell Cycle of Microalgae. In: Borowitzka MA, Beardall J, Raven JA, editors. The Physiology of Microalgae. Cham: Springer International Publishing; 2016. pp. 3-46. [DOI: 10.1007/978-3-319-24945-2_1] [Cited by in Crossref: 7] [Cited by in F6Publishing: 1] [Article Influence: 1.2] [Reference Citation Analysis]
473 Anzola M, Cuevas N, Lopez-Martinez M, Martinez de Pancorbo M, Burgos JJ. p16INK4A gene alterations are not a prognostic indicator for survival in patients with hepatocellular carcinoma undergoing curative hepatectomy. J Gastroenterol Hepatol. 2004;19:397-405. [PMID: 15012776 DOI: 10.1111/j.1440-1746.2003.03305.x] [Cited by in Crossref: 13] [Cited by in F6Publishing: 16] [Article Influence: 0.7] [Reference Citation Analysis]
474 Dhulipala V, Maddali K, Welshons W, Reddy C. Secalonic acid D blocks embryonic palatal mesenchymal cell-cycle by altering the activity of CDK2 and the expression of p21 and cyclin E. Birth Defect Res B 2005;74:233-42. [DOI: 10.1002/bdrb.20043] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 0.5] [Reference Citation Analysis]
475 Zhu CQ, Shih W, Ling CH, Tsao MS. Immunohistochemical markers of prognosis in non-small cell lung cancer: a review and proposal for a multiphase approach to marker evaluation. J Clin Pathol 2006;59:790-800. [PMID: 16873561 DOI: 10.1136/jcp.2005.031351] [Cited by in Crossref: 130] [Cited by in F6Publishing: 111] [Article Influence: 8.1] [Reference Citation Analysis]
476 Molenaar JJ, Ebus ME, Geerts D, Koster J, Lamers F, Valentijn LJ, Westerhout EM, Versteeg R, Caron HN. Inactivation of CDK2 is synthetically lethal to MYCN over-expressing cancer cells. Proc Natl Acad Sci U S A 2009;106:12968-73. [PMID: 19525400 DOI: 10.1073/pnas.0901418106] [Cited by in Crossref: 121] [Cited by in F6Publishing: 110] [Article Influence: 9.3] [Reference Citation Analysis]
477 Arima Y, Hayashi N, Hayashi H, Sasaki M, Kai K, Sugihara E, Abe E, Yoshida A, Mikami S, Nakamura S, Saya H. Loss of p16 expression is associated with the stem cell characteristics of surface markers and therapeutic resistance in estrogen receptor-negative breast cancer. Int J Cancer 2012;130:2568-79. [DOI: 10.1002/ijc.26271] [Cited by in Crossref: 51] [Cited by in F6Publishing: 49] [Article Influence: 4.6] [Reference Citation Analysis]
478 Meng Y, Zhang C, Zhou X. Association between the Cyclin D1 G870A polymorphism and the susceptibility to and prognosis of upper aerodigestive tract squamous cell carcinomas: an updated meta-analysis. Onco Targets Ther 2016;9:367-76. [PMID: 26855585 DOI: 10.2147/OTT.S94635] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
479 Sun X, Xu R, Deng Y, Cheng H, Ma J, Ji J, Zhou Y. Effects of tetrandrine on apoptosis and radiosensitivity of nasopharyngeal carcinoma cell line CNE. Acta Biochim Biophys Sin (Shanghai) 2007;39:869-78. [PMID: 17989878 DOI: 10.1111/j.1745-7270.2007.00349.x] [Cited by in Crossref: 22] [Cited by in F6Publishing: 21] [Article Influence: 1.6] [Reference Citation Analysis]
480 Igarashi T, Jiang S, Kameya T, Asamura H, Sato Y, Nagai K, Okayasu I. Divergent cyclin B1 expression and Rb/p16/cyclin D1 pathway aberrations among pulmonary neuroendocrine tumors. Mod Pathol 2004;17:1259-67. [DOI: 10.1038/modpathol.3800176] [Cited by in Crossref: 43] [Cited by in F6Publishing: 35] [Article Influence: 2.4] [Reference Citation Analysis]
481 Osada S, Kanematsu M, Imai H, Goshima S, Sugiyama Y. Evaluation of Extracellular Signal Regulated Kinase Expression and Its Relation to Treatment of Hepatocellular Carcinoma. Journal of the American College of Surgeons 2005;201:405-11. [DOI: 10.1016/j.jamcollsurg.2005.05.015] [Cited by in Crossref: 30] [Cited by in F6Publishing: 22] [Article Influence: 1.8] [Reference Citation Analysis]
482 Yoshida K, Inoue I. Regulation of Geminin and Cdt1 expression by E2F transcription factors. Oncogene 2004;23:3802-12. [PMID: 14990995 DOI: 10.1038/sj.onc.1207488] [Cited by in Crossref: 69] [Cited by in F6Publishing: 66] [Article Influence: 3.8] [Reference Citation Analysis]
483 Singh A, Fatima K, Singh A, Behl A, Mintoo MJ, Hasanain M, Ashraf R, Luqman S, Shanker K, Mondhe DM, Sarkar J, Chanda D, Negi AS. Anticancer activity and toxicity profiles of 2-benzylidene indanone lead molecule. Eur J Pharm Sci 2015;76:57-67. [PMID: 25933717 DOI: 10.1016/j.ejps.2015.04.020] [Cited by in Crossref: 17] [Cited by in F6Publishing: 9] [Article Influence: 2.4] [Reference Citation Analysis]
484 Zhang R, Li X, Wei L, Qin Y, Fang J. Lemur tyrosine kinase 2 acts as a positive regulator of NF-κB activation and colon cancer cell proliferation. Cancer Lett 2019;454:70-7. [PMID: 30980866 DOI: 10.1016/j.canlet.2019.04.011] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 2.3] [Reference Citation Analysis]
485 Tsutsui T, Tamura Y, Yagi E, Someya H, Hori I, Metzler M, Barrett JC. Cell-transforming activity and mutagenicity of 5 phytoestrogens in cultured mammalian cells. Int J Cancer 2003;105:312-20. [DOI: 10.1002/ijc.11046] [Cited by in Crossref: 24] [Cited by in F6Publishing: 15] [Article Influence: 1.3] [Reference Citation Analysis]
486 Brosh R, Rotter V. Transcriptional control of the proliferation cluster by the tumor suppressor p53. Mol BioSyst 2010;6:17-29. [DOI: 10.1039/b911416e] [Cited by in Crossref: 23] [Cited by in F6Publishing: 14] [Article Influence: 1.9] [Reference Citation Analysis]
487 Hakim S, Craig JM, Koblinski JE, Clevenger CV. Inhibition of the Activity of Cyclophilin A Impedes Prolactin Receptor-Mediated Signaling, Mammary Tumorigenesis, and Metastases. iScience 2020;23:101581. [PMID: 33083747 DOI: 10.1016/j.isci.2020.101581] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
488 Palmqvist R, Rutegârd JN, Bozoky B, Landberg G, Stenling R. Human colorectal cancers with an intact p16/cyclin D1/pRb pathway have up-regulated p16 expression and decreased proliferation in small invasive tumor clusters. Am J Pathol 2000;157:1947-53. [PMID: 11106567 DOI: 10.1016/S0002-9440(10)64833-X] [Cited by in Crossref: 51] [Cited by in F6Publishing: 25] [Article Influence: 2.4] [Reference Citation Analysis]
489 Atallah D, Marsaud V, Radanyi C, Kornprobst M, Rouzier R, Elias D, Renoir JM. Thermal enhancement of oxaliplatin-induced inhibition of cell proliferation and cell cycle progression in human carcinoma cell lines. Int J Hyperthermia. 2004;20:405-419. [PMID: 15204521 DOI: 10.1080/02656730310001637325] [Cited by in Crossref: 27] [Cited by in F6Publishing: 25] [Article Influence: 1.5] [Reference Citation Analysis]
490 Horn L, Lindner K, Szepankiewicz G, Edelmann J, Hentschel B, Tannapfel A, Bilek K, Liebert U, Richter CE, Einenkel J, Leo C. p16, p14, p53, and Cyclin D1 Expression and HPV Analysis in Small Cell Carcinomas of the Uterine Cervix: . International Journal of Gynecological Pathology 2006;25:182-6. [DOI: 10.1097/01.pgp.0000185406.85685.df] [Cited by in Crossref: 48] [Cited by in F6Publishing: 33] [Article Influence: 3.0] [Reference Citation Analysis]
491 Wang L, Peng Y, Shi K, Wang H, Lu J, Li Y, Ma C. Osthole inhibits proliferation of human breast cancer cells by inducing cell cycle arrest and apoptosis. J Biomed Res 2015;29:132-8. [PMID: 25859268 DOI: 10.7555/JBR.27.20120115] [Cited by in Crossref: 7] [Cited by in F6Publishing: 17] [Article Influence: 0.7] [Reference Citation Analysis]
492 Joseph C, Arshad M, Kurozomi S, Althobiti M, Miligy IM, Al-izzi S, Toss MS, Goh FQ, Johnston SJ, Martin SG, Ellis IO, Mongan NP, Green AR, Rakha EA. Overexpression of the cancer stem cell marker CD133 confers a poor prognosis in invasive breast cancer. Breast Cancer Res Treat 2019;174:387-99. [DOI: 10.1007/s10549-018-05085-9] [Cited by in Crossref: 27] [Cited by in F6Publishing: 27] [Article Influence: 6.8] [Reference Citation Analysis]
493 Zaika A, Irwin M, Sansome C, Moll UM. Oncogenes Induce and Activate Endogenous p73 Protein. Journal of Biological Chemistry 2001;276:11310-6. [DOI: 10.1074/jbc.m005737200] [Cited by in Crossref: 89] [Cited by in F6Publishing: 35] [Article Influence: 4.2] [Reference Citation Analysis]
494 Yenugonda VM, Deb TB, Grindrod SC, Dakshanamurthy S, Yang Y, Paige M, Brown ML. Fluorescent cyclin-dependent kinase inhibitors block the proliferation of human breast cancer cells. Bioorg Med Chem 2011;19:2714-25. [PMID: 21440449 DOI: 10.1016/j.bmc.2011.02.052] [Cited by in Crossref: 19] [Cited by in F6Publishing: 16] [Article Influence: 1.7] [Reference Citation Analysis]
495 Kuszak JR, Costello MJ. The Structure of the Vertebrate Lens. In: Lovicu FJ, Robinson ML, editors. Development of the Ocular Lens. Cambridge University Press; 2010. pp. 71-118. [DOI: 10.1017/cbo9780511529825.005] [Cited by in Crossref: 8] [Article Influence: 0.4] [Reference Citation Analysis]
496 Knowles MA. What we could do now: molecular pathology of bladder cancer. Mol Pathol 2001;54:215-21. [PMID: 11477133 DOI: 10.1136/mp.54.4.215] [Cited by in Crossref: 100] [Cited by in F6Publishing: 84] [Article Influence: 4.8] [Reference Citation Analysis]
497 Du S, Lu L, Miao Y, Jin W, Li C, Xin Y, Xuan S. E167K polymorphism of TM6SF2 gene affects cell cycle of hepatocellular carcinoma cell HEPA 1-6. Lipids Health Dis 2017;16:76. [PMID: 28407767 DOI: 10.1186/s12944-017-0468-8] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
498 Ouadah Y, Rojas ER, Riordan DP, Capostagno S, Kuo CS, Krasnow MA. Rare Pulmonary Neuroendocrine Cells Are Stem Cells Regulated by Rb, p53, and Notch. Cell 2019;179:403-416.e23. [PMID: 31585080 DOI: 10.1016/j.cell.2019.09.010] [Cited by in Crossref: 56] [Cited by in F6Publishing: 40] [Article Influence: 28.0] [Reference Citation Analysis]
499 Terada Y, Inoshita S, Nakashima O, Kuwahara M, Sasaki S, Marumo F. Regulation of cyclin D1 expression and cell cycle progression by mitogen-activated protein kinase cascade. Kidney Int. 1999;56:1258-1261. [PMID: 10504469 DOI: 10.1046/j.1523-1755.1999.00704.x] [Cited by in Crossref: 39] [Cited by in F6Publishing: 38] [Article Influence: 1.7] [Reference Citation Analysis]
500 Lukas C, Jensen SK, Bartkova J, Lukas J, Bartek J. Immunohistochemical analysis of the D-type cyclin-dependent kinases Cdk4 and Cdk6, using a series of monoclonal antibodies. Hybridoma 1999;18:225-34. [PMID: 10475236 DOI: 10.1089/027245799315871] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 0.3] [Reference Citation Analysis]
501 Liu WD, Wang HW, Muguira M, Breslin MB, Lan MS. INSM1 functions as a transcriptional repressor of the neuroD/beta2 gene through the recruitment of cyclin D1 and histone deacetylases. Biochem J 2006;397:169-77. [PMID: 16569215 DOI: 10.1042/BJ20051669] [Cited by in Crossref: 44] [Cited by in F6Publishing: 26] [Article Influence: 2.8] [Reference Citation Analysis]
502 Ikuta M, Kamata K, Fukasawa K, Honma T, Machida T, Hirai H, Suzuki-Takahashi I, Hayama T, Nishimura S. Crystallographic approach to identification of cyclin-dependent kinase 4 (CDK4)-specific inhibitors by using CDK4 mimic CDK2 protein. J Biol Chem 2001;276:27548-54. [PMID: 11335721 DOI: 10.1074/jbc.M102060200] [Cited by in Crossref: 69] [Cited by in F6Publishing: 14] [Article Influence: 3.3] [Reference Citation Analysis]
503 Sun J, Qian Y, Chen Z, Marfurt J, Hamilton AD, Sebti SM. The geranylgeranyltransferase I inhibitor GGTI-298 induces hypophosphorylation of retinoblastoma and partner switching of cyclin-dependent kinase inhibitors. A potential mechanism for GGTI-298 antitumor activity. J Biol Chem 1999;274:6930-4. [PMID: 10066746 DOI: 10.1074/jbc.274.11.6930] [Cited by in Crossref: 39] [Cited by in F6Publishing: 40] [Article Influence: 1.7] [Reference Citation Analysis]
504 Brugarolas J, Bronson RT, Jacks T. p21 is a critical CDK2 regulator essential for proliferation control in Rb-deficient cells. J Cell Biol 1998;141:503-14. [PMID: 9548727 DOI: 10.1083/jcb.141.2.503] [Cited by in Crossref: 105] [Cited by in F6Publishing: 105] [Article Influence: 4.4] [Reference Citation Analysis]
505 Dannenberg JH, van Rossum A, Schuijff L, te Riele H. Ablation of the retinoblastoma gene family deregulates G(1) control causing immortalization and increased cell turnover under growth-restricting conditions. Genes Dev 2000;14:3051-64. [PMID: 11114893 DOI: 10.1101/gad.847700] [Cited by in Crossref: 283] [Cited by in F6Publishing: 300] [Article Influence: 13.5] [Reference Citation Analysis]
506 Kwong FM, Tang JCO, Srivastava G, Lung ML. Inactivation mechanisms and growth suppressive effects of p16INK4a in Asian esophageal squamous carcinoma cell lines. Cancer Letters 2004;208:207-13. [DOI: 10.1016/j.canlet.2003.11.017] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.3] [Reference Citation Analysis]
507 Reyes JC, Barra J, Muchardt C, Camus A, Babinet C, Yaniv M. Altered control of cellular proliferation in the absence of mammalian brahma (SNF2alpha). EMBO J 1998;17:6979-91. [PMID: 9843504 DOI: 10.1093/emboj/17.23.6979] [Cited by in Crossref: 322] [Cited by in F6Publishing: 316] [Article Influence: 14.0] [Reference Citation Analysis]
508 Gladden AB, Woolery R, Aggarwal P, Wasik MA, Diehl JA. Expression of constitutively nuclear cyclin D1 in murine lymphocytes induces B-cell lymphoma. Oncogene 2006;25:998-1007. [PMID: 16247460 DOI: 10.1038/sj.onc.1209147] [Cited by in Crossref: 94] [Cited by in F6Publishing: 93] [Article Influence: 5.9] [Reference Citation Analysis]
509 Fuentes-garí M, Misener R, Georgiadis MC, Kostoglou M, Panoskaltsis N, Mantalaris A, Pistikopoulos EN. Selecting a Differential Equation Cell Cycle Model for Simulating Leukemia Treatment. Ind Eng Chem Res 2015;54:8847-59. [DOI: 10.1021/acs.iecr.5b01150] [Cited by in Crossref: 6] [Cited by in F6Publishing: 2] [Article Influence: 0.9] [Reference Citation Analysis]
510 El-Moghazy SM, Ibrahim DA, Abdelgawad NM, Farag NA, El-Khouly AS. Design, Synthesis and Biological Evaluation of Novel Pyrimido[4,5-d]pyrimidine CDK2 Inhibitors as Anti-Tumor Agents. Sci Pharm 2011;79:429-47. [PMID: 21886895 DOI: 10.3797/scipharm.1103-16] [Cited by in Crossref: 16] [Cited by in F6Publishing: 5] [Article Influence: 1.5] [Reference Citation Analysis]
511 Shin S, Hwang B, Lee S, Kim W, Moon S. Ethanol extract of loquat fruit skin inhibits the proliferation and metastatic potential of EJ human bladder carcinoma cells. Animal Cells and Systems 2017;21:323-31. [DOI: 10.1080/19768354.2017.1358665] [Reference Citation Analysis]
512 Garrett MD, Workman P. Discovering novel chemotherapeutic drugs for the third millennium. Eur J Cancer 1999;35:2010-30. [PMID: 10711243 DOI: 10.1016/s0959-8049(99)00280-4] [Cited by in Crossref: 98] [Cited by in F6Publishing: 13] [Article Influence: 4.5] [Reference Citation Analysis]
513 Ma D, Zhou P, Harbour JW. Distinct Mechanisms for Regulating the Tumor Suppressor and Antiapoptotic Functions of Rb. Journal of Biological Chemistry 2003;278:19358-66. [DOI: 10.1074/jbc.m301761200] [Cited by in Crossref: 43] [Cited by in F6Publishing: 16] [Article Influence: 2.3] [Reference Citation Analysis]
514 Zhang W, Chen H, Chen Y, Liu J, Wang X, Yu X, Chen JJ, Zhao W. Cancerous inhibitor of protein phosphatase 2A contributes to human papillomavirus oncoprotein E7-induced cell proliferation via E2F1. Oncotarget 2015;6:5253-62. [PMID: 25650660 DOI: 10.18632/oncotarget.2867] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 1.8] [Reference Citation Analysis]
515 Tsai KY, MacPherson D, Rubinson DA, Nikitin AY, Bronson R, Mercer KL, Crowley D, Jacks T. ARF mutation accelerates pituitary tumor development in Rb+/- mice. Proc Natl Acad Sci U S A 2002;99:16865-70. [PMID: 12486224 DOI: 10.1073/pnas.262499599] [Cited by in Crossref: 29] [Cited by in F6Publishing: 25] [Article Influence: 1.5] [Reference Citation Analysis]
516 Edelman MJ. The potential role of bortezomib in combination with chemotherapy and radiation in non-small-cell lung cancer. Clin Lung Cancer 2005;7 Suppl 2:S64-6. [PMID: 16250930 DOI: 10.3816/clc.2005.s.011] [Cited by in Crossref: 11] [Cited by in F6Publishing: 8] [Article Influence: 0.7] [Reference Citation Analysis]
517 Henchoz S, Chi Y, Catarin B, Herskowitz I, Deshaies RJ, Peter M. Phosphorylation- and ubiquitin-dependent degradation of the cyclin-dependent kinase inhibitor Far1p in budding yeast. Genes Dev 1997;11:3046-60. [PMID: 9367986 DOI: 10.1101/gad.11.22.3046] [Cited by in Crossref: 148] [Cited by in F6Publishing: 157] [Article Influence: 5.9] [Reference Citation Analysis]
518 Horibe Y, Adachi S, Yasuda I, Yamauchi T, Kawaguchi J, Kozawa O, Shimizu M, Moriwaki H. Anticancer effect of arsenite on cell migration, cell cycle and apoptosis in human pancreatic cancer cells. Oncol Lett 2016;12:177-82. [PMID: 27347121 DOI: 10.3892/ol.2016.4564] [Cited by in Crossref: 1] [Article Influence: 0.2] [Reference Citation Analysis]
519 Ma D, Lian F, Wang X. PLCG2 promotes hepatocyte proliferation in vitro via NF-κB and ERK pathway by targeting bcl2, myc and ccnd1. Artif Cells Nanomed Biotechnol 2019;47:3786-92. [PMID: 31549850 DOI: 10.1080/21691401.2019.1669616] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
520 Klausen P, Bjerregaard MD, Borregaard N, Cowland JB. End-stage differentiation of neutrophil granulocytes in vivo is accompanied by up-regulation of p27kip1 and down-regulation of CDK2, CDK4, and CDK6. J Leukoc Biol. 2004;75:569-578. [PMID: 14694185 DOI: 10.1189/jlb.1003474] [Cited by in Crossref: 42] [Cited by in F6Publishing: 42] [Article Influence: 2.2] [Reference Citation Analysis]
521 Min JW, Kim WJ, Han JA, Jung YJ, Kim KT, Park WY, Lee HO, Choi SS. Identification of Distinct Tumor Subpopulations in Lung Adenocarcinoma via Single-Cell RNA-seq. PLoS One 2015;10:e0135817. [PMID: 26305796 DOI: 10.1371/journal.pone.0135817] [Cited by in Crossref: 41] [Cited by in F6Publishing: 37] [Article Influence: 5.9] [Reference Citation Analysis]
522 Bello MJ, Amiñoso C, Lopez-Marin I, Arjona D, Gonzalez-Gomez P, Alonso ME, Lomas J, de Campos JM, Kusak ME, Vaquero J, Isla A, Gutierrez M, Sarasa JL, Rey JA. DNA methylation of multiple promoter-associated CpG islands in meningiomas: relationship with the allelic status at 1p and 22q. Acta Neuropathol 2004;108:413-21. [PMID: 15365725 DOI: 10.1007/s00401-004-0911-6] [Cited by in Crossref: 46] [Cited by in F6Publishing: 40] [Article Influence: 2.6] [Reference Citation Analysis]
523 Lasorella A, Uo T, Iavarone A. Id proteins at the cross-road of development and cancer. Oncogene 2001;20:8326-33. [DOI: 10.1038/sj.onc.1205093] [Cited by in Crossref: 182] [Cited by in F6Publishing: 183] [Article Influence: 9.1] [Reference Citation Analysis]
524 Liu S, Premnath PN, Bolger JK, Perkins TL, Kirkland LO, Kontopidis G, McInnes C. Optimization of non-ATP competitive CDK/cyclin groove inhibitors through REPLACE-mediated fragment assembly. J Med Chem 2013;56:1573-82. [PMID: 23323521 DOI: 10.1021/jm3013882] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 1.6] [Reference Citation Analysis]
525 Koziczak M, Holbro T, Hynes NE. Blocking of FGFR signaling inhibits breast cancer cell proliferation through downregulation of D-type cyclins. Oncogene 2004;23:3501-8. [DOI: 10.1038/sj.onc.1207331] [Cited by in Crossref: 116] [Cited by in F6Publishing: 112] [Article Influence: 6.4] [Reference Citation Analysis]
526 Wei Q, Paterson BM. Regulation of MyoD function in the dividing myoblast. FEBS Lett 2001;490:171-8. [PMID: 11223032 DOI: 10.1016/s0014-5793(01)02120-2] [Cited by in Crossref: 89] [Cited by in F6Publishing: 38] [Article Influence: 4.2] [Reference Citation Analysis]
527 Zhang Z, Chen C, Wang G, Yang Z, San J, Zheng J, Li Q, Luo X, Hu Q, Li Z. Aberrant expression of the p53-inducible antiproliferative gene BTG2 in hepatocellular carcinoma is associated with overexpression of the cell cycle-related proteins. Cell Biochem Biophys. 2011;61:83-91. [PMID: 21327578 DOI: 10.1007/s12013-011-9164-x] [Cited by in Crossref: 16] [Cited by in F6Publishing: 13] [Article Influence: 1.5] [Reference Citation Analysis]
528 Fonseca R, Bailey RJ, Ahmann GJ, Rajkumar SV, Hoyer JD, Lust JA, Kyle RA, Gertz MA, Greipp PR, Dewald GW. Genomic abnormalities in monoclonal gammopathy of undetermined significance. Blood 2002;100:1417-24. [DOI: 10.1182/blood.v100.4.1417.h81602001417_1417_1424] [Cited by in Crossref: 253] [Article Influence: 12.7] [Reference Citation Analysis]
529 Kim KK, Shim JC, Kim JR. Overexpression of p21, cyclin E and decreased expression of p27 in DMBA (7, 12-dimethylbenzanthracene)-induced rat ovarian carcinogenesis. Pathol Int 2003;53:291-6. [DOI: 10.1046/j.1440-1827.2003.01477.x] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 0.4] [Reference Citation Analysis]
530 Young AP, Nagarajan R, Longmore GD. Mechanisms of transcriptional regulation by Rb-E2F segregate by biological pathway. Oncogene. 2003;22:7209-7217. [PMID: 14562049 DOI: 10.1038/sj.onc.1206804] [Cited by in Crossref: 54] [Cited by in F6Publishing: 60] [Article Influence: 2.8] [Reference Citation Analysis]
531 van de Putte G, Holm R, Lie AK, Tropé CG, Kristensen GB. Expression of p27, p21, and p16 protein in early squamous cervical cancer and its relation to prognosis. Gynecol Oncol 2003;89:140-7. [PMID: 12694668 DOI: 10.1016/s0090-8258(03)00010-6] [Cited by in Crossref: 45] [Cited by in F6Publishing: 23] [Article Influence: 2.4] [Reference Citation Analysis]
532 Doherty SC, Mckeown SR, Mckelvey-martin V, Downes CS, Atala A, Yoo JJ, Simpson DA, Kaufmann WK. Cell Cycle Checkpoint Function in Bladder Cancer. JNCI Journal of the National Cancer Institute 2003;95:1859-68. [DOI: 10.1093/jnci/djg120] [Cited by in Crossref: 49] [Cited by in F6Publishing: 48] [Article Influence: 2.6] [Reference Citation Analysis]
533 Shin SS, Ko MC, Park YJ, Hwang B, Park SL, Kim WJ, Moon SK. Hydrangenol inhibits the proliferation, migration, and invasion of EJ bladder cancer cells via p21WAF1-mediated G1-phase cell cycle arrest, p38 MAPK activation, and reduction in Sp-1-induced MMP-9 expression. EXCLI J 2018;17:531-43. [PMID: 30034317 DOI: 10.17179/excli2018-1361] [Cited by in F6Publishing: 5] [Reference Citation Analysis]
534 De Leon G, Cavino M, D'Angelo M, Krucher NA. PNUTS knockdown potentiates the apoptotic effect of Roscovitine in breast and colon cancer cells. Int J Oncol 2010;36:1269-75. [PMID: 20372802 DOI: 10.3892/ijo_00000611] [Cited by in Crossref: 2] [Cited by in F6Publishing: 8] [Article Influence: 0.2] [Reference Citation Analysis]
535 Lim S, Kook S, Lee J. COMP-Ang1 enhances DNA synthesis and cell cycle progression in human periodontal ligament cells via Tie2-mediated phosphorylation of PI3K/Akt and MAPKs. Mol Cell Biochem 2016;416:157-68. [DOI: 10.1007/s11010-016-2704-3] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
536 Lo JF, Hayashi M, Woo-Kim S, Tian B, Huang JF, Fearns C, Takayama S, Zapata JM, Yang Y, Lee JD. Tid1, a cochaperone of the heat shock 70 protein and the mammalian counterpart of the Drosophila tumor suppressor l(2)tid, is critical for early embryonic development and cell survival. Mol Cell Biol 2004;24:2226-36. [PMID: 14993262 DOI: 10.1128/MCB.24.6.2226-2236.2004] [Cited by in Crossref: 38] [Cited by in F6Publishing: 23] [Article Influence: 2.1] [Reference Citation Analysis]
537 Burri N, Shaw P, Bouzourene H, Sordat I, Sordat B, Gillet M, Schorderet D, Bosman FT, Chaubert P. Methylation silencing and mutations of the p14ARF and p16INK4a genes in colon cancer. Lab Invest 2001;81:217-29. [PMID: 11232644 DOI: 10.1038/labinvest.3780230] [Cited by in Crossref: 114] [Cited by in F6Publishing: 114] [Article Influence: 5.4] [Reference Citation Analysis]
538 Shang M, Xu X, Zhang M, Yang H. Long non-coding RNA linc-ITGB1 promotes cell proliferation and migration in human hepatocellular carcinoma cells. Exp Ther Med 2017;14:4687-92. [PMID: 29201168 DOI: 10.3892/etm.2017.5143] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 0.2] [Reference Citation Analysis]
539 Liu XP, Oga A, Suehiro Y, Furuya T, Kawauchi S, Sasaki K. Inverse relationship between matrilysin expression and proliferative activity of cells in advanced gastric carcinoma. Hum Pathol. 2002;33:741-747. [PMID: 12196926 DOI: 10.1053/hupa.2002.126193] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 0.4] [Reference Citation Analysis]
540 Shah SA, Potter MW, Callery MP. Ubiquitin proteasome pathway: implications and advances in cancer therapy. Surgical Oncology 2001;10:43-52. [DOI: 10.1016/s0960-7404(01)00018-4] [Cited by in Crossref: 33] [Cited by in F6Publishing: 8] [Article Influence: 1.6] [Reference Citation Analysis]
541 Zangardi ML, Spring LM, Blouin GC, Bardia A. Ribociclib for post-menopausal women with HR+/HER2- advanced or metastatic breast cancer. Expert Review of Clinical Pharmacology 2017;10:1169-76. [DOI: 10.1080/17512433.2017.1376653] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
542 Schrump DS, Nguyen DM. Strategies for molecular intervention in esophageal cancers and their precursor lesions. Diseases of the Esophagus 1999;12:181-5. [DOI: 10.1046/j.1442-2050.1999.00044.x] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 0.5] [Reference Citation Analysis]
543 Abe S, Kubota T, Otani Y, Furukawa T, Watanabe M, Kumai K, Kitajima M. UCN-01 (7-hydroxystaurosporine) enhances 5-fluorouracil cytotoxicity through down-regulation of thymidylate synthetase messenger RNA. Jpn J Cancer Res 2000;91:1192-8. [PMID: 11092986 DOI: 10.1111/j.1349-7006.2000.tb00904.x] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 0.5] [Reference Citation Analysis]
544 Kim EJ, Shin H, Cho JS, Lee SK, Won MH, Kim JW, Park JHY. trans -10, cis -12 Conjugated Linoleic Acid Inhibits the G1–S Cell Cycle Progression in DU145 Human Prostate Carcinoma Cells. Journal of Medicinal Food 2006;9:293-9. [DOI: 10.1089/jmf.2006.9.293] [Cited by in Crossref: 18] [Cited by in F6Publishing: 14] [Article Influence: 1.1] [Reference Citation Analysis]
545 Ramljak D, Calvert RJ, Wiesenfeld PW, Diwan BA, Catipovic B, Marasas WF, Victor TC, Anderson LM, Gelderblom WC. A potential mechanism for fumonisin B 1 -mediated hepatocarcinogenesis: cyclin D1 stabilization associated with activation of Akt and inhibition of GSK-3β activity. Carcinogenesis 2000;21:1537-46. [DOI: 10.1093/carcin/21.8.1537] [Cited by in Crossref: 17] [Cited by in F6Publishing: 14] [Article Influence: 0.8] [Reference Citation Analysis]
546 Li M, Lu J, Zhang F, Li H, Zhang B, Wu X, Tan Z, Zhang L, Gao G, Mu J, Shu Y, Bao R, Ding Q, Wu W, Dong P, Gu J, Liu Y. Yes-associated protein 1 (YAP1) promotes human gallbladder tumor growth via activation of the AXL/MAPK pathway. Cancer Lett. 2014;355:201-209. [PMID: 25218593 DOI: 10.1016/j.canlet.2014.08.036] [Cited by in Crossref: 37] [Cited by in F6Publishing: 37] [Article Influence: 4.6] [Reference Citation Analysis]
547 Chiarugi V, Magnelli L, Cinelli M. COMPLEX INTERPLAY AMONG APOPTOSIS FACTORS: RB, P53, E2F, TGF- β , CELL CYCLE INHIBITORS AND THE BCL2 GENE FAMILY. Pharmacological Research 1997;35:257-61. [DOI: 10.1006/phrs.1997.0140] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 0.6] [Reference Citation Analysis]
548 Okami K, Reed AL, Cairns P, Koch WM, Westra WH, Wehage S, Jen J, Sidransky D. Cyclin D1 amplification is independent of p16 inactivation in head and neck squamous cell carcinoma. Oncogene 1999;18:3541-5. [PMID: 10376532 DOI: 10.1038/sj.onc.1202837] [Cited by in Crossref: 51] [Cited by in F6Publishing: 50] [Article Influence: 2.2] [Reference Citation Analysis]
549 Klippel A, Escobedo MA, Wachowicz MS, Apell G, Brown TW, Giedlin MA, Kavanaugh WM, Williams LT. Activation of phosphatidylinositol 3-kinase is sufficient for cell cycle entry and promotes cellular changes characteristic of oncogenic transformation. Mol Cell Biol 1998;18:5699-711. [PMID: 9742087 DOI: 10.1128/MCB.18.10.5699] [Cited by in Crossref: 189] [Cited by in F6Publishing: 53] [Article Influence: 7.9] [Reference Citation Analysis]
550 Chatrath P, Scott IS, Morris LS, Davies RJ, Bird K, Vowler SL, Coleman N. Immunohistochemical estimation of cell cycle phase in laryngeal neoplasia. Br J Cancer 2006;95:314-21. [PMID: 16832409 DOI: 10.1038/sj.bjc.6603262] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 0.6] [Reference Citation Analysis]
551 Pan Q, Yang GL, Yang JH, Lin SL, Liu N, Liu SS, Liu MY, Zhang LH, Huang YR, Shen RL, Liu Q, Gao JX, Bo JJ. Metformin can block precancerous progression to invasive tumors of bladder through inhibiting STAT3-mediated signaling pathways. J Exp Clin Cancer Res 2015;34:77. [PMID: 26245871 DOI: 10.1186/s13046-015-0183-0] [Cited by in Crossref: 29] [Cited by in F6Publishing: 29] [Article Influence: 4.1] [Reference Citation Analysis]
552 Bisio A, Nasti S, Jordan JJ, Gargiulo S, Pastorino L, Provenzani A, Quattrone A, Queirolo P, Bianchi-Scarrà G, Ghiorzo P, Inga A. Functional analysis of CDKN2A/p16INK4a 5'-UTR variants predisposing to melanoma. Hum Mol Genet 2010;19:1479-91. [PMID: 20093296 DOI: 10.1093/hmg/ddq022] [Cited by in Crossref: 36] [Cited by in F6Publishing: 34] [Article Influence: 3.0] [Reference Citation Analysis]
553 Strasser K, Bloomfield G, MacWilliams A, Ceccarelli A, MacWilliams H, Tsang A. A retinoblastoma orthologue is a major regulator of S-phase, mitotic, and developmental gene expression in Dictyostelium. PLoS One 2012;7:e39914. [PMID: 22768168 DOI: 10.1371/journal.pone.0039914] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 0.9] [Reference Citation Analysis]
554 Chiariello M, Gomez E, Gutkind JS. Regulation of cyclin-dependent kinase (Cdk) 2 Thr-160 phosphorylation and activity by mitogen-activated protein kinase in late G1 phase. Biochem J. 2000;349:869-876. [PMID: 10903150 DOI: 10.1042/bj3490869] [Cited by in Crossref: 27] [Cited by in F6Publishing: 30] [Article Influence: 1.3] [Reference Citation Analysis]
555 Zhou JX, Niehans GA, Shar A, Rubins JB, Frizelle SP, Kratzke RA. Mechanisms of G1 checkpoint loss in resected early stage non-small cell lung cancer. Lung Cancer. 2001;32:27-38. [PMID: 11282426 DOI: 10.1016/S0169-5002(00)00210-5] [Cited by in Crossref: 16] [Cited by in F6Publishing: 12] [Article Influence: 0.8] [Reference Citation Analysis]
556 Kawano T, Horiguchi-Yamada J, Saito S, Iwase S, Furukawa Y, Kano Y, Yamada H. Ectopic cyclin D1 expression blocks STI571-induced erythroid differentiation of K562 cells. Leuk Res. 2004;28:623-629. [PMID: 15120940 DOI: 10.1016/j.leukres.2003.10.022] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 0.7] [Reference Citation Analysis]
557 Pajic A, Spitkovsky D, Christoph B, Kempkes B, Schuhmacher M, Staege MS, Brielmeier M, Ellwart J, Kohlhuber F, Bornkamm GW. Cell cycle activation by c-myc in a burkitt lymphoma model cell line. Int J Cancer. 2000;87:787-793. [PMID: 10956386 DOI: 10.1002/1097-0215(20000915)87:6%3C787::AID-IJC4%3E3.0.CO;2-6] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
558 Fabiani R, Rosignoli P, De Bartolomeo A, Fuccelli R, Morozzi G. Inhibition of Cell Cycle Progression by Hydroxytyrosol Is Associated with Upregulation of Cyclin-Dependent Protein Kinase Inhibitors p21WAF1/Cip1 and p27Kip1 and with Induction of Differentiation in HL60 Cells. The Journal of Nutrition 2008;138:42-8. [DOI: 10.1093/jn/138.1.42] [Cited by in Crossref: 55] [Cited by in F6Publishing: 52] [Article Influence: 3.9] [Reference Citation Analysis]
559 N B, K R C. Tetrandrine and cancer - An overview on the molecular approach. Biomed Pharmacother 2018;97:624-32. [PMID: 29101806 DOI: 10.1016/j.biopha.2017.10.116] [Cited by in Crossref: 44] [Cited by in F6Publishing: 41] [Article Influence: 8.8] [Reference Citation Analysis]
560 Alagbala AA, Johnson CS, Trump DL, Posner GH, Foster BA. Antitumor effects of two less-calcemic vitamin D analogs (Paricalcitol and QW-1624F2-2) in squamous cell carcinoma cells. Oncology 2006;70:483-92. [PMID: 17237623 DOI: 10.1159/000098813] [Cited by in Crossref: 15] [Cited by in F6Publishing: 13] [Article Influence: 1.0] [Reference Citation Analysis]
561 Cheng M, Olivier P, Diehl JA, Fero M, Roussel MF, Roberts JM, Sherr CJ. The p21(Cip1) and p27(Kip1) CDK 'inhibitors' are essential activators of cyclin D-dependent kinases in murine fibroblasts. EMBO J 1999;18:1571-83. [PMID: 10075928 DOI: 10.1093/emboj/18.6.1571] [Cited by in Crossref: 787] [Cited by in F6Publishing: 760] [Article Influence: 34.2] [Reference Citation Analysis]
562 Zhang S, Cai M, Zhang S, Xu S, Chen S, Chen X, Chen C, Gu J. Interaction of p58PITSLRE, a G2/M-specific Protein Kinase, with Cyclin D3. Journal of Biological Chemistry 2002;277:35314-22. [DOI: 10.1074/jbc.m202179200] [Cited by in Crossref: 67] [Cited by in F6Publishing: 26] [Article Influence: 3.4] [Reference Citation Analysis]
563 Shariat SF, Tokunaga H, Zhou J, Kim J, Ayala GE, Benedict WF, Lerner SP. p53, p21, pRB, and p16 Expression Predict Clinical Outcome in Cystectomy With Bladder Cancer. JCO 2004;22:1014-24. [DOI: 10.1200/jco.2004.03.118] [Cited by in Crossref: 232] [Cited by in F6Publishing: 63] [Article Influence: 12.9] [Reference Citation Analysis]
564 Sunil P, Ramachandran C, Gokul S, Jaisanghar N. Fluorescence in-situ hybridization technique as a diagnostic and prognostic tool in oral squamous cell carcinoma. J Oral Maxillofac Pathol 2013;17:61-4. [PMID: 23798832 DOI: 10.4103/0973-029X.110731] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
565 Elmeliegy M, Den Haese J, Talati C, Wetzler M, Jusko WJ. Towards better combination regimens of cytarabine and FLT3 inhibitors in acute myeloid leukemia. Cancer Chemother Pharmacol 2020;86:325-37. [PMID: 32748108 DOI: 10.1007/s00280-020-04114-z] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
566 Cui H, Bulleit RF. Expression of the POU Transcription Factor Brn-5 Inhibits Proliferation of NG108-15 Cells. Biochemical and Biophysical Research Communications 1997;236:693-6. [DOI: 10.1006/bbrc.1997.6996] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 0.3] [Reference Citation Analysis]
567 Denault J, Salvesen GS. Caspases. Current Protocols in Protein Science 2001;26. [DOI: 10.1002/0471140864.ps2108s26] [Cited by in Crossref: 3] [Cited by in F6Publishing: 6] [Article Influence: 0.1] [Reference Citation Analysis]
568 Shao J, Jung C, Liu C, Sheng H. Prostaglandin E2 Stimulates the beta-catenin/T cell factor-dependent transcription in colon cancer. J Biol Chem. 2005;280:26565-26572. [PMID: 15899904 DOI: 10.1074/jbc.m413056200] [Cited by in Crossref: 169] [Cited by in F6Publishing: 85] [Article Influence: 9.9] [Reference Citation Analysis]
569 Bowen C, Birrer M, Gelmann EP. Retinoblastoma Protein-mediated Apoptosis After γ-Irradiation. Journal of Biological Chemistry 2002;277:44969-79. [DOI: 10.1074/jbc.m202000200] [Cited by in Crossref: 34] [Cited by in F6Publishing: 11] [Article Influence: 1.7] [Reference Citation Analysis]
570 Rozpędek W, Pytel D, Nowak-Zduńczyk A, Lewko D, Wojtczak R, Diehl JA, Majsterek I. Breaking the DNA Damage Response via Serine/Threonine Kinase Inhibitors to Improve Cancer Treatment. Curr Med Chem 2019;26:1425-45. [PMID: 29345572 DOI: 10.2174/0929867325666180117102233] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
571 Schmid RM. Genetic basis of pancreatic cancer. Best Pract Res Clin Gastroenterol. 2002;16:421-433. [PMID: 12079267 DOI: 10.1053/bega.2002.0316] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 0.7] [Reference Citation Analysis]
572 Gorecki L, Andrs M, Korabecny J. Clinical Candidates Targeting the ATR-CHK1-WEE1 Axis in Cancer. Cancers (Basel) 2021;13:795. [PMID: 33672884 DOI: 10.3390/cancers13040795] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 5.0] [Reference Citation Analysis]
573 Arata Y, Fujita M, Ohtani K, Kijima S, Kato J. Cdk2-dependent and -independent Pathways in E2F-mediated S Phase Induction. Journal of Biological Chemistry 2000;275:6337-45. [DOI: 10.1074/jbc.275.9.6337] [Cited by in Crossref: 64] [Cited by in F6Publishing: 58] [Article Influence: 2.9] [Reference Citation Analysis]
574 Tong W, Pollard JW. Genetic evidence for the interactions of cyclin D1 and p27(Kip1) in mice. Mol Cell Biol 2001;21:1319-28. [PMID: 11158317 DOI: 10.1128/MCB.21.4.1319-1328.2001] [Cited by in Crossref: 60] [Cited by in F6Publishing: 22] [Article Influence: 2.9] [Reference Citation Analysis]
575 Rane SG, Dubus P, Mettus RV, Galbreath EJ, Boden G, Reddy EP, Barbacid M. Loss of Cdk4 expression causes insulin-deficient diabetes and Cdk4 activation results in beta-islet cell hyperplasia. Nat Genet 1999;22:44-52. [PMID: 10319860 DOI: 10.1038/8751] [Cited by in Crossref: 516] [Cited by in F6Publishing: 481] [Article Influence: 22.4] [Reference Citation Analysis]
576 Ou L, Ferreira AM, Otieno S, Xiao L, Bashford D, Kriwacki RW. Incomplete folding upon binding mediates Cdk4/cyclin D complex activation by tyrosine phosphorylation of inhibitor p27 protein. J Biol Chem 2011;286:30142-51. [PMID: 21715330 DOI: 10.1074/jbc.M111.244095] [Cited by in Crossref: 29] [Cited by in F6Publishing: 21] [Article Influence: 2.6] [Reference Citation Analysis]
577 Schuppler U, He PH, John PC, Munns R. Effect of water stress on cell division and cell-division-cycle 2-like cell-cycle kinase activity in wheat leaves. Plant Physiol 1998;117:667-78. [PMID: 9625720 DOI: 10.1104/pp.117.2.667] [Cited by in Crossref: 139] [Cited by in F6Publishing: 98] [Article Influence: 5.8] [Reference Citation Analysis]
578 Wang L, Wang Z, Gao X, Li X, Sun X, Liu C. Association between Cyclin D1 polymorphism and oral cancer susceptibility: a meta-analysis. Tumor Biol 2014;35:1149-55. [DOI: 10.1007/s13277-013-1154-8] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.6] [Reference Citation Analysis]
579 Zhao L, Li YY, Li CW, Chao SS, Liu J, Nam HN, Dung NTN, Shi L, Wang DY. Increase of poorly proliferated p63+ /Ki67+ basal cells forming multiple layers in the aberrant remodeled epithelium in nasal polyps. Allergy 2017;72:975-84. [PMID: 27807867 DOI: 10.1111/all.13074] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 2.5] [Reference Citation Analysis]
580 Jirström K, Ringberg A, Fernö M, Anagnostaki L, Landberg G. Tissue microarray analyses of G1/S-regulatory proteins in ductal carcinoma in situ of the breast indicate that low cyclin D1 is associated with local recurrence. Br J Cancer. 2003;89:1920-1926. [PMID: 14612904 DOI: 10.1038/sj.bjc.6601398] [Cited by in Crossref: 29] [Cited by in F6Publishing: 26] [Article Influence: 1.6] [Reference Citation Analysis]
581 Tannoch VJ, Hinds PW, Tsai LH. Cell cycle control. Adv Exp Med Biol. 2000;465:127-140. [PMID: 10810621 DOI: 10.1007/0-306-46817-4_12] [Cited by in Crossref: 21] [Cited by in F6Publishing: 20] [Article Influence: 1.0] [Reference Citation Analysis]
582 Yang J, Zhang G, Chen J. CCND1 G870A polymorphism is associated with increased risk of colorectal cancer, especially for sporadic colorectal cancer and in Caucasians: A meta-analysis. Clinics and Research in Hepatology and Gastroenterology 2012;36:169-77. [DOI: 10.1016/j.clinre.2011.11.007] [Cited by in Crossref: 10] [Cited by in F6Publishing: 12] [Article Influence: 1.0] [Reference Citation Analysis]
583 Zhang H, Liu J, Li G, Wei J, Chen H, Zhang C, Zhao J, Wang Y, Dang S, Li X, Fang X, Liu L, Liu M. Fresh red raspberry phytochemicals suppress the growth of hepatocellular carcinoma cells by PTEN/AKT pathway. Int J Biochem Cell Biol 2018;104:55-65. [PMID: 30195065 DOI: 10.1016/j.biocel.2018.09.003] [Cited by in Crossref: 11] [Cited by in F6Publishing: 8] [Article Influence: 2.8] [Reference Citation Analysis]
584 Jin Z, Qing K, Ouyang Y, Liu Z, Wang W, Li X, Xu Z, Li J. Low dose of lenalidmide and PI3K/mTOR inhibitor trigger synergistic cytoxicity in activated B cell-like subtype of diffuse large B cell lymphoma. J Exp Clin Cancer Res 2016;35:52. [PMID: 27009084 DOI: 10.1186/s13046-016-0327-x] [Cited by in Crossref: 14] [Cited by in F6Publishing: 12] [Article Influence: 2.3] [Reference Citation Analysis]
585 Jarnagin WR, Klimstra DS, Hezel M, Gonen M, Fong Y, Roggin K, Cymes K, DeMatteo RP, D’Angelica M, Blumgart LH. Differential cell cycle-regulatory protein expression in biliary tract adenocarcinoma: correlation with anatomic site, pathologic variables, and clinical outcome. J Clin Oncol. 2006;24:1152-1160. [PMID: 16505435 DOI: 10.1200/jco.2005.04.6631] [Cited by in Crossref: 64] [Cited by in F6Publishing: 32] [Article Influence: 4.0] [Reference Citation Analysis]
586 Thosani N, Dasari CS, Bhutani MS, Raimondo M, Guha S. Molecular pathogenesis of intraductal papillary mucinous neoplasms of the pancreas. Pancreas 2010;39:1129-33. [PMID: 20881900 DOI: 10.1097/MPA.0b013e3181f66cdf] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
587 Egger JV, Lane MV, Antonucci LA, Dedi B, Krucher NA. Dephosphorylation of the Retinoblastoma protein (Rb) inhibits cancer cell EMT via Zeb. Cancer Biol Ther 2016;17:1197-205. [PMID: 27645778 DOI: 10.1080/15384047.2016.1235668] [Cited by in Crossref: 10] [Cited by in F6Publishing: 13] [Article Influence: 1.7] [Reference Citation Analysis]
588 Rosenwald IB. The role of translation in neoplastic transformation from a pathologist's point of view. Oncogene. 2004;23:3230-3247. [PMID: 15094773 DOI: 10.1038/sj.onc.1207552] [Cited by in Crossref: 81] [Cited by in F6Publishing: 76] [Article Influence: 4.5] [Reference Citation Analysis]
589 Kawada N, Seki S, Inoue M, Kuroki T. Effect of antioxidants, resveratrol, quercetin, and N-acetylcysteine, on the functions of cultured rat hepatic stellate cells and Kupffer cells. Hepatology. 1998;27:1265-1274. [PMID: 9581680 DOI: 10.1002/hep.510270512] [Cited by in Crossref: 282] [Cited by in F6Publishing: 273] [Article Influence: 11.8] [Reference Citation Analysis]
590 Xu Z, Zeng X, Xu J, Xu D, Li J, Jin H, Jiang G, Han X, Huang C. Isorhapontigenin suppresses growth of patient-derived glioblastoma spheres through regulating miR-145/SOX2/cyclin D1 axis. Neuro Oncol 2016;18:830-9. [PMID: 26681767 DOI: 10.1093/neuonc/nov298] [Cited by in Crossref: 21] [Cited by in F6Publishing: 22] [Article Influence: 3.0] [Reference Citation Analysis]
591 Daniel DC. Highlight: BRCA1 and BRCA2 proteins in breast cancer. Microsc Res Tech 2002;59:68-83. [PMID: 12242698 DOI: 10.1002/jemt.10178] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.3] [Reference Citation Analysis]
592 Neurauter CG, Luna L, Bjørås M. Release from quiescence stimulates the expression of human NEIL3 under the control of the Ras dependent ERK-MAP kinase pathway. DNA Repair (Amst) 2012;11:401-9. [PMID: 22365498 DOI: 10.1016/j.dnarep.2012.01.007] [Cited by in Crossref: 35] [Cited by in F6Publishing: 36] [Article Influence: 3.5] [Reference Citation Analysis]
593 Jia ZM, Liu Y, Cui SY. Lack of association between cyclin-dependent kinase inhibitor 1B rs2066827 polymorphism and breast cancer susceptibility. Tumour Biol 2014;35:5527-31. [PMID: 24523023 DOI: 10.1007/s13277-014-1727-1] [Cited by in Crossref: 3] [Article Influence: 0.4] [Reference Citation Analysis]
594 Katayama T, Sekimizu K. Inactivation of Escherichia coli DnaA protein by DNA polymerase III and negative regulations for initiation of chromosomal replication. Biochimie 1999;81:835-40. [PMID: 10572296 DOI: 10.1016/s0300-9084(99)00213-8] [Cited by in Crossref: 26] [Cited by in F6Publishing: 15] [Article Influence: 1.2] [Reference Citation Analysis]
595 Kawada N, Ikeda K, Seki S, Kuroki T. Expression of cyclins D1, D2 and E correlates with proliferation of rat stellate cells in culture. J Hepatol. 1999;30:1057-1064. [PMID: 10406184 DOI: 10.1016/s0168-8278(99)80260-8] [Cited by in Crossref: 31] [Cited by in F6Publishing: 11] [Article Influence: 1.3] [Reference Citation Analysis]
596 Anderson M, Beattie JF, Breault GA, Breed J, Byth KF, Culshaw JD, Ellston RP, Green S, Minshull CA, Norman RA, Pauptit RA, Stanway J, Thomas AP, Jewsbury PJ. Imidazo[1,2-a]pyridines: A potent and selective class of cyclin-Dependent kinase inhibitors identified through structure-Based hybridisation. Bioorganic & Medicinal Chemistry Letters 2003;13:3021-6. [DOI: 10.1016/s0960-894x(03)00638-3] [Cited by in Crossref: 90] [Cited by in F6Publishing: 7] [Article Influence: 4.7] [Reference Citation Analysis]
597 Deng W, Jiang X, Mei Y, Sun J, Ma R, Liu X, Sun H, Tian H, Sun X. Role of ornithine decarboxylase in breast cancer. Acta Biochim Biophys Sin (Shanghai) 2008;40:235-43. [PMID: 18330478 DOI: 10.1111/j.1745-7270.2008.00397.x] [Cited by in Crossref: 20] [Cited by in F6Publishing: 20] [Article Influence: 1.4] [Reference Citation Analysis]
598 Tong B, Grimes HL, Yang TY, Bear SE, Qin Z, Du K, El-Deiry WS, Tsichlis PN. The Gfi-1B proto-oncoprotein represses p21WAF1 and inhibits myeloid cell differentiation. Mol Cell Biol 1998;18:2462-73. [PMID: 9566867 DOI: 10.1128/MCB.18.5.2462] [Cited by in Crossref: 88] [Cited by in F6Publishing: 46] [Article Influence: 3.7] [Reference Citation Analysis]
599 Marchetti F, Sayle KL, Bentley J, Clegg W, Curtin NJ, Endicott JA, Golding BT, Griffin RJ, Haggerty K, Harrington RW, Mesguiche V, Newell DR, Noble ME, Parsons RJ, Pratt DJ, Wang LZ, Hardcastle IR. Structure-based design of 2-arylamino-4-cyclohexylmethoxy-5-nitroso-6-aminopyrimidine inhibitors of cyclin-dependent kinase 2. Org Biomol Chem 2007;5:1577-85. [PMID: 17571187 DOI: 10.1039/b703241b] [Cited by in Crossref: 14] [Cited by in F6Publishing: 11] [Article Influence: 0.9] [Reference Citation Analysis]
600 Shintani S, Mihara M, Nakahara Y, Kiyota A, Ueyama Y, Matsumura T, Wong DT. Expression of cell cycle control proteins in normal epithelium, premalignant and malignant lesions of oral cavity. Oral Oncology 2002;38:235-43. [DOI: 10.1016/s1368-8375(01)00048-3] [Cited by in Crossref: 63] [Cited by in F6Publishing: 18] [Article Influence: 3.2] [Reference Citation Analysis]
601 Jameson JL. Oncogenes and Tumor Suppressor Genes. In: Jameson JL, editor. Principles of Molecular Medicine. Totowa: Humana Press; 1998. pp. 73-82. [DOI: 10.1007/978-1-59259-726-0_7] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
602 Blagosklonny MV, Darzynkiewicz Z. Strategies of Protection of Normal Cells During Chemo- and Radio-Therapy Based on Modulation of Cell Cycle and Apoptotic Pathways. In: Los M, Gibson SB, editors. Apoptotic Pathways as Targets for Novel Therapies in Cancer and Other Diseases. New York: Springer-Verlag; 2005. pp. 357-76. [DOI: 10.1007/0-387-23695-3_17] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
603 Knudsen ES, Pruitt SC, Hershberger PA, Witkiewicz AK, Goodrich DW. Cell Cycle and Beyond: Exploiting New RB1 Controlled Mechanisms for Cancer Therapy. Trends Cancer 2019;5:308-24. [PMID: 31174843 DOI: 10.1016/j.trecan.2019.03.005] [Cited by in Crossref: 43] [Cited by in F6Publishing: 35] [Article Influence: 14.3] [Reference Citation Analysis]
604 Coutts M, Zou X, Calame K. v-Abl utilizes multiple mechanisms to drive G1/S progression in fibroblasts. Oncogene 2000;19:801-9. [DOI: 10.1038/sj.onc.1203398] [Cited by in Crossref: 4] [Cited by in F6Publishing: 6] [Article Influence: 0.2] [Reference Citation Analysis]
605 Parry D, Mahony D, Wills K, Lees E. Cyclin D-CDK subunit arrangement is dependent on the availability of competing INK4 and p21 class inhibitors. Mol Cell Biol 1999;19:1775-83. [PMID: 10022865 DOI: 10.1128/MCB.19.3.1775] [Cited by in Crossref: 118] [Cited by in F6Publishing: 54] [Article Influence: 5.1] [Reference Citation Analysis]
606 Baudry D, Faussillon M, Cabanis MO, Rigolet M, Zucker JM, Patte C, Sarnacki S, Boccon-Gibod L, Junien C, Jeanpierre C. Changes in WT1 splicing are associated with a specific gene expression profile in Wilms' tumour. Oncogene 2002;21:5566-73. [PMID: 12165855 DOI: 10.1038/sj.onc.1205752] [Cited by in Crossref: 17] [Cited by in F6Publishing: 17] [Article Influence: 0.9] [Reference Citation Analysis]
607 Xu XM, Ni XB, Yang GL, Luo ZG, Niu YM, Shen M. CCND1 G870A polymorphism and colorectal cancer risk: An updated meta-analysis. Mol Clin Oncol 2016;4:1078-84. [PMID: 27284448 DOI: 10.3892/mco.2016.844] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 1.2] [Reference Citation Analysis]
608 Choi CS, Choi G, Jung KY, Choi JO, Chae YS. Low expression of p27Kip1 in advanced mucoepidermoid carcinomas of head and neck. Head Neck 2001;23:292-7. [DOI: 10.1002/hed.1033] [Cited by in Crossref: 11] [Cited by in F6Publishing: 8] [Article Influence: 0.5] [Reference Citation Analysis]
609 Kook S, Lee J. Tensile force inhibits the proliferation of human periodontal ligament fibroblasts through Ras-p38 MAPK up-regulation. J Cell Physiol 2012;227:1098-106. [DOI: 10.1002/jcp.22829] [Cited by in Crossref: 22] [Cited by in F6Publishing: 21] [Article Influence: 2.0] [Reference Citation Analysis]
610 Lee J, Choi H, Kim KH, Jeong S, Park JW, Baek CS, Lee SH. Synthesis and biological evaluation of 3,5-diaminoindazoles as cyclin-dependent kinase inhibitors. Bioorg Med Chem Lett 2008;18:2292-5. [PMID: 18353638 DOI: 10.1016/j.bmcl.2008.03.002] [Cited by in Crossref: 26] [Cited by in F6Publishing: 20] [Article Influence: 1.9] [Reference Citation Analysis]
611 Dannenberg JH, Schuijff L, Dekker M, van der Valk M, te Riele H. Tissue-specific tumor suppressor activity of retinoblastoma gene homologs p107 and p130. Genes Dev 2004;18:2952-62. [PMID: 15574596 DOI: 10.1101/gad.322004] [Cited by in Crossref: 92] [Cited by in F6Publishing: 91] [Article Influence: 5.4] [Reference Citation Analysis]
612 Jude CD, Gaudet JJ, Speck NA, Ernst P. Leukemia and hematopoietic stem cells: balancing proliferation and quiescence. Cell Cycle 2008;7:586-91. [PMID: 18239455 DOI: 10.4161/cc.7.5.5549] [Cited by in Crossref: 39] [Cited by in F6Publishing: 37] [Article Influence: 2.8] [Reference Citation Analysis]
613 Said TK, Medina D. Interaction of retinoblastoma protein and D cyclins during cell-growth inhibition by hexamethylenebisacetamide in TM2H mouse epithelial cells. Mol Carcinog 1998;22:128-43. [DOI: 10.1002/(sici)1098-2744(199806)22:2<128::aid-mc8>3.0.co;2-i] [Cited by in Crossref: 1] [Article Influence: 0.0] [Reference Citation Analysis]
614 Machen S, Prayson RA. Cyclin D1 and MIB-1 immunohistochemistry in pilocytic astrocytomas: A study of 48 cases. Human Pathology 1998;29:1511-6. [DOI: 10.1016/s0046-8177(98)90023-5] [Cited by in Crossref: 18] [Cited by in F6Publishing: 9] [Article Influence: 0.8] [Reference Citation Analysis]
615 Souza RF. Molecular and biologic basis of upper gastrointestinal malignancy--esophageal carcinoma. Surg Oncol Clin N Am 2002;11:257-72, viii. [PMID: 12424849 DOI: 10.1016/s1055-3207(02)00003-0] [Cited by in Crossref: 20] [Cited by in F6Publishing: 13] [Article Influence: 1.1] [Reference Citation Analysis]
616 Alcázar JA, Polo JR, Tardío JC, Anguita J, Martínez-Montero JC, Jofré R, García-Criado FJ, Menárguez J. Comparative study of the expression of proteins involved in the cell cycle in renal secondary hyperparathyroidism. Kidney Int Suppl 2003;:S28-31. [PMID: 12753261 DOI: 10.1046/j.1523-1755.63.s85.8.x] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.1] [Reference Citation Analysis]
617 Viñals F, Chambard JC, Pouysségur J. p70 S6 Kinase-mediated Protein Synthesis Is a Critical Step for Vascular Endothelial Cell Proliferation. Journal of Biological Chemistry 1999;274:26776-82. [DOI: 10.1074/jbc.274.38.26776] [Cited by in Crossref: 124] [Cited by in F6Publishing: 113] [Article Influence: 5.4] [Reference Citation Analysis]
618 Lee HJ, Kwon HK, Kim HS, Kim MI, Park HJ. Hair Growth Promoting Effect of 4HGF Encapsulated with PGA Nanoparticles (PGA-4HGF) by β-Catenin Activation and Its Related Cell Cycle Molecules. Int J Mol Sci 2019;20:E3447. [PMID: 31337050 DOI: 10.3390/ijms20143447] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.7] [Reference Citation Analysis]
619 Kipreos ET, van den Heuvel S. Developmental Control of the Cell Cycle: Insights from Caenorhabditis elegans. Genetics 2019;211:797-829. [PMID: 30846544 DOI: 10.1534/genetics.118.301643] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 4.0] [Reference Citation Analysis]
620 Moroni MC, Hickman ES, Lazzerini Denchi E, Caprara G, Colli E, Cecconi F, Müller H, Helin K. Apaf-1 is a transcriptional target for E2F and p53. Nat Cell Biol 2001;3:552-8. [PMID: 11389439 DOI: 10.1038/35078527] [Cited by in Crossref: 393] [Cited by in F6Publishing: 383] [Article Influence: 18.7] [Reference Citation Analysis]
621 Chen YW, Huang SC, Lin-Shiau SY, Lin JK. Bowman-Birk inhibitor abates proteasome function and suppresses the proliferation of MCF7 breast cancer cells through accumulation of MAP kinase phosphatase-1. Carcinogenesis. 2005;26:1296-1306. [PMID: 15746161 DOI: 10.1093/carcin/bgi062] [Cited by in Crossref: 71] [Cited by in F6Publishing: 64] [Article Influence: 4.2] [Reference Citation Analysis]
622 Yu L, Ye F, Li YY, Zhan YZ, Liu Y, Yan HM, Fang Y, Xie YW, Zhang FJ, Chen LH, Ding Y, Chen KL. Histone methyltransferase SETDB1 promotes colorectal cancer proliferation through the STAT1-CCND1/CDK6 axis. Carcinogenesis 2020;41:678-88. [PMID: 31306481 DOI: 10.1093/carcin/bgz131] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 6.0] [Reference Citation Analysis]
623 Song L, Li Y, He B, Gong Y. Development of Small Molecules Targeting the Wnt Signaling Pathway in Cancer Stem Cells for the Treatment of Colorectal Cancer. Clin Colorectal Cancer. 2015;14:133-145. [PMID: 25799881 DOI: 10.1016/j.clcc.2015.02.001] [Cited by in Crossref: 26] [Cited by in F6Publishing: 29] [Article Influence: 3.7] [Reference Citation Analysis]
624 Richter H, Slezak P, Walch A, Werner M, Braselmann H, Jaramillo E, Ost A, Hirata I, Takahama K, Zitzelsberger H. Distinct chromosomal imbalances in nonpolypoid and polypoid colorectal adenomas indicate different genetic pathways in the development of colorectal neoplasms. Am J Pathol. 2003;163:287-294. [PMID: 12819033 DOI: 10.1016/s0002-9440(10)63652-8] [Cited by in Crossref: 33] [Cited by in F6Publishing: 15] [Article Influence: 1.7] [Reference Citation Analysis]
625 Zhang QX, Gao R, Xiang J, Yuan ZY, Qian YM, Yan M, Wang ZF, Liu Q, Zhao HD, Liu CH. Cell cycle protein Bora serves as a novel poor prognostic factor in multiple adenocarcinomas. Oncotarget 2017;8:43838-52. [PMID: 28402276 DOI: 10.18632/oncotarget.16631] [Cited by in Crossref: 4] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
626 Yao M, Song DH, Rana B, Wolfe MM. COX-2 selective inhibition reverses the trophic properties of gastrin in colorectal cancer. Br J Cancer 2002;87:574-9. [PMID: 12189559 DOI: 10.1038/sj.bjc.6600495] [Cited by in Crossref: 26] [Cited by in F6Publishing: 26] [Article Influence: 1.3] [Reference Citation Analysis]
627 Knight-Krajewski S, Welsh CF, Liu Y, Lyons LS, Faysal JM, Yang ES, Burnstein KL. Deregulation of the Rho GTPase, Rac1, suppresses cyclin-dependent kinase inhibitor p21(CIP1) levels in androgen-independent human prostate cancer cells. Oncogene 2004;23:5513-22. [PMID: 15077174 DOI: 10.1038/sj.onc.1207708] [Cited by in Crossref: 31] [Cited by in F6Publishing: 29] [Article Influence: 1.7] [Reference Citation Analysis]
628 Villeneuve JB, Silverman MB, Alderete B, Cliby WA, Li H, Croghan GA, Podratz KC, Jenkins RB. Loss of markers linked toBRCA1 precedes loss at important cell cycle regulatory genes in epithelial ovarian cancer. Genes Chromosom Cancer 1999;25:65-9. [DOI: 10.1002/(sici)1098-2264(199905)25:1<65::aid-gcc10>3.0.co;2-f] [Cited by in Crossref: 5] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
629 Li Z, Zhang W, Xing F. Graphene Optical Biosensors. Int J Mol Sci 2019;20:E2461. [PMID: 31109057 DOI: 10.3390/ijms20102461] [Cited by in Crossref: 25] [Cited by in F6Publishing: 15] [Article Influence: 8.3] [Reference Citation Analysis]
630 Kwon H, Lee J, Lee J, Cho W, Gu MJ, Lee KJ, Ma JY. Cinnamon and its Components Suppress Vascular Smooth Muscle Cell Proliferation by Up-Regulating Cyclin-Dependent Kinase Inhibitors. Am J Chin Med 2015;43:621-36. [DOI: 10.1142/s0192415x1550038x] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
631 Vairo G, Soos TJ, Upton TM, Zalvide J, DeCaprio JA, Ewen ME, Koff A, Adams JM. Bcl-2 retards cell cycle entry through p27(Kip1), pRB relative p130, and altered E2F regulation. Mol Cell Biol. 2000;20:4745-4753. [PMID: 10848600 DOI: 10.1128/mcb.20.13.4745-4753.2000] [Cited by in Crossref: 90] [Cited by in F6Publishing: 40] [Article Influence: 4.1] [Reference Citation Analysis]
632 Carlberg AL, Pucci B, Rallapalli R, Tuan RS, Hall DJ. Efficient chondrogenic differentiation of mesenchymal cells in micromass culture by retroviral gene transfer of BMP-2. Differentiation 2001;67:128-38. [DOI: 10.1046/j.1432-0436.2001.670405.x] [Cited by in Crossref: 70] [Cited by in F6Publishing: 65] [Article Influence: 3.3] [Reference Citation Analysis]
633 Wells AD, Walsh MC, Bluestone JA, Turka LA. Signaling through CD28 and CTLA-4 controls two distinct forms of T cell anergy. J Clin Invest. 2001;108:895-903. [PMID: 11560959 DOI: 10.1172/jci13220] [Cited by in Crossref: 92] [Cited by in F6Publishing: 42] [Article Influence: 4.4] [Reference Citation Analysis]
634 Romagnoli S, Fasoli E, Vaira V, Falleni M, Pellegrini C, Catania A, Roncalli M, Marchetti A, Santambrogio L, Coggi G, Bosari S. Identification of potential therapeutic targets in malignant mesothelioma using cell-cycle gene expression analysis. Am J Pathol 2009;174:762-70. [PMID: 19218339 DOI: 10.2353/ajpath.2009.080721] [Cited by in Crossref: 39] [Cited by in F6Publishing: 35] [Article Influence: 3.0] [Reference Citation Analysis]
635 Thomas NA, Abraham RG, Dedi B, Krucher NA. Targeting retinoblastoma protein phosphorylation in combination with EGFR inhibition in pancreatic cancer cells. Int J Oncol 2019;54:527-36. [PMID: 30535494 DOI: 10.3892/ijo.2018.4658] [Cited by in F6Publishing: 4] [Reference Citation Analysis]
636 Kumar BS, Ravi K, Verma AK, Fatima K, Hasanain M, Singh A, Sarkar J, Luqman S, Chanda D, Negi AS. Synthesis of pharmacologically important naphthoquinones and anticancer activity of 2-benzyllawsone through DNA topoisomerase-II inhibition. Bioorganic & Medicinal Chemistry 2017;25:1364-73. [DOI: 10.1016/j.bmc.2016.12.043] [Cited by in Crossref: 21] [Cited by in F6Publishing: 13] [Article Influence: 4.2] [Reference Citation Analysis]
637 Brantley, Jr. MA, Harbour JW. The molecular biology of retinoblastoma. Ocular Immunology and Inflammation 2009;9:1-8. [DOI: 10.1076/ocii.9.1.1.3984] [Cited by in Crossref: 11] [Cited by in F6Publishing: 5] [Article Influence: 0.8] [Reference Citation Analysis]
638 Sekiguchi T, Nishimoto T, Hunter T. Overexpression of D-type cyclins, E2F-1, SV40 large T antigen and HPV16 E7 rescue cell cycle arrest of tsBN462 cells caused by the CCG1/TAF(II)250 mutation. Oncogene 1999;18:1797-806. [PMID: 10086334 DOI: 10.1038/sj.onc.1202508] [Cited by in Crossref: 16] [Cited by in F6Publishing: 17] [Article Influence: 0.7] [Reference Citation Analysis]
639 Gu Y, Belury MA. Selective induction of apoptosis in murine skin carcinoma cells (CH72) by an ethanol extract of Lentinula edodes. Cancer Letters 2005;220:21-8. [DOI: 10.1016/j.canlet.2004.06.037] [Cited by in Crossref: 40] [Cited by in F6Publishing: 30] [Article Influence: 2.4] [Reference Citation Analysis]
640 Khan N, Mukhtar H. Modulation of signaling pathways in prostate cancer by green tea polyphenols. Biochem Pharmacol 2013;85:667-72. [PMID: 23041649 DOI: 10.1016/j.bcp.2012.09.027] [Cited by in Crossref: 43] [Cited by in F6Publishing: 43] [Article Influence: 4.3] [Reference Citation Analysis]
641 Guevara C, Korver W, Mahony D, Parry D, Seghezzi W, Shanahan F, Lees E. Regulation of G1/S transition in mammalian cells. Kidney Int 1999;56:1181-92. [PMID: 10504463 DOI: 10.1046/j.1523-1755.1999.00711.x] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.1] [Reference Citation Analysis]
642 Park SG, Chung C, Kang H, Kim J, Jung G. Up-regulation of Cyclin D1 by HBx Is Mediated by NF-κB2/BCL3 Complex through κB Site of Cyclin D1 Promoter. Journal of Biological Chemistry 2006;281:31770-7. [DOI: 10.1016/s0021-9258(19)84092-9] [Cited by in Crossref: 5] [Article Influence: 0.3] [Reference Citation Analysis]
643 Jones SM, Kazlauskas A. Connecting signaling and cell cycle progression in growth factor-stimulated cells. Oncogene 2000;19:5558-67. [PMID: 11114735 DOI: 10.1038/sj.onc.1203858] [Cited by in Crossref: 41] [Cited by in F6Publishing: 40] [Article Influence: 2.0] [Reference Citation Analysis]
644 Sladek TL. E2F transcription factor action, regulation and possible role in human cancer. Cell Prolif 1997;30:97-105. [PMID: 9375022 [PMID: 9375022 DOI: 10.1046/j.1365-2184.1997.00085.x] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
645 Kim H, You S, Farris J, Kong BW, Christman SA, Foster LK, Foster DN. Expression profiles of p53-, p16(INK4a)-, and telomere-regulating genes in replicative senescent primary human, mouse, and chicken fibroblast cells. Exp Cell Res 2002;272:199-208. [PMID: 11777345 DOI: 10.1006/excr.2001.5420] [Cited by in Crossref: 41] [Cited by in F6Publishing: 38] [Article Influence: 2.1] [Reference Citation Analysis]
646 Long J, Zhang Z, Liu Z, Xu Y, Ge C. Identification of genes and pathways associated with pancreatic ductal adenocarcinoma by bioinformatics analyses. Oncol Lett 2016;11:1391-7. [PMID: 26893748 DOI: 10.3892/ol.2015.4042] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 1.4] [Reference Citation Analysis]
647 Crowe DL, Nguyen DC. Rb and E2F-1 regulate telomerase activity in human cancer cells. Biochim Biophys Acta 2001;1518:1-6. [PMID: 11267653 DOI: 10.1016/s0167-4781(00)00296-7] [Cited by in Crossref: 27] [Cited by in F6Publishing: 8] [Article Influence: 1.3] [Reference Citation Analysis]
648 Boward B, Wu T, Dalton S. Concise Review: Control of Cell Fate Through Cell Cycle and Pluripotency Networks. Stem Cells 2016;34:1427-36. [PMID: 26889666 DOI: 10.1002/stem.2345] [Cited by in Crossref: 71] [Cited by in F6Publishing: 64] [Article Influence: 11.8] [Reference Citation Analysis]
649 Tamamori M, Ito H, Hiroe M, Terada Y, Marumo F, Ikeda MA. Essential roles for G1 cyclin-dependent kinase activity in development of cardiomyocyte hypertrophy. Am J Physiol 1998;275:H2036-40. [PMID: 9843802 DOI: 10.1152/ajpheart.1998.275.6.H2036] [Cited by in Crossref: 8] [Cited by in F6Publishing: 17] [Article Influence: 0.3] [Reference Citation Analysis]
650 N'cho M, Brahmi Z. Fas-mediated apoptosis in T cells involves the dephosphorylation of the retinoblastoma protein by type 1 protein phosphatases. Hum Immunol 1999;60:1183-94. [PMID: 10626732 DOI: 10.1016/s0198-8859(99)00125-1] [Cited by in Crossref: 7] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
651 Brukhin V, Morozova N. Plant Growth and Development - Basic Knowledge and Current Views. Math Model Nat Phenom 2011;6:1-53. [DOI: 10.1051/mmnp/20116201] [Cited by in Crossref: 15] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]
652 Tsai WC, Yu TY, Lin LP, Lin MS, Wu YC, Liao CH, Pang JS. Platelet rich plasma releasate promotes proliferation of skeletal muscle cells in association with upregulation of PCNA, cyclins and cyclin dependent kinases. Platelets. 2017;28:491-497. [PMID: 27780401 DOI: 10.1080/09537104.2016.1227061] [Cited by in Crossref: 18] [Cited by in F6Publishing: 21] [Article Influence: 3.0] [Reference Citation Analysis]
653 Geldof AA, Plaizier MA, Duivenvoorden I, Ringelberg M, Versteegh RT, Newling DW, Teule GJ. Cell cycle perturbations and radiosensitization effects in a human prostate cancer cell line. J Cancer Res Clin Oncol 2003;129:175-82. [PMID: 12684891 DOI: 10.1007/s00432-002-0412-8] [Cited by in Crossref: 22] [Cited by in F6Publishing: 20] [Article Influence: 1.2] [Reference Citation Analysis]
654 Aldoss IT, Tashi T, Ganti AK. Seliciclib in malignancies. Expert Opin Investig Drugs 2009;18:1957-65. [PMID: 19938906 DOI: 10.1517/13543780903418445] [Cited by in Crossref: 40] [Cited by in F6Publishing: 38] [Article Influence: 3.3] [Reference Citation Analysis]
655 Xu Y, Qu X, Zhang X, Luo Y, Zhang Y, Luo Y, Hou K, Liu Y. Midkine positively regulates the proliferation of human gastric cancer cells. Cancer Lett 2009;279:137-44. [PMID: 19250738 DOI: 10.1016/j.canlet.2009.01.024] [Cited by in Crossref: 25] [Cited by in F6Publishing: 24] [Article Influence: 1.9] [Reference Citation Analysis]
656 Yu B, Lane ME, Pestell RG, Albanese C, Wadler S. Downregulation of cyclin D1 alters cdk 4- and cdk 2-specific phosphorylation of retinoblastoma protein. Mol Cell Biol Res Commun 2000;3:352-9. [PMID: 11032757 DOI: 10.1006/mcbr.2000.0238] [Cited by in Crossref: 26] [Cited by in F6Publishing: 27] [Article Influence: 1.2] [Reference Citation Analysis]
657 Moriuchi A, Hirono S, Ido A, Ochiai T, Nakama T, Uto H, Hori T, Hayashi K, Tsubouchi H. Additive and inhibitory effects of simultaneous treatment with growth factors on DNA synthesis through MAPK pathway and G1 cyclins in rat hepatocytes. Biochem Biophys Res Commun. 2001;280:368-373. [PMID: 11162525 DOI: 10.1006/bbrc.2000.4063] [Cited by in Crossref: 30] [Cited by in F6Publishing: 26] [Article Influence: 1.4] [Reference Citation Analysis]
658 Mazumder S, Gong B, Almasan A. Cyclin E induction by genotoxic stress leads to apoptosis of hematopoietic cells. Oncogene 2000;19:2828-35. [PMID: 10851086 DOI: 10.1038/sj.onc.1203623] [Cited by in Crossref: 34] [Cited by in F6Publishing: 38] [Article Influence: 1.5] [Reference Citation Analysis]
659 Williams TM, Medina F, Badano I, Hazan RB, Hutchinson J, Muller WJ, Chopra NG, Scherer PE, Pestell RG, Lisanti MP. Caveolin-1 gene disruption promotes mammary tumorigenesis and dramatically enhances lung metastasis in vivo. Role of Cav-1 in cell invasiveness and matrix metalloproteinase (MMP-2/9) secretion. J Biol Chem 2004;279:51630-46. [PMID: 15355971 DOI: 10.1074/jbc.M409214200] [Cited by in Crossref: 219] [Cited by in F6Publishing: 115] [Article Influence: 12.2] [Reference Citation Analysis]
660 Brockes JP. Regeneration and cancer. Biochim Biophys Acta 1998;1377:M1-11. [PMID: 9540808 DOI: 10.1016/s0304-419x(97)00029-2] [Cited by in Crossref: 2] [Cited by in F6Publishing: 10] [Article Influence: 0.1] [Reference Citation Analysis]
661 Wang S, Li Y. Expression of constitutively active cGMP-dependent protein kinase inhibits glucose-induced vascular smooth muscle cell proliferation. Am J Physiol Heart Circ Physiol 2009;297:H2075-83. [PMID: 19717728 DOI: 10.1152/ajpheart.00521.2009] [Cited by in Crossref: 10] [Cited by in F6Publishing: 12] [Article Influence: 0.8] [Reference Citation Analysis]
662 Aaltonen K, Amini RM, Heikkilä P, Aittomäki K, Tamminen A, Nevanlinna H, Blomqvist C. High cyclin B1 expression is associated with poor survival in breast cancer. Br J Cancer 2009;100:1055-60. [PMID: 19293801 DOI: 10.1038/sj.bjc.6604874] [Cited by in Crossref: 75] [Cited by in F6Publishing: 72] [Article Influence: 5.8] [Reference Citation Analysis]
663 Ringnér M, Fredlund E, Häkkinen J, Borg Å, Staaf J. GOBO: gene expression-based outcome for breast cancer online. PLoS One 2011;6:e17911. [PMID: 21445301 DOI: 10.1371/journal.pone.0017911] [Cited by in Crossref: 272] [Cited by in F6Publishing: 257] [Article Influence: 24.7] [Reference Citation Analysis]
664 McCormick F, Wood DA. The role of p53 in virally associated tumors. Trends Microbiol 1997;5:181-2. [PMID: 9160505 DOI: 10.1016/S0966-842X(97)85013-5] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.0] [Reference Citation Analysis]
665 Tsuji T, Miyazaki M, Fushimi K, Mihara K, Inoue Y, Ohashi R, Ohtsubo M, Hamazaki K, Furusako S, Namba M. Cyclin E overexpression responsible for growth of human hepatic tumors with p21WAF1/CIP1/SDI1. Biochem Biophys Res Commun. 1998;242:317-321. [PMID: 9446792 DOI: 10.1006/bbrc.1997.7958] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 0.3] [Reference Citation Analysis]
666 Schulz TF, Chang Y, Moore PS. Kaposi's Sarcoma-Associated Herpesvirus (Human Herpesvirus 8). In: Mccance DJ, editor. Human Tumor Viruses. Washington: ASM Press; 1998. pp. 87-134. [DOI: 10.1128/9781555818289.ch3] [Cited by in Crossref: 18] [Cited by in F6Publishing: 2] [Article Influence: 2.3] [Reference Citation Analysis]
667 Kim H, Jo C, Jang BG, Oh U, Jo SA. Oncostatin M induces growth arrest of skeletal muscle cells in G1 phase by regulating cyclin D1 protein level. Cell Signal 2008;20:120-9. [PMID: 17976956 DOI: 10.1016/j.cellsig.2007.09.004] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 0.9] [Reference Citation Analysis]
668 Cheng J, Imanishi H, Liu W, Nakamura H, Morisaki T, Higashino K, Hada T. Involvement of cell cycle regulatory proteins and MAP kinase signaling pathway in growth inhibition and cell cycle arrest by a selective cyclooxygenase 2 inhibitor, etodolac, in human hepatocellular carcinoma cell lines. Cancer Sci 2004;95:666-73. [PMID: 15298730 DOI: 10.1111/j.1349-7006.2004.tb03327.x] [Cited by in Crossref: 24] [Cited by in F6Publishing: 20] [Article Influence: 1.3] [Reference Citation Analysis]
669 Sauroja I, Smeds J, Vlaykova T, Kumar R, Talve L, Hahka-Kemppinen M, Punnonen K, Jansèn CT, Hemminki K, Pyrhönen S. Analysis of G(1)/S checkpoint regulators in metastatic melanoma. Genes Chromosomes Cancer 2000;28:404-14. [PMID: 10862049 DOI: 10.1002/1098-2264(200008)28:4<404::aid-gcc6>3.0.co;2-p] [Cited by in Crossref: 57] [Cited by in F6Publishing: 24] [Article Influence: 2.6] [Reference Citation Analysis]
670 Zhang R, Wang L, Pan JH, Han J. A critical role of E2F transcription factor 2 in proinflammatory cytokines-dependent proliferation and invasiveness of fibroblast-like synoviocytes in rheumatoid Arthritis. Sci Rep 2018;8:2623. [PMID: 29422529 DOI: 10.1038/s41598-018-20782-7] [Cited by in F6Publishing: 8] [Reference Citation Analysis]
671 Polanowska J, Le Cam L, Orsetti B, Vall�s H, Fabbrizio E, Fajas L, Taviaux S, Theillet C, Sardet C. HumanE2F5 gene is oncogenic in primary rodent cells and is amplified in human breast tumors. Genes Chromosom Cancer 2000;28:126-30. [DOI: 10.1002/(sici)1098-2264(200005)28:1<126::aid-gcc15>3.0.co;2-g] [Cited by in Crossref: 32] [Article Influence: 1.5] [Reference Citation Analysis]
672 Melnick A, Licht JD. Deconstructing a Disease: RAR, Its Fusion Partners, and Their Roles in the Pathogenesis of Acute Promyelocytic Leukemia. Blood 1999;93:3167-215. [DOI: 10.1182/blood.v93.10.3167.410k44_3167_3215] [Cited by in Crossref: 784] [Article Influence: 34.1] [Reference Citation Analysis]
673 Kim YR, Oh KJ, Park RY, Xuan NT, Kang TW, Kwon DD, Choi C, Kim MS, Nam KI, Ahn KY, Jung C. HOXB13 promotes androgen independent growth of LNCaP prostate cancer cells by the activation of E2F signaling. Mol Cancer 2010;9:124. [PMID: 20504375 DOI: 10.1186/1476-4598-9-124] [Cited by in Crossref: 45] [Cited by in F6Publishing: 42] [Article Influence: 3.8] [Reference Citation Analysis]
674 Sousa LO, Sobral LM, de Almeida LO, Garcia CB, Greene LJ, Leopoldino AM. SET protein modulates H4 histone methylation status and regulates miR-137 level in oral squamous cell carcinoma. Epigenomics 2020;12:475-85. [PMID: 32267167 DOI: 10.2217/epi-2019-0181] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
675 Oliveira AM, Nascimento AG, Okuno SH, Lloyd RV. p27 kip1 Protein Expression Correlates With Survival in Myxoid and Round-Cell Liposarcoma. JCO 2000;18:2888-93. [DOI: 10.1200/jco.2000.18.15.2888] [Cited by in Crossref: 24] [Cited by in F6Publishing: 1] [Article Influence: 1.1] [Reference Citation Analysis]
676 Dai M, Mantel CR, Xia Z, Broxmeyer HE, Lu L. An expansion phase precedes terminal erythroid differentiation of hematopoietic progenitor cells from cord blood in vitro and is associated with up-regulation of cyclin E and cyclin-dependent kinase 2. Blood 2000;96:3985-7. [DOI: 10.1182/blood.v96.12.3985] [Cited by in Crossref: 25] [Article Influence: 1.1] [Reference Citation Analysis]
677 Asghar U, Witkiewicz AK, Turner NC, Knudsen ES. The history and future of targeting cyclin-dependent kinases in cancer therapy. Nat Rev Drug Discov 2015;14:130-46. [PMID: 25633797 DOI: 10.1038/nrd4504] [Cited by in Crossref: 805] [Cited by in F6Publishing: 749] [Article Influence: 115.0] [Reference Citation Analysis]
678 Maussang D, Verzijl D, van Walsum M, Leurs R, Holl J, Pleskoff O, Michel D, van Dongen GA, Smit MJ. Human cytomegalovirus-encoded chemokine receptor US28 promotes tumorigenesis. Proc Natl Acad Sci USA. 2006;103:13068-13073. [PMID: 16924106 DOI: 10.1073/pnas.0604433103] [Cited by in Crossref: 158] [Cited by in F6Publishing: 152] [Article Influence: 9.9] [Reference Citation Analysis]
679 Yue Z, Guan X, Chao R, Huang C, Li D, Yang P, Liu S, Hasegawa T, Guo J, Li M. Diallyl Disulfide Induces Apoptosis and Autophagy in Human Osteosarcoma MG-63 Cells through the PI3K/Akt/mTOR Pathway. Molecules 2019;24:E2665. [PMID: 31340526 DOI: 10.3390/molecules24142665] [Cited by in Crossref: 13] [Cited by in F6Publishing: 17] [Article Influence: 4.3] [Reference Citation Analysis]
680 Michalides RJ. Cell cycle regulators: mechanisms and their role in aetiology, prognosis, and treatment of cancer. J Clin Pathol 1999;52:555-68. [PMID: 10645224 DOI: 10.1136/jcp.52.8.555] [Cited by in Crossref: 66] [Cited by in F6Publishing: 62] [Article Influence: 3.0] [Reference Citation Analysis]
681 Wu M, Li X, Li X, Li G. Signaling Transduction Network Mediated by Tumor Suppressor/Susceptibility Genes in NPC. Curr Genomics 2009;10:216-22. [PMID: 19949542 DOI: 10.2174/138920209788488481] [Cited by in Crossref: 21] [Cited by in F6Publishing: 22] [Article Influence: 1.9] [Reference Citation Analysis]
682 Fanton CP, Mcmahon M, Pieper RO. Dual Growth Arrest Pathways in Astrocytes and Astrocytic Tumors in Response to Raf-1 Activation. Journal of Biological Chemistry 2001;276:18871-7. [DOI: 10.1074/jbc.m011514200] [Cited by in Crossref: 40] [Cited by in F6Publishing: 13] [Article Influence: 1.9] [Reference Citation Analysis]
683 Sathyan K, Nalinakumari K, Abraham T, Kannan S. CCND1 polymorphisms (A870G and C1722G) modulate its protein expression and survival in oral carcinoma. Oral Oncology 2008;44:689-97. [DOI: 10.10